FORM N-PX PROXY VOTING RECORD

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 COLUMN 9 COLUMN 10 COLUMN 11 COLUMN 12 COLUMN 13 COLUMN 14 COLUMN 15
NAME   OF   ISSUER
 CUSIP ISIN FIGI MEETING   DATE VOTE   DESCRIPTION VOTE   CATEGORY DESCRIPTION   OF   OTHER  CATEGORY VOTE   SOURCE SHARES   VOTED SHARES   ON   LOAN DETAILS   OF   VOTE MANAGER   NUMBER SERIES   ID OTHER   INFO
HOW   VOTED SHARES  VOTED FOR   OR   AGAINST   MANAGEMENT
Fluent, Inc. 34380C201 US34380C2017 - 07/02/2024 To approve, for purposes of compliance with Nasdaq Listing Rule 3635(d), the exercise of the Company's pre-funded warrants into shares of the Company's common stock; CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 07/02/2024 To approve, for purposes of compliance with Nasdaq Listing Rule 3635(c), the issuance of the Company's pre-funded warrants to certain of the Company's directors and/or officers and employees and to a consultant of the Company, and any shares of the Company's common stock issuable upon exercise thereof; and CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 07/02/2024 To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof. CORPORATE GOVERNANCE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 AGAINST
 565.000000
 AGAINST
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 07/05/2024 Company Proposal - Approval of an Amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan. COMPENSATION
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Anika Therapeutics, Inc. 035255108 US0352551081 - 07/09/2024 Election of three Class I Directors: Sheryl L. Conley DIRECTOR ELECTIONS
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Anika Therapeutics, Inc. 035255108 US0352551081 - 07/09/2024 Election of three Class I Directors: William R. Jellison DIRECTOR ELECTIONS
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Anika Therapeutics, Inc. 035255108 US0352551081 - 07/09/2024 Election of three Class I Directors: Stephen O. Richard DIRECTOR ELECTIONS
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Anika Therapeutics, Inc. 035255108 US0352551081 - 07/09/2024 Ratification of appointment of Deloitte & Touche LLP as Anika's independent auditor for 2024; and AUDIT-RELATED
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Anika Therapeutics, Inc. 035255108 US0352551081 - 07/09/2024 Advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Stephen E. Croskrey DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Richard N. Altice DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: John P. Amboian DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 WITHHOLD
 1055.000000
 AGAINST
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Philip Gregory Calhoun DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 WITHHOLD
 1055.000000
 AGAINST
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Cynthia Cohen DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Richard Hendrix DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Gregory Hunt DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Allison M. Leopold Tilley DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 WITHHOLD
 1055.000000
 AGAINST
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Dr. David Moody DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Dr. Isao Noda DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Election of Directors: Stuart W. Pratt DIRECTOR ELECTIONS
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Approval of the Company's Fifth Amended & Restated Certificate of Incorporation. CAPITAL STRUCTURE
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 07/09/2024 Approval of an amendment to the Company's 2020 Long-Term Incentive Plan. COMPENSATION
 - ISSUER 1055.000000 0 AGAINST
 1055.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Mario J. Gabelli DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Raymond C. Avansino, Jr. DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Leslie B. Daniels DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 FOR
 30.000000
 FOR
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Alexis Glick DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Douglas R. Jamieson DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Agnes Mullady DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Robert S. Prather, Jr. DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Elect Director Elisa M. Wilson DIRECTOR ELECTIONS
 - ISSUER 30.000000 0 WITHHOLD
 30.000000
 AGAINST
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Reduce Authorized Class A Common Stock CAPITAL STRUCTURE
 - ISSUER 30.000000 0 FOR
 30.000000
 FOR
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Reduce Authorized Class B Common Stock CAPITAL STRUCTURE
 - ISSUER 30.000000 0 FOR
 30.000000
 FOR
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Eliminate Class of Preferred Stock CAPITAL STRUCTURE
 - ISSUER 30.000000 0 FOR
 30.000000
 FOR
 - -
GAMCO Investors, Inc. 361438104 US3614381040 - 07/10/2024 Ratify Deloitte & Touche LLP as Auditors AUDIT-RELATED
 - ISSUER 30.000000 0 FOR
 30.000000
 FOR
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Three (3) nominees to serve on our Board of Directors (the "Board"), each for a term of three (3) years or until his or her respective successor is duly elected and qualified. Vote "FOR" up to three (3) nominees in total. If you vote "FOR" less than 3 nominees, your shares will only be voted for those nominees you have marked. If you vote "FOR" more than 3 nominees, your votes on Proposal 1 will become invalid and will not be counted. COMPANY NOMINEES: COMPANY RECOMMENDED NOMINEE: Douglas T. Moore DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Three (3) nominees to serve on our Board of Directors (the "Board"), each for a term of three (3) years or until his or her respective successor is duly elected and qualified. Vote "FOR" up to three (3) nominees in total. If you vote "FOR" less than 3 nominees, your shares will only be voted for those nominees you have marked. If you vote "FOR" more than 3 nominees, your votes on Proposal 1 will become invalid and will not be counted. COMPANY NOMINEES: COMPANY RECOMMENDED NOMINEE: Ashish Parmar DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Three (3) nominees to serve on our Board of Directors (the "Board"), each for a term of three (3) years or until his or her respective successor is duly elected and qualified. Vote "FOR" up to three (3) nominees in total. If you vote "FOR" less than 3 nominees, your shares will only be voted for those nominees you have marked. If you vote "FOR" more than 3 nominees, your votes on Proposal 1 will become invalid and will not be counted. COMPANY NOMINEES: COMPANY RECOMMENDED NOMINEE: Nancy M. Taylor DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 THOMAS SULLIVAN NOMINEES: NOMINEE OPPOSED BY THE COMPANY: John Jason Delves DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 THOMAS SULLIVAN NOMINEES: NOMINEE OPPOSED BY THE COMPANY: Thomas D. Sullivan DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 THOMAS SULLIVAN NOMINEES: NOMINEE OPPOSED BY THE COMPANY: Jill Witter DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 JERALD HAMMANN NOMINEE: NOMINEE OPPOSED BY THE COMPANY: Jerald Hammann DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve a non-binding advisory resolution approving the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve an amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve an amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to increase the number of shares authorized for issuance. CAPITAL STRUCTURE
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 A proposal submitted by Donovan S. Royal, a stockholder of the Company, with respect to enabling stockholders to call special meetings of stockholders as set forth in the proxy statement. CORPORATE GOVERNANCE
 - SECURITY HOLDER 0.000000 0 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Directors for terms ending in 2027: F9 Nominees: John Jason Delves DIRECTOR ELECTIONS
 - SECURITY HOLDER 170.000000 0 FOR
 170.000000
 FOR
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Directors for terms ending in 2027: F9 Nominees: Thomas D. Sullivan DIRECTOR ELECTIONS
 - SECURITY HOLDER 170.000000 0 WITHHOLD
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Election of Directors for terms ending in 2027: F9 Nominees: Jill Witter DIRECTOR ELECTIONS
 - SECURITY HOLDER 170.000000 0 WITHHOLD
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Company Nominees: Douglas T. Moore DIRECTOR ELECTIONS
 - ISSUER 170.000000 0 WITHHOLD
 170.000000
 FOR
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Company Nominees: Ashish Parmar DIRECTOR ELECTIONS
 - ISSUER 170.000000 0 FOR
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Company Nominees: Nancy M. Taylor DIRECTOR ELECTIONS
 - ISSUER 170.000000 0 FOR
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Hammann Nominee: Jerald Hammann DIRECTOR ELECTIONS
 - SECURITY HOLDER 170.000000 0 WITHHOLD
 170.000000
 NONE
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve a non-binding advisory resolution approving the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 170.000000 0 FOR
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve an amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to declassify the Board of Directors SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 170.000000 0 FOR
 170.000000
 FOR
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To approve an amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to increase the number of shares authorized for issuance CAPITAL STRUCTURE
 - ISSUER 170.000000 0 FOR
 170.000000
 AGAINST
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 AUDIT-RELATED
 - ISSUER 170.000000 0 FOR
 170.000000
 FOR
 - -
LL Flooring Holdings, Inc. 55003T107 US55003T1079 - 07/10/2024 Stockholder proposal, if properly presented, to enable stockholders to call special meetings of stockholders CORPORATE GOVERNANCE
 - SECURITY HOLDER 170.000000 0 AGAINST
 170.000000
 NONE
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Ritsaart J.M. van Montfrans DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Brendan S. Jones DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Aviv Hillo DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Jack Levine DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Kristina A. Peterson DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Elect six directors to the Board of Directors of Blink Charging Co. for a one-year term of office expiring at the 2025 Annual Meeting of Stockholders: Cedric L. Richmond DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Approve, on a non-binding advisory basis, the compensation paid to our executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 428.000000 0 AGAINST
 428.000000
 AGAINST
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Approve, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 428.000000 0 ONE YEAR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 07/16/2024 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Hibbett, Inc. 428567101 US4285671016 - 07/19/2024 To adopt the Agreement and Plan of Merger, dated as of April 23, 2024 (the "Merger Agreement"), by and among Hibbett, Inc. ("Hibbett"), Genesis Holdings, Inc., Steps Merger Sub, Inc.,, and, solely for purposes of certain provisions specified within the Merger Agreement, JD Sports Fashion plc, the ultimate parent company of Genesis Holdings, Inc. and Steps Merger Sub, Inc.; EXTRAORDINARY TRANSACTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Hibbett, Inc. 428567101 US4285671016 - 07/19/2024 To approve, by non-binding, advisory vote, the compensation that will or may become payable to Hibbett's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Hibbett, Inc. 428567101 US4285671016 - 07/19/2024 To approve one or more adjournments of the Special Meeting from time to time, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to adopt the Merger Agreement or to seek a quorum if one is not initially obtained. CORPORATE GOVERNANCE
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Gerald G. Colella DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Kathryn V. Roedel DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: David J. Wilson DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Aziz S. Aghili DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Jeanne Beliveau-Dunn DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Michael Dastoor DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Chad R. Abraham DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Rebecca Yeung DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To elect as directors of the Company the 9 persons named in the accompanying Proxy Statement for terms expiring at the 2025 Annual Meeting of Shareholders: Chris J. Stephens, Jr. DIRECTOR ELECTIONS
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025; AUDIT-RELATED
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Columbus McKinnon Corporation 199333105 US1993331057 - 07/22/2024 To approve the Columbus McKinnon Corporation Second Amended and Restated 2016 Long Term Incentive Plan; and COMPENSATION
 - ISSUER 163.000000 0 FOR
 163.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Election of Class C Directors: Lishan Aklog, M.D. DIRECTOR ELECTIONS
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Election of Class C Directors: Debra J. White DIRECTOR ELECTIONS
 - ISSUER 39.000000 0 WITHHOLD
 39.000000
 AGAINST
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Election of Class C Directors: Dennis A. Matheis DIRECTOR ELECTIONS
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock under the Series B Convertible Preferred Stock sold by the Company in a private offering in March 2024 and under the Series B-1 Convertible Preferred Stock sold by the Company in a private offering in May 2024. CAPITAL STRUCTURE
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Approval of an amendment to the Company's certificate of incorporation to increase the total number of shares of common stock the Company's authorized to issue by 100,000,000 shares, from 200,000,000 shares to 300,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 07/23/2024 Ratification of the appointment of the independent registered certified public accounting firm. AUDIT-RELATED
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Richard T. Carucci DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Alexander K. Cho DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Juliana L. Chugg DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Bracken P. Darrell DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Trevor A. Edwards DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Mindy F. Grossman DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Mark S. Hoplamazian DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Laura W. Lang DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: W. Rodney McMullen DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Clarence Otis, Jr. DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Carol L. Roberts DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Matthew J. Shattock DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 To elect the directors to serve until the 2025 Annual Meeting of Shareholders: Kirk C. Tanner DIRECTOR ELECTIONS
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 Vote to approve the amendment and restatement of the 1996 Stock Compensation Plan. COMPENSATION
 - ISSUER 4779.000000 0 AGAINST
 4779.000000
 AGAINST
 - -
VF Corporation 918204108 US9182041080 - 07/23/2024 Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2025. AUDIT-RELATED
 - ISSUER 4779.000000 0 FOR
 4779.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Rhodes R. Bobbitt DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Tracy A. Bolt DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: J. Taylor Crandall DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Hill A. Feinberg DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Gerald J. Ford DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Jeremy B. Ford DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: J. Markham Green DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Charlotte Jones DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Lee Lewis DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Thomas C. Nichols DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: W. Robert Nichols, III DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 WITHHOLD
 362.000000
 AGAINST
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Kenneth D. Russell DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: A. Haag Sherman DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Jonathan S. Sobel DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Robert C. Taylor, Jr. DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Election of Directors: Carl B. Webb DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Non-binding advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Hilltop Holdings, Inc. 432748101 US4327481010 - 07/25/2024 Ratification of the appointment of PricewaterhouseCoopers LLP as Hilltop Holdings Inc.'s independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: THOMAS E. CAPASSE DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 FOR
 355.000000
 FOR
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: JACK J. ROSS DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 FOR
 355.000000
 FOR
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: MEREDITH MARSHALL DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 FOR
 355.000000
 FOR
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: DOMINIQUE MIELLE DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 WITHHOLD
 355.000000
 AGAINST
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: GILBERT E. NATHAN DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 WITHHOLD
 355.000000
 AGAINST
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: J. MITCHELL REESE DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 WITHHOLD
 355.000000
 AGAINST
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Election of Directors: TODD M. SINAI DIRECTOR ELECTIONS
 - ISSUER 355.000000 0 WITHHOLD
 355.000000
 AGAINST
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED
 - ISSUER 355.000000 0 FOR
 355.000000
 FOR
 - -
Ready Capital Corporation 75574U101 US75574U1016 - 07/25/2024 Approval, on an advisory basis, of the compensation of our named executive officers, as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 355.000000 0 AGAINST
 355.000000
 AGAINST
 - -
BlackRock Credit Allocation Income Trust 092508100 US0925081004 - 07/26/2024 To Elect Board Member Nominees: J. Phillip Holloman DIRECTOR ELECTIONS
 - ISSUER 290333.000000 0 WITHHOLD
FOR
 13001.299000
277331.701000
 AGAINST
FOR
 - -
BlackRock Credit Allocation Income Trust 092508100 US0925081004 - 07/26/2024 To Elect Board Member Nominees: Arthur P. Steinmetz DIRECTOR ELECTIONS
 - ISSUER 290333.000000 0 WITHHOLD
FOR
 6701.277990
283631.722010
 AGAINST
FOR
 - -
BlackRock Credit Allocation Income Trust 092508100 US0925081004 - 07/26/2024 To Elect Board Member Nominees: Catherine A. Lynch DIRECTOR ELECTIONS
 - ISSUER 290333.000000 0 WITHHOLD
FOR
 11983.515820
278349.484180
 AGAINST
FOR
 - -
BlackRock Debt Strategies Fund, Inc. 09255R202 US09255R2022 - 07/26/2024 To Elect Board Member Nominees: R. Glenn Hubbard DIRECTOR ELECTIONS
 - ISSUER 157089.000000 0 FOR
 157089.000000
 FOR
 - -
BlackRock Debt Strategies Fund, Inc. 09255R202 US09255R2022 - 07/26/2024 To Elect Board Member Nominees: W. Carl Kester DIRECTOR ELECTIONS
 - ISSUER 157089.000000 0 FOR
 157089.000000
 FOR
 - -
BlackRock Debt Strategies Fund, Inc. 09255R202 US09255R2022 - 07/26/2024 To Elect Board Member Nominees: John M. Perlowski DIRECTOR ELECTIONS
 - ISSUER 157089.000000 0 FOR
 157089.000000
 FOR
 - -
Perficient, Inc. 71375U101 US71375U1016 - 07/30/2024 To approve the adoption of the Agreement and Plan of Merger, dated as of May 5, 2024, by and among Perficient, Inc. ("Perficient"), Plano HoldCo, Inc., and Plano BidCo, Inc. (the "Merger Agreement"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 380.000000 0 FOR
 380.000000
 FOR
 - -
Perficient, Inc. 71375U101 US71375U1016 - 07/30/2024 To approve, on an advisory, non-binding basis, the compensation that will or may be paid or may become payable to the named executives officers of Perficient in connection with the consummation of the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 380.000000 0 FOR
 380.000000
 FOR
 - -
Perficient, Inc. 71375U101 US71375U1016 - 07/30/2024 To approve the adjournment of the special meeting of stockholders of Perficient (the "Special Meeting") to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 380.000000 0 FOR
 380.000000
 FOR
 - -
Whole Earth Brands, Inc. 96684W100 US96684W1009 - 07/31/2024 To consider and vote on the proposal to adopt that certain Agreement of Merger, dated as of February 12, 2024, (as it may be amended, supplemented, or modified from time to time, the "Merger Agreement"), by and among Ozark Holdings, LLC, a Delaware limited liability company ("Parent"), Sweet Oak Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent ("Merger Sub") and Whole Earth Brands, Inc., pursuant to which Merger Sub will merge with and into Whole Earth Brands, Inc. (the "Merger"), with Whole Earth Brands, Inc. surviving the Merger as a wholly owned subsidiary of Parent (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 222.000000 0 FOR
 222.000000
 FOR
 - -
Whole Earth Brands, Inc. 96684W100 US96684W1009 - 07/31/2024 To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 222.000000 0 FOR
 222.000000
 FOR
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 Election of Directors: Roderick de Greef DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 Election of Directors: Joydeep Goswami DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 WITHHOLD
 61.000000
 AGAINST
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 Election of Directors: Amy DuRoss DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 Election of Directors: Rachel Ellingson DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 WITHHOLD
 61.000000
 AGAINST
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 Election of Directors: Timothy L. Moore DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
BioLife Solutions, Inc. 09062W204 US09062W2044 - 08/01/2024 To ratify the appointment by the Board of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Dr. Daniel Aghion DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Dr. Miriam Kidron DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Nadav Kidron DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Dr. Arie Mayer DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Yehuda Reznick DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Leonard Sank DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To re-elect the following directors of the Company to hold office until our next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal: Benjamin Shapiro DIRECTOR ELECTIONS
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 212.000000 0 AGAINST
 212.000000
 AGAINST
 - -
Oramed Pharmaceuticals Inc. 68403P203 US68403P2039 - 08/01/2024 To ratify the appointment of Kesselman & Kesselman, certified public accountants in Israel, a member of PricewaterhouseCoopers International Limited, as the independent registered public accounting firm of the Company for the 2024 fiscal year. AUDIT-RELATED
 - ISSUER 212.000000 0 FOR
 212.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 08/06/2024 Election of Directors: Jeffrey Jordan DIRECTOR ELECTIONS
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 08/06/2024 Election of Directors: Cindy Kent DIRECTOR ELECTIONS
 - ISSUER 601.000000 0 WITHHOLD
 601.000000
 AGAINST
 - -
Accolade, Inc. 00437E102 US00437E1029 - 08/06/2024 Election of Directors: Michael Hilton DIRECTOR ELECTIONS
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 08/06/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement in accordance with SEC rules. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 08/06/2024 To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending February 28, 2025. AUDIT-RELATED
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Morgan E. O'Brien DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Robert H. Schwartz DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Jeffrey A. Altman DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Leslie B. Daniels DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 AGAINST
 68.000000
 AGAINST
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Mark A. Fleischhauer DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Thomas R. Kuhn DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: William E. Heard DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Scott A. Lang DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To elect nine directors to hold office until the 2025 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Mahvash Yazdi DIRECTOR ELECTIONS
 - ISSUER 68.000000 0 AGAINST
 68.000000
 AGAINST
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 68.000000 0 AGAINST
 68.000000
 AGAINST
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To approve Amendment No. 1 to the Anterix Inc. 2023 Stock Plan to increase the number of shares available for issuance under the plan and clarify certain vesting restriction provisions. COMPENSATION
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Anterix Inc. 03676C100 US03676C1009 - 08/06/2024 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 68.000000 0 FOR
 68.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Stavros G. Vizirgianakis DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Charles D. Goodwin DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Michael E. Geraghty DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Lawrence J. Waldman DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: John Andres DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Craig Swandal DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Minnie Baylor-Henry DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The election of the following nominees to the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders: Wendy Levine DIRECTOR ELECTIONS
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
Apyx Medical Corporation 03837C106 US03837C1062 - 08/08/2024 The ratification of RSM US LLP as the Company's independent public accountants for the year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 185.000000 0 FOR
 185.000000
 FOR
 - -
John Bean Technologies Corporation 477839104 US4778391049 - 08/08/2024 consider and vote on a proposal to approve the issuance of shares of common stock, par value $0.01 per share, of JBT (the "JBT Shares," and such JBT Shares to be issued, the "JBT Offer Shares") to the shareholders of Marel hf., a public limited liability company incorporated under the laws of Iceland with registration no. 620483-0369 and registered at Austurhraun 9, 210 Garoabaer, Iceland ("Marel," and such shareholders, the "Marel Shareholders"), in connection with the transactions contemplated by the transaction agreement, dated as of April 4, 2024, by and among John Bean Technologies Europe B.V., a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands, with its seat in Rotterdam, the Netherlands and address at Deccaweg 32, 1042 AD Amsterdam, the Netherlands and registered with the Dutch Trade Register under no. 63675013, and a wholly owned subsidiary of JBT (the "Offeror"), JBT and Marel (as it may be amended from time to time, the "Transaction Agreement") (such proposal, the "Share Issuance Proposal"); and EXTRAORDINARY TRANSACTIONS
 - ISSUER 366.000000 0 FOR
 366.000000
 FOR
 - -
John Bean Technologies Corporation 477839104 US4778391049 - 08/08/2024 consider and vote on a proposal to approve one or more adjournments of the Special Meeting to another date, time or place, if necessary or appropriate, to solicit additional proxies in favor of the Share Issuance Proposal (such proposal, the "Adjournment Proposal"). CORPORATE GOVERNANCE
 - ISSUER 366.000000 0 FOR
 366.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Leslie C.G. Campbell DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Sandra Y. Campos DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Gian M. Fulgoni DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Justin Mennen DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Diana Garvis Purcel DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To elect six (6) Directors to the Board of Directors: Leah A. Solivan DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 An advisory (non-binding) vote to approve named executive officer compensation: SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To approve the PetMed Express, Inc. 2024 Omnibus Incentive Plan: COMPENSATION
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
PetMed Express, Inc. 716382106 US7163821066 - 08/08/2024 To ratify the appointment of RSM US LLP as the independent registered public accounting firm for the Company to serve for the 2025 fiscal year: AUDIT-RELATED
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Patrick E. Allen DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Mark C. Cherry DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Daniel J. Crowley DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Cynthia M. Egnotovich DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Daniel P. Garton DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Barbara W. Humpton DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Neal J. Keating DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Courtney R. Mather DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Election of Directors: Colleen C. Repplier DIRECTOR ELECTIONS
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 To approve, by advisory vote, the compensation paid to our named executive officers for the fiscal year ended March 31, 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 373.000000 0 FOR
 373.000000
 FOR
 - -
Triumph Group, Inc. 896818101 US8968181011 - 08/08/2024 To consider a stockholder proposal to adopt a policy and amend the Company's governing documents so that two separate people hold the office of Chairman and Chief Executive Officer of the Company. CORPORATE GOVERNANCE
 - SECURITY HOLDER 373.000000 0 FOR
 373.000000
 AGAINST
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 08/12/2024 To elect two (2) nominees as Class A directors, each to serve three-year terms expiring in 2027 and to hold office until his successor is duly elected and qualified: John P. Miller DIRECTOR ELECTIONS
 - ISSUER 78.000000 0 AGAINST
 78.000000
 AGAINST
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 08/12/2024 To elect two (2) nominees as Class A directors, each to serve three-year terms expiring in 2027 and to hold office until his successor is duly elected and qualified: Eric Tech DIRECTOR ELECTIONS
 - ISSUER 78.000000 0 FOR
 78.000000
 FOR
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 08/12/2024 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 78.000000 0 FOR
 78.000000
 FOR
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 08/12/2024 To conduct an advisory vote on the compensation of our named executive officers as described in this proxy statement SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 78.000000 0 AGAINST
 78.000000
 AGAINST
 - -
Vincerx Pharma, Inc. 92731L304 US92731L3042 - 08/12/2024 Approval of a one-time stock option repricing and exchange program. COMPENSATION
 - ISSUER 95.000000 0 AGAINST
 95.000000
 AGAINST
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Garry Neil, M.D. DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: June Almenoff, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Mitchell Chan DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Jonathan Goldman, M.D. DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Aaron Kantoff DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Gilla Kaplan, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To elect the seven directors nominated by our board of directors and named herein to hold office for a one-year term until the 2025 Annual Meeting of Stockholders: Samantha Truex DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To approve, for purposes of Rule 5635 of The Nasdaq Stock Market LLC, the issuance of shares of the Company's common stock (i) in exchange for the outstanding shares of the Company's Series C Non-Voting Convertible Preferred Stock, (ii) upon the exercise of the warrants to purchase shares of the Company's common stock issued on March 28, 2024, and (iii) as possible payment for the milestone obligations to the former stockholders of AlmataBio, Inc.; CAPITAL STRUCTURE
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To approve the Avalo Therapeutics, Inc. Fourth Amended and Restated Equity Incentive Plan; COMPENSATION
 - ISSUER 1.000000 0 AGAINST
 1.000000
 AGAINST
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To approve the Avalo Therapeutics, Inc. Amended and Restated Employee Stock Purchase Plan; COMPENSATION
 - ISSUER 1.000000 0 AGAINST
 1.000000
 AGAINST
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 08/13/2024 To approve the adjournment or postponement of the Annual Meeting, if necessary, to continue to solicit votes for Proposals Nos. 1, 2, 3, 4, and/or 5; and CORPORATE GOVERNANCE
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Election of Directors: John L. Battelle DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Election of Directors: Omar Tawakol DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Election of Directors: Debora B. Tomlin DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Approval of an increase in the number of shares available for issuance under the Company's Amended and Restated 2005 Equity Compensation Plan. COMPENSATION
 - ISSUER 775.000000 0 AGAINST
 775.000000
 AGAINST
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Approval of an amendment to the Company's Certificate of Incorporation to limit the liability of certain officers of the company. CORPORATE GOVERNANCE
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Advisory (non-binding) vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LiveRamp Holdings, Inc. 53815P108 US53815P1084 - 08/13/2024 Ratification of KPMG LLP as the Company's independent registered public accountant for Fiscal Year 2025. AUDIT-RELATED
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Elect five directors to Class 1 of the Board of Directors to serve a one-year term and until their successors are duly elected and qualified at the 2025 annual meeting of shareholders: John L. Auerbach DIRECTOR ELECTIONS
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Elect five directors to Class 1 of the Board of Directors to serve a one-year term and until their successors are duly elected and qualified at the 2025 annual meeting of shareholders: Michael T. Broderick DIRECTOR ELECTIONS
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Elect five directors to Class 1 of the Board of Directors to serve a one-year term and until their successors are duly elected and qualified at the 2025 annual meeting of shareholders: Lindsay N. Hyde DIRECTOR ELECTIONS
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Elect five directors to Class 1 of the Board of Directors to serve a one-year term and until their successors are duly elected and qualified at the 2025 annual meeting of shareholders: Leah C. Johnson DIRECTOR ELECTIONS
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Elect five directors to Class 1 of the Board of Directors to serve a one-year term and until their successors are duly elected and qualified at the 2025 annual meeting of shareholders: Thomas B. Okray DIRECTOR ELECTIONS
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Monro, Inc. 610236101 US6102361010 - 08/13/2024 Ratify the re-appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending March 29, 2025; and AUDIT-RELATED
 - ISSUER 194.000000 0 FOR
 194.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: Robert A. Bruggeworth DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: Judy Bruner DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: John R. Harding DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: David H. Y. Ho DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: Roderick D. Nelson DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: Walden C. Rhines DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 ELECTION OF DIRECTORS: Susan L. Spradley DIRECTOR ELECTIONS
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 To approve, on an advisory basis, the compensation of our Named Executive Officers (as disclosed in the proxy statement). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Qorvo, Inc. 74736K101 US74736K1016 - 08/13/2024 To ratify the appointment of Ernst & Young LLP as Qorvo's independent registered public accounting firm for the fiscal year ending March 29, 2025. AUDIT-RELATED
 - ISSUER 5008.000000 0 FOR
 5008.000000
 FOR
 - -
Surmodics, Inc. 868873100 US8688731004 - 08/13/2024 Approve the Merger Agreement, dated as of May 28, 2024, by and among Surmodics, Inc., BCE Parent, LLC, and BCE Merger Sub, Inc., pursuant to which Surmodics, Inc. would be acquired by way of a merger and become a wholly owned subsidiary of BCE Parent, LLC; EXTRAORDINARY TRANSACTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Surmodics, Inc. 868873100 US8688731004 - 08/13/2024 Approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Surmodics, Inc. 868873100 US8688731004 - 08/13/2024 Approve one or more adjournments of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the merger agreement at the time of the special meeting. CORPORATE GOVERNANCE
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 08/14/2024 To approve Article V, Section 1(c) of the Company's Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's Board of Directors, a reverse stock split of the issued and outstanding shares of Class A common stock and Class B common stock, which would combine a whole number of outstanding shares of the Class A common stock and Class B common stock in a range of not less than one-for-twenty (1:20) shares and not more than one-for-forty (1:40) shares into one share of Class A common stock or Class B common stock, as applicable, and reduce the number of outstanding shares of Class A common stock and Class B common stock. CAPITAL STRUCTURE
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 08/14/2024 To approve Article VIII of the Company's Amended and Restated Certificate of Incorporation to permit officer exculpation. CORPORATE GOVERNANCE
 - ISSUER 428.000000 0 AGAINST
 428.000000
 AGAINST
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 08/14/2024 To approve the Company's Amended and Restated Certificate of Incorporation, which has been updated to, among other things, remove provisions related to our merger with Soaring Eagle Acquisition Corp. and our domestication process, which are no longer relevant to our business. CORPORATE GOVERNANCE
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Ellen N. Artist DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Mitchell I. Gordon DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Dana J. Lockhart DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Jonathan G. Ornstein DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Harvey W. Schiller DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 Election of Directors: Spyridon P. Skiados DIRECTOR ELECTIONS
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 To approve, on an advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 204.000000 0 ONE YEAR
 204.000000
 FOR
 - -
Mesa Air Group, Inc. 590479135 US5904791358 - 08/14/2024 The ratification of the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2024. AUDIT-RELATED
 - ISSUER 204.000000 0 FOR
 204.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Jaswinder Pal Singh DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Monique Bonner DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Andrew Burton DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Todd Ford DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Alison Gleeson DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Elizabeth Theophille DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 Election of Directors: Samuel Wilson DIRECTOR ELECTIONS
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 To ratify the appointment of Moss Adams LLP as 8x8, Inc.'s independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 To approve, through an advisory vote, 8x8, Inc.'s executive compensation for the fiscal year ended March 31, 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. COMPENSATION
 - ISSUER 1327.000000 0 AGAINST
 1327.000000
 AGAINST
 - -
8x8, Inc. 282914100 US2829141009 - 08/15/2024 To approve an amendment to the Company's existing charter to provide for the elimination of certain officers' personal liability for monetary damages stemming from breaches of the duty of care as permitted by Section 102(b)(7) of the General Corporation Law of the State of Delaware. CORPORATE GOVERNANCE
 - ISSUER 1327.000000 0 FOR
 1327.000000
 FOR
 - -
Ampio Pharmaceuticals, Inc. 03209T307 US03209T3077 - 08/15/2024 Approve Plan of Liquidation and Dissolution EXTRAORDINARY TRANSACTIONS
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
Ampio Pharmaceuticals, Inc. 03209T307 US03209T3077 - 08/15/2024 Adjourn Meeting CORPORATE GOVERNANCE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
Aterian, Inc. 02156U200 US02156U2006 - 08/16/2024 To elect Susan Lattmann as a Class II director to serve until our 2027 Annual Meeting of Stockholders: Susan Lattmann DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 WITHHOLD
 12.000000
 AGAINST
 - -
Aterian, Inc. 02156U200 US02156U2006 - 08/16/2024 To ratify the appointment of UHY LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Atrion Corporation 049904105 US0499041053 - 08/19/2024 To adopt the Agreement and Plan of Merger, dated May 28, 2024 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger Agreement"), by and among Nordson Corporation, an Ohio corporation ("Nordson"), Alpha Medical Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Nordson ("Merger Sub"), and Atrion. Upon the terms and subject to the conditions of the Merger Agreement, Nordson will acquire Atrion via a merger of Merger Sub with and into Atrion, with the separate corporate existence of Merger Sub thereupon ceasing and Atrion continuing as the surviving corporation and a wholly owned subsidiary of Nordson. EXTRAORDINARY TRANSACTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Atrion Corporation 049904105 US0499041053 - 08/19/2024 To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Atrion's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Atrion Corporation 049904105 US0499041053 - 08/19/2024 To adjourn the special meeting of the Atrion stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: Marco Fregenal DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: Scott Flanders DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: Ravila Gupta DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: David Hood DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: Stephen Murray DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 Election of Directors: Jennifer Venable DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 To approve an amendment to the Fathom Holdings Inc. 2019 Omnibus Stock Incentive Plan to increase the share reserve by one million six hundred thousand (1,600,000) shares of common stock. COMPENSATION
 - ISSUER 36.000000 0 AGAINST
 36.000000
 AGAINST
 - -
Fathom Holdings Inc. 31189V109 US31189V1098 - 08/19/2024 To ratify the selection of Deloitte & Touche LLP, an independent registered public accounting firm, as the auditor of the Company for the year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: H. Allan Dow DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: W. Dennis Hogue DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: Thomas L. Newberry, V DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: Celena Matlock DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: Matthew G. McKenna DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: James B. Miller, Jr. DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: Lizanne Thomas DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 Election of Directors: Nicole Wu DIRECTOR ELECTIONS
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending on April 30, 2025. AUDIT-RELATED
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve the adoption of the 2024 Equity Compensation Plan. COMPENSATION
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve the Company's Reclassification. CAPITAL STRUCTURE
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve the amendment and restatement of the Company's Amended and Restated Articles of Incorporation to give effect to the Reclassification. CORPORATE GOVERNANCE
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve the amendment and restatement of the Company's Amended and Restated Articles of Incorporation to give effect to the indemnification of directors and officers amendment. CORPORATE GOVERNANCE
 - ISSUER 187.000000 0 FOR
 187.000000
 FOR
 - -
American Software, Inc. 029683109 US0296831094 - 08/20/2024 To approve the amendment and restatement of the Company's Amended and Restated Articles of Incorporation to give effect to the blank check preferred stock amendment. CAPITAL STRUCTURE
 - ISSUER 187.000000 0 AGAINST
 187.000000
 AGAINST
 - -
Asensus Surgical, Inc. 04367G103 US04367G1031 - 08/20/2024 To approve and adopt the Agreement and Plan of Merger, dated as of June 6, 2024 (the "Merger Agreement"), by and among KARL STORZ Endoscopy-America, Inc., a California corporation ("Parent"), and Karl Storz California Inc., a California corporation ("Merger Sub"), pursuant to which Asensus Surgical, Inc. would be acquired by way of a merger with and into Merger Sub with Asensus Surgical, Inc. surviving the merger. EXTRAORDINARY TRANSACTIONS
 - ISSUER 1394.000000 0 FOR
 1394.000000
 FOR
 - -
Asensus Surgical, Inc. 04367G103 US04367G1031 - 08/20/2024 To approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1394.000000 0 FOR
 1394.000000
 FOR
 - -
Asensus Surgical, Inc. 04367G103 US04367G1031 - 08/20/2024 To approve one or more adjournments of the special meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to approve the merger proposal at the time of the special meeting. CORPORATE GOVERNANCE
 - ISSUER 1394.000000 0 FOR
 1394.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The election of three (3) Class I directors to hold office until our 2027 annual meeting of stockholders and until his or her successor is elected and qualified: Barbara K. Finck, M.D. DIRECTOR ELECTIONS
 - ISSUER 67.000000 0 FOR
 67.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The election of three (3) Class I directors to hold office until our 2027 annual meeting of stockholders and until his or her successor is elected and qualified: Donald A. Williams DIRECTOR ELECTIONS
 - ISSUER 67.000000 0 WITHHOLD
 67.000000
 AGAINST
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The election of three (3) Class I directors to hold office until our 2027 annual meeting of stockholders and until his or her successor is elected and qualified: Stephen K. Doberstein, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 67.000000 0 WITHHOLD
 67.000000
 AGAINST
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The ratification of the appointment of KPMG LLP P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 67.000000 0 FOR
 67.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The approval of an amended and restated 2021 Equity Incentive Plan. COMPENSATION
 - ISSUER 67.000000 0 AGAINST
 67.000000
 AGAINST
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 08/20/2024 The approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock by a ratio of not less than one-for-five and not more than one-for-thirty. CAPITAL STRUCTURE
 - ISSUER 67.000000 0 FOR
 67.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Election of Directors: David K. Chene DIRECTOR ELECTIONS
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Election of Directors: Patrick J. Bartels DIRECTOR ELECTIONS
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Election of Directors: Howard M. Lorber DIRECTOR ELECTIONS
 - ISSUER 449.000000 0 WITHHOLD
 449.000000
 AGAINST
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Approval of ratification of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2024: AUDIT-RELATED
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Advisory vote on executive compensation (the "say-on-pay vote"): SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 08/21/2024 Advisory vote on a stockholder proposal requesting the Company amend its governing documents to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES
 - SECURITY HOLDER 449.000000 0 FOR
 449.000000
 AGAINST
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Noel M. Geoffroy DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Timothy F. Meeker DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Krista L. Berry DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Vincent D. Carson DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Thurman K. Case DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Tabata L. Gomez DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Elena B. Otero DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Beryl B. Raff DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 Election of Directors: Darren G. Woody DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 To provide advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Helen of Troy Limited G4388N106 BMG4388N1065 - 08/21/2024 To appoint Grant Thornton LLP as the Company's auditor and independent registered public accounting firm to serve for the 2025 fiscal year and to authorize the Audit Committee of the Board of Directors to set the auditor's remuneration. AUDIT-RELATED
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Ken R. Bramlett, Jr. DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: R. Chad Prashad DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Scott J. Vassalluzzo DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Charles D. Way DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Darrell E. Whitaker DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Elizabeth R. Neuhoff DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 ELECTION OF DIRECTORS: Benjamin E. Robinson III DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
World Acceptance Corporation 981419104 US9814191048 - 08/21/2024 RATIFY THE APPOINTMENT OF RSM US LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 31, 2025. AUDIT-RELATED
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Michael Callahan DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Gerard Gibbons DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Bruce E. Grooms DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Gary L. McArthur DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Eric C. Nyman DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Michael D. Robinson DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Robert M. Tarola DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Lynn M. Utter DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Election of Directors: Jason R. Vanderbrink DIRECTOR ELECTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Advisory Vote to Approve Compensation of Vista Outdoor's Named Executive Officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 08/23/2024 Ratification of the Appointment of Vista Outdoor's Independent Registered Public Accounting Firm for the fiscal year ending March 31, 2025 AUDIT-RELATED
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Margaret M. FitzPatrick, M.A. DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 WITHHOLD
 38.000000
 AGAINST
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Ann M. Cunningham, MBA DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 WITHHOLD
 38.000000
 AGAINST
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Joanne Curley, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 FOR
 38.000000
 FOR
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Jerry B. Gin, Ph.D., MBA DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 WITHHOLD
 38.000000
 AGAINST
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Mary L. Rotunno, J.D. DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 FOR
 38.000000
 FOR
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Jon S. Saxe, J.D., LL.M. DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 WITHHOLD
 38.000000
 AGAINST
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 ELECTION OF DIRECTORS: To elect seven directors to the Company's Board of Directors, each to serve until the Company's next annual meeting of stockholders, or until her or his respective successor is elected and qualified: Shawn K. Singh, J.D. DIRECTOR ELECTIONS
 - ISSUER 38.000000 0 FOR
 38.000000
 FOR
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 38.000000 0 AGAINST
 38.000000
 AGAINST
 - -
VistaGen Therapeutics, Inc. 92840H400 US92840H4002 - 08/26/2024 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 38.000000 0 FOR
 38.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Roy H. Chestnutt DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Robert Deutschman DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Holly Hess Groos DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Mohan S. Gyani DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Jeffrey Karish DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Mollie V. Spilman DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: Michelle Sterling DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 Election of Directors: William G. Stone III DIRECTOR ELECTIONS
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 To approve, in a non-binding advisory vote, the compensation of our named executive officers, commonly referred to as "Say-on-pay." SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
Digital Turbine, Inc. 25400W102 US25400W1027 - 08/27/2024 To approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,560,000 shares, from 12,000,0000 shares to 20,560,000 shares, and make certain other changes. COMPENSATION
 - ISSUER 1060.000000 0 FOR
 1060.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Election of Class II Directors: J. Kristofer Galashan DIRECTOR ELECTIONS
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Election of Class II Directors: Anthony Laday DIRECTOR ELECTIONS
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Election of Class II Directors: Nicole Otto DIRECTOR ELECTIONS
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 29, 2025. AUDIT-RELATED
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
The Container Store Group, Inc. 210751202 US2107512020 - 08/28/2024 Approval of amendments to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at ratio ranging from any whole number between 1-for-10 and 1-for-15, as determined by our Board of Directors in its discretion. CAPITAL STRUCTURE
 - ISSUER 189.000000 0 FOR
 189.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The approval, on an advisory basis, of the compensation paid to our named executive officers in 2023; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The approval of the amendment and restatement of the 2015 Incentive Plan that, among other things, increases the number of shares reserved for issuance thereunder by 4,000,000 shares; and COMPENSATION
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 08/30/2024 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2024. AUDIT-RELATED
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: J. Alltoft DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: S. Ladiwala DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: S. Hall DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: T. Tripeny DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: G. Owens DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: J. Sullivan DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 Election of directors: M. Capone DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Mesa Laboratories, Inc. 59064R109 US59064R1095 - 08/30/2024 To approve, on an advisory basis, the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 09/03/2024 Election of Director: Min Cui, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 09/03/2024 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 09/03/2024 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 09/03/2024 To approve conversion of the Company's Series A Non-Voting Convertible Preferred Stock to the Company's Class A Common Stock. CAPITAL STRUCTURE
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 09/03/2024 To approve adjournment of the annual meeting, if necessary or appropriate, to solicit additional proxies. CORPORATE GOVERNANCE
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 Election of Directors: Sushil Patel DIRECTOR ELECTIONS
 - ISSUER 177.000000 0 FOR
 177.000000
 FOR
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 Election of Directors: Dieter Weinand DIRECTOR ELECTIONS
 - ISSUER 177.000000 0 WITHHOLD
 177.000000
 AGAINST
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 Election of Directors: Madhavan Balachandran DIRECTOR ELECTIONS
 - ISSUER 177.000000 0 FOR
 177.000000
 FOR
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Replimune Group, Inc. for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 177.000000 0 FOR
 177.000000
 FOR
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 177.000000 0 FOR
 177.000000
 FOR
 - -
Replimune Group, Inc. 76029N106 US76029N1063 - 09/04/2024 To approve, on a non-binding advisory basis, the preferred frequency of future advisory votes on the compensation of Replimune Group, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 177.000000 0 ONE YEAR
 177.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Douglas E. Coltharp DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Jerri L. DeVard DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 WITHHOLD
 8161.000000
 AGAINST
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Mohamed A. El-Erian DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Carolyn N. Everson DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 WITHHOLD
 8161.000000
 AGAINST
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: David W. Gibbs DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 WITHHOLD
 8161.000000
 AGAINST
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Eric T. Olson DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 WITHHOLD
 8161.000000
 AGAINST
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Kevin A. Plank DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 WITHHOLD
 8161.000000
 AGAINST
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Election of Directors: Patrick W. Whitesell DIRECTOR ELECTIONS
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 To approve, by a non-binding advisory vote, the compensation of executives as disclosed in the "Executive Compensation" section of the proxy statement, including the Compensation Discussion and Analysis and tables. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 To approve the amendment and restatement of the Company's Class C Employee Stock Purchase Plan to increase the number of shares of Class C Common Stock authorized for issuance, among other changes. COMPENSATION
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Under Armour, Inc. 904311107 US9043111072 - 09/04/2024 Ratification of appointment of independent registered public accounting firm for the fiscal year ending March 31, 2025. AUDIT-RELATED
 - ISSUER 8161.000000 0 FOR
 8161.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 09/10/2024 Approval, in accordance with Nasdaq Marketplace Rule 5635(d), of the Issuance Cap Proposal. CAPITAL STRUCTURE
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 09/10/2024 Approval of the Adjournment Proposal. CORPORATE GOVERNANCE
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: Scott Carter DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 FOR
 255.000000
 FOR
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: Rahul Gupta DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 WITHHOLD
 255.000000
 AGAINST
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: James C. Hale DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 WITHHOLD
 255.000000
 AGAINST
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: Susan Repo DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 WITHHOLD
 255.000000
 AGAINST
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: Kimberly S. Stevenson DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 WITHHOLD
 255.000000
 AGAINST
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To elect the following directors to serve until our 2025 annual meeting of stockholders and until their respective successors have been elected and qualified: Donna C. Wells DIRECTOR ELECTIONS
 - ISSUER 255.000000 0 FOR
 255.000000
 FOR
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending September 30, 2024; AUDIT-RELATED
 - ISSUER 255.000000 0 FOR
 255.000000
 FOR
 - -
Mitek Systems, Inc. 606710200 US6067102003 - 09/10/2024 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers as presented in the Proxy Statement accompanying this notice; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 255.000000 0 FOR
 255.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 Class B director nominees: To elect a Board of Directors for the ensuing year: Cathleen Benko DIRECTOR ELECTIONS
 - ISSUER 2085.000000 0 FOR
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr. DIRECTOR ELECTIONS
 - ISSUER 2085.000000 0 WITHHOLD
 2085.000000
 AGAINST
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 Class B director nominees: To elect a Board of Directors for the ensuing year: Robert Swan DIRECTOR ELECTIONS
 - ISSUER 2085.000000 0 FOR
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To approve executive compensation by an advisory vote. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2085.000000 0 FOR
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To ratify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 2085.000000 0 FOR
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To consider a shareholder proposal regarding Supplemental Pay Equity Disclosure, if properly presented at the meeting. DIVERSITY, EQUITY, AND INCLUSION
 - SECURITY HOLDER 2085.000000 0 FOR
 2085.000000
 AGAINST
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To consider a shareholder proposal regarding a Supply Chain Management Report, if properly presented at the meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE
 - SECURITY HOLDER 2085.000000 0 AGAINST
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To consider a shareholder proposal regarding Worker-Driven Social Responsibility, if properly presented at the meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE
 - SECURITY HOLDER 2085.000000 0 AGAINST
 2085.000000
 FOR
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To consider a shareholder proposal regarding Environmental Targets, if properly presented at the meeting. ENVIRONMENT OR CLIMATE
 - SECURITY HOLDER 2085.000000 0 FOR
 2085.000000
 AGAINST
 - -
NIKE, Inc. 654106103 US6541061031 - 09/10/2024 To consider a shareholder proposal regarding a Divisive Partnerships Congruency Report, if properly presented at the meeting. ENVIRONMENT OR CLIMATE
DIVERSITY, EQUITY, AND INCLUSION
OTHER SOCIAL ISSUES
 - SECURITY HOLDER 2085.000000 0 AGAINST
 2085.000000
 FOR
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To elect three directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified: Michael E. Sherman DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 WITHHOLD
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To elect three directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified: Richard A. Berman DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 WITHHOLD
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To elect three directors to hold office until the next annual meeting of stockholders and until their respective successors are elected and qualified: James M. Messina DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 WITHHOLD
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To ratify the appointment of EisnerAmper LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To approve the Company's Amended and Restated 2017 Stock Incentive Plan. COMPENSATION
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To approve the Company's non-employee director retention plan. COMPENSATION
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To indicate, on an advisory basis, the preferred frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 ONE YEAR
 10.000000
 AGAINST
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To approve a proposal to give the Company's board of directors, the authority to file, at its discretion, a certificate of amendment to the Company's amended and restated certificate of incorporation, as amended, to effect a reverse split of the Company's issued common stock at a ratio that is not less than 1-for-2 and not greater than 1-for-15, without reducing the authorized number of shares of the Company's common stock, with the exact ratio to be selected by the Company's board of directors in its discretion and to be effected, if at all, in the sole discretion of the Company's board of directors, at any time following stockholder approval and before September 10, 2025 without further approval or authorization of the Company's stockholders. CAPITAL STRUCTURE
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ontrak, Inc. 683373401 US6833734014 - 09/10/2024 To approve the adjournment of the meeting, if necessary or advisable, to solicit proxies in favor of Proposal 7 if there are not sufficient voles to approve Proposal 7. CORPORATE GOVERNANCE
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Alerus Financial Corporation 01446U103 US01446U1034 - 09/12/2024 a proposal to approve and adopt the Agreement and Plan of Merger, dated as of May 14, 2024, between Alerus and HMN Financial, Inc. ("HMNF"), pursuant to which HMNF will merge with and into Alerus (the "merger"), and the transactions contemplated therein, including the issuance of Alerus common stock pursuant to the merger agreement (the "Alerus merger proposal"); and EXTRAORDINARY TRANSACTIONS
 - ISSUER 89.000000 0 FOR
 89.000000
 FOR
 - -
Alerus Financial Corporation 01446U103 US01446U1034 - 09/12/2024 a proposal to approve the adjournment of the special meeting to permit further solicitation in the event that an insufficient number of votes are cast to approve the Alerus merger proposal (the "Alerus adjournment proposal"). CORPORATE GOVERNANCE
 - ISSUER 89.000000 0 FOR
 89.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Anita D. Britt DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Fred M. Diaz DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Michelle J. Lohmeier DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Barry M. Monheit DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Robert L. Scott DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Mark P. Smith DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 ELECTION OF DIRECTORS: Denis G. Suggs DIRECTOR ELECTIONS
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 To approve on an advisory basis the compensation of our named executive officers for fiscal 2024 ("say-on-pay"); SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 285.000000 0 FOR
 285.000000
 FOR
 - -
Smith & Wesson Brands, Inc. 831754106 US8317541063 - 09/17/2024 A stockholder proposal (human rights impact assessment); HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE
 - SECURITY HOLDER 285.000000 0 FOR
 285.000000
 AGAINST
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: William C. Martin DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Emily S. Hoffman DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Sean Vijay Madnani DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Elias N. Nader DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Eric B. Singer DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Kathryn ("Kate") Eberle Walker DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To elect seven (7) directors to serve until the 2025 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation, retirement, disqualification or removal: Denise Warren DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To approve the Company's Amended and Restated Equity Incentive Plan to, among other things, increase the number of shares authorized to be issued under the Plan. COMPENSATION
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To vote on an advisory (non-binding) basis to approve executive compensation for named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To ratify the appointment of BDO USA, P.C. as the independent registered public accountants for the Company's fiscal year ending May 3, 2025. AUDIT-RELATED
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To approve the Company's Amended and Restated Certificate of Incorporation to decrease the aggregate number of authorized shares of the Company's common stock, par value $0.01 per share. CAPITAL STRUCTURE
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Barnes & Noble Education, Inc. 06777U200 US06777U2006 - 09/18/2024 To approve the adjournment of the 2024 annual meeting of stockholders (the "Annual Meeting") to a later date, if necessary or appropriate, to allow for the solicitation of additional proxies in the event that there are insufficient votes at the time of the Annual Meeting to approve the other proposals. CORPORATE GOVERNANCE
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Ariel Halperin as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Ronald Kaplan as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Tom Pardo Izhaki as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Giora Wegman as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Ornit Raz as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Maxim Ohana as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reelect Yuval Beeri as Director DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Reappoint Kost, Forer, Gabbay & Kasierer as Auditors and Authorize Board to Fix Their Remuneration AUDIT-RELATED
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Approve Extension of Service Agreement with Tene Growth Capital 3 Funds Management Company Ltd. CORPORATE GOVERNANCE
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Caesarstone Ltd. M20598104 IL0011259137 - 09/19/2024 Issue Updated Indemnification Agreements to Directors/Officers CORPORATE GOVERNANCE
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Vapotherm, Inc. 922107305 US9221073052 - 09/19/2024 To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated as of June 17, 2024 (the "Merger Agreement"), by and among Veronica Holdings, LLC, a Delaware limited liability company ("Topco"), Veronica Intermediate Holdings, LLC, a Delaware limited liability company and a wholly owned subsidiary of Topco ("Parent"), Veronica Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), and Vapotherm, Inc. ("Vapotherm"), pursuant to which and upon the terms and subject to the conditions thereof, Merger Sub will merge with and into Vapotherm, with Vapotherm continuing as the surviving corporation and as a wholly owned subsidiary of Parent; EXTRAORDINARY TRANSACTIONS
 - ISSUER 16.000000 0 FOR
 16.000000
 FOR
 - -
Vapotherm, Inc. 922107305 US9221073052 - 09/19/2024 To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Vapotherm's named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 16.000000 0 FOR
 16.000000
 FOR
 - -
Vapotherm, Inc. 922107305 US9221073052 - 09/19/2024 To consider and vote on any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies to approve the Merger Agreement Proposal if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 16.000000 0 FOR
 16.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Bradford B. Briner DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Tom Burt DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Brendan J. Keating DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Frank H. Kenan II DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Jeffrey C. Royal DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 Election of Directors (other than the Class B common stock Director): Vishnu Srinivasan DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 To ratify the selection by our Board of Directors of the firm of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 To conduct a non-binding advisory vote to approve the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 To conduct an advisory (non-binding) vote on the frequency of the vote to approve the executive compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 118.000000 0 ONE YEAR
 118.000000
 FOR
 - -
Boston Omaha Corporation 101044105 US1010441053 - 09/20/2024 To approve the Officer Exculpation Charter Amendment. CORPORATE GOVERNANCE
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 09/20/2024 To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of common stock, par value $0.0001 per share ("Common Stock"), of Cartesian Therapeutics, Inc. (the "Company") upon conversion of the Company's Series B Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Conversion Proposal" or "Proposal No. 1"); and CAPITAL STRUCTURE
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 09/20/2024 To approve the adjournment or postponement of the special meeting of stockholders of the Company (the "Special Meeting"), if necessary, to continue to solicit votes for Proposal No. 1 (the "Adjournment Proposal" or "Proposal No. 2"). CORPORATE GOVERNANCE
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Election of Directors: Anthony Posawatz DIRECTOR ELECTIONS
 - ISSUER 52.000000 0 WITHHOLD
 52.000000
 AGAINST
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Election of Directors: Judy Krandel DIRECTOR ELECTIONS
 - ISSUER 52.000000 0 FOR
 52.000000
 FOR
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Election of Directors: George Syllantavos DIRECTOR ELECTIONS
 - ISSUER 52.000000 0 FOR
 52.000000
 FOR
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Election of Directors: Desmond Wheatley DIRECTOR ELECTIONS
 - ISSUER 52.000000 0 FOR
 52.000000
 FOR
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 52.000000 0 AGAINST
 52.000000
 AGAINST
 - -
Beam Global 07373B109 US07373B1098 - 09/23/2024 Ratify the appointment of Marcum LLP as our independent registered public accountants for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 52.000000 0 FOR
 52.000000
 FOR
 - -
Inseego Corp. 45782B302 US45782B3024 - 09/23/2024 Elect one director to serve until the 2027 annual meeting of stockholders: Christopher Harland DIRECTOR ELECTIONS
 - ISSUER 49.000000 0 WITHHOLD
 49.000000
 AGAINST
 - -
Inseego Corp. 45782B302 US45782B3024 - 09/23/2024 Ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; AUDIT-RELATED
 - ISSUER 49.000000 0 FOR
 49.000000
 FOR
 - -
Inseego Corp. 45782B302 US45782B3024 - 09/23/2024 Hold an advisory vote to approve the compensation of our named executive officers, as presented in the proxy statement accompanying this notice; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 49.000000 0 FOR
 49.000000
 FOR
 - -
Inseego Corp. 45782B302 US45782B3024 - 09/23/2024 Approve an amendment of the Inseego Corp. 2018 Omnibus Incentive Compensation Plan to increase the number of shares issuable under the plan by 2,500,000 shares; COMPENSATION
 - ISSUER 49.000000 0 AGAINST
 49.000000
 AGAINST
 - -
Inseego Corp. 45782B302 US45782B3024 - 09/23/2024 Approve an amendment to the Amended and Restated Inseego Corp. 2000 Employee Stock Purchase Plan to increase the number of shares issuable under the plan by 500,000 shares; and COMPENSATION
 - ISSUER 49.000000 0 FOR
 49.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Bradley T. Favreau DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Mary E. Gallagher DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 WITHHOLD
 84.000000
 AGAINST
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Gregory J. Gluchowski DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 WITHHOLD
 84.000000
 AGAINST
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Luis G. Marconi DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Barry M. Monheit DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 WITHHOLD
 84.000000
 AGAINST
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification or removal: Brian D. Murphy DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 09/24/2024 To ratify the appointment of Grant Thornton LLP, an independent registered public accounting firm, as the independent registered public accountant of our company for the fiscal year ending April 30, 2025. AUDIT-RELATED
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
Envestnet, Inc. 29404K106 US29404K1060 - 09/24/2024 To adopt the Agreement and Plan of Merger, dated as of July 11, 2024 (as it may be amended from time to time, the "Merger Agreement"), by and among BCPE Pequod Buyer, Inc. ("Parent"), BCPE Pequod Merger Sub, Inc., a direct, wholly-owned subsidiary of Parent ("Merger Sub"), and Envestnet, pursuant to which Merger Sub will merge with and into Envestnet (the "Merger"), with Envestnet surviving the Merger and becoming a wholly owned subsidiary of Parent, and to approve the Merger (the "Merger Proposal"); EXTRAORDINARY TRANSACTIONS
 - ISSUER 635.000000 0 FOR
 635.000000
 FOR
 - -
Envestnet, Inc. 29404K106 US29404K1060 - 09/24/2024 To approve, on a non-binding advisory basis, the compensation that will or may become payable by Envestnet to its named executive officers in connection with the Merger; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 635.000000 0 FOR
 635.000000
 FOR
 - -
Envestnet, Inc. 29404K106 US29404K1060 - 09/24/2024 To approve an adjournment of the Special Meeting, from time to time, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal or in the absence of a quorum. CORPORATE GOVERNANCE
 - ISSUER 635.000000 0 FOR
 635.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Election of Directors: Mohammad Azab DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Election of Directors: James E. Brown DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Election of Directors: Gail M. Farfel DIRECTOR ELECTIONS
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 150,000,000 to 350,000,000; CAPITAL STRUCTURE
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Approve the amendment to the Company's Amended and Restated Certificate of Incorporation to provide for exculpation of officers to the extent permitted by the Delaware General Corporation Law; CORPORATE GOVERNANCE
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Approve the amendment and restatement of the Company's 2000 Stock Plan to increase the number of shares of the Company's common stock available for issuance pursuant to the plan by 2,000,000 shares and to extend the plan's term for ten years from the date of the Annual Meeting; COMPENSATION
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Hold a non-binding advisory vote to approve executive compensation; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
DURECT Corporation 266605500 US2666055007 - 09/25/2024 Ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the current fiscal year. AUDIT-RELATED
 - ISSUER 134.000000 0 FOR
 134.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Doyle N. Beneby DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Laura M. Bishop DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Gary D. Burnison DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Matthew J. Espe DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Russell A. Hagey DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Charles L. Harrington DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Jerry P. Leamon DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Angel R. Martinez DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Debra J. Perry DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Election of Directors: Lori J. Robinson DIRECTOR ELECTIONS
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Advisory (non-binding) resolution to approve the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Approval of the Korn Ferry Amended and Restated 2022 Stock Incentive Plan. COMPENSATION
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
Korn Ferry 500643200 US5006432000 - 09/25/2024 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2025 fiscal year. AUDIT-RELATED
 - ISSUER 630.000000 0 FOR
 630.000000
 FOR
 - -
The Aaron's Company, Inc. 00258W108 US00258W1080 - 09/25/2024 To approve the Agreement and Plan of Merger, dated June 16, 2024 (as it may be amended from time to time, the "merger agreement"), by and among IQVentures Holdings, LLC, Polo Merger Sub, Inc. and The Aaron's Company, Inc. (the "Company"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
The Aaron's Company, Inc. 00258W108 US00258W1080 - 09/25/2024 To approve on a non-binding, advisory basis, the compensation that may be paid or may become payable to the Company's named executive officers in connection with, or following, the consummation of the merger of Polo Merger Sub, Inc., a wholly-owned direct subsidiary of IQVentures Holdings, LLC, with and into the Company. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
The Aaron's Company, Inc. 00258W108 US00258W1080 - 09/25/2024 To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the merger agreement. CORPORATE GOVERNANCE
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 09/26/2024 To approve the proposed sale (the "Transaction") of Seres' VOWST microbiome therapeutic business to Societe des Produits Nestle S.A. ("SPN") pursuant to the terms of the Asset Purchase Agreement, dated as of August 5, 2024, by and between Seres and SPN (the "Transaction Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 09/26/2024 To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Transaction. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 09/26/2024 To approve the adjournment of the special meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt the Transaction Proposal at the time of the special meeting. CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Molecular Templates, Inc. 608550208 US6085502085 - 09/27/2024 To elect one director to serve a three-year term expiring in 2027: Corsee Sanders, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 14.000000 0 AGAINST
 14.000000
 AGAINST
 - -
Molecular Templates, Inc. 608550208 US6085502085 - 09/27/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending 2024. AUDIT-RELATED
 - ISSUER 14.000000 0 FOR
 14.000000
 FOR
 - -
Molecular Templates, Inc. 608550208 US6085502085 - 09/27/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 14.000000 0 FOR
 14.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Paul Colucci DIRECTOR ELECTIONS
 - ISSUER 327.000000 0 FOR
 327.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Thomas Dircks DIRECTOR ELECTIONS
 - ISSUER 327.000000 0 FOR
 327.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Michael Lempres DIRECTOR ELECTIONS
 - ISSUER 327.000000 0 FOR
 327.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Scott Reed DIRECTOR ELECTIONS
 - ISSUER 327.000000 0 FOR
 327.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Ivona Smith DIRECTOR ELECTIONS
 - ISSUER 327.000000 0 FOR
 327.000000
 FOR
 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Dissident Nominee Director Joseph D. Stilwell DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Paul D. Colucci DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Thomas C. Dircks DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Michael T. Lempres DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Scott A. Reed DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Silvergate Capital Corporation 82837P408 US82837P4081 - 09/27/2024 Elect Management Nominee Director Ivona Smith DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
First Foundation Inc. 32026V104 US32026V1044 - 09/30/2024 To approve and adopt an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 100,000,000 shares to 200,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 284.000000 0 FOR
 284.000000
 FOR
 - -
First Foundation Inc. 32026V104 US32026V1044 - 09/30/2024 To approve the issuance of shares of common stock in connection with the July 2024 Capital Raise (as defined in the accompanying proxy statement) pursuant to New York Stock Exchange listing rules. CAPITAL STRUCTURE
 - ISSUER 284.000000 0 FOR
 284.000000
 FOR
 - -
First Foundation Inc. 32026V104 US32026V1044 - 09/30/2024 To adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, sufficient votes to approve Proposals 1 and 2 have not been obtained. CORPORATE GOVERNANCE
 - ISSUER 284.000000 0 FOR
 284.000000
 FOR
 - -
Infinera Corporation 45667G103 US45667G1031 - 10/01/2024 To adopt the Agreement and Plan of Merger, dated as of June 27, 2024 (as it may be amended, modified, supplemented or waived from time to time, the "Merger Agreement"), by and among Nokia Corporation, Neptune of America Corporation, and Infinera. EXTRAORDINARY TRANSACTIONS
 - ISSUER 1081.000000 0 FOR
 1081.000000
 FOR
 - -
Infinera Corporation 45667G103 US45667G1031 - 10/01/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Infinera to its named executive officers in connection with the merger contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1081.000000 0 FOR
 1081.000000
 FOR
 - -
Infinera Corporation 45667G103 US45667G1031 - 10/01/2024 To postpone or adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 1081.000000 0 FOR
 1081.000000
 FOR
 - -
Desktop Metal, Inc. 25058X303 US25058X3035 - 10/02/2024 To approve and adopt the Agreement and Plan of Merger, dated July 2, 2024 (as it may be amended from time to time, the "Merger Agreement"), by and among Desktop Metal, Inc. ("Desktop Metal"), Nano Dimension Ltd., an Israeli company ("Nano"), and Nano US I, Inc. a Delaware corporation ("Merger Sub"), which Merger Sub is a direct, wholly-owned subsidiary of Nano Dimension USA Inc., a Delaware corporation, which is a direct, wholly-owned subsidiary of Nano, pursuant to which Merger Sub will merge with and into Desktop Metal (the "Merger"), with Desktop Metal continuing as the surviving corporation of the Merger and as an indirect wholly-owned subsidiary of Nano. EXTRAORDINARY TRANSACTIONS
 - ISSUER 219.000000 0 FOR
 219.000000
 FOR
 - -
Desktop Metal, Inc. 25058X303 US25058X3035 - 10/02/2024 To approve, on a non-binding advisory basis, the executive officer compensation that will or may be paid to Desktop Metal's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 219.000000 0 FOR
 219.000000
 FOR
 - -
Desktop Metal, Inc. 25058X303 US25058X3035 - 10/02/2024 To approve the adjournment of the special meeting to solicit additional proxies if there are not sufficient votes to approve and adopt the Merger Agreement at the time of the special meeting or to ensure that any supplement or amendment to the accompanying proxy statement is timely provided to Desktop Metal stockholders. CORPORATE GOVERNANCE
 - ISSUER 219.000000 0 FOR
 219.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Travis Washko DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Vincent Puccio DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Mark Carrington DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Michael Freed DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Michael Dunn DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 WITHHOLD
 2.000000
 AGAINST
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To elect six directors to our Board of Directors to serve until the next Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified (the "Election of Directors Proposal"): Loic Gautier DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Society Pass Incorporated 83370P201 US83370P2011 - 10/03/2024 To ratify the appointment of Onestop Assurance PAC as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 (the "Auditor Ratification Proposal"). AUDIT-RELATED
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 10/08/2024 The adoption and approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 110,000,000 to 210,000,000 and increase the number of authorized shared of our common stock from 100,000,000 to 200,000,000. CAPITAL STRUCTURE
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 10/08/2024 The approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary to permit further solicitation of proxies in the event that there are insufficient votes for the adoption and approval of Proposal 1. CORPORATE GOVERNANCE
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Affimed NV N01045207 NL0015001ZQ0 - 10/10/2024 Elect Shawn Leland to Management Board CORPORATE GOVERNANCE
 - ISSUER 69.000000 0 FOR
 69.000000
 FOR
 - -
Affimed NV N01045207 NL0015001ZQ0 - 10/10/2024 Approve Addendum to the Remuneration Policy for the Management Board in Respect of Shawn Leland COMPENSATION
 - ISSUER 69.000000 0 AGAINST
 69.000000
 AGAINST
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 10/11/2024 Approval of an amendment and restatement of the 2018 Equity Incentive Plan. COMPENSATION
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 10/11/2024 Approval of an adjournment of the meeting in the event a quorum is not achieved. CORPORATE GOVERNANCE
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT FOUR DIRECTORS, EACH TO SERVE A THREE YEAR TERM EXPIRING IN 2027: Douglas D. French DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT FOUR DIRECTORS, EACH TO SERVE A THREE YEAR TERM EXPIRING IN 2027: John R. Hoke III DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT FOUR DIRECTORS, EACH TO SERVE A THREE YEAR TERM EXPIRING IN 2027: Heidi J. Manheimer DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT FOUR DIRECTORS, EACH TO SERVE A THREE YEAR TERM EXPIRING IN 2027: Tina Edekar Edmundson DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT ONE DIRECTOR TO SERVE A ONE-YEAR TERM EXPIRING IN 2025: John Maeda DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Director Vote TO ELECT ONE DIRECTOR TO SERVE A TWO-YEAR TERM EXPIRING IN 2026: Jeanne K. Gang DIRECTOR ELECTIONS
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Proposal to approve, on an advisory basis, the Company's Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
MillerKnoll, Inc. 600544100 US6005441000 - 10/14/2024 Proposal to ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal 2025. AUDIT-RELATED
 - ISSUER 872.000000 0 FOR
 872.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 10/15/2024 Approve an amendment to Purple Innovation, Inc.'s Second Amended and Restated Certificate of Incorporation, to prohibit certain acquisitions of shares of our common stock in order to protect the tax benefits of our approximately $238 million of net operating loss carryforwards, as described in our Proxy Statement. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 10/15/2024 Ratify Purple Innovation Inc.'s NOL Rights Plan in order to deter certain acquisitions of shares of our common stock in order to the tax benefits of our approximately $238 million of net operating loss carryforwards, as described in our Proxy Statement. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 10/15/2024 Approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal Nos. 1 and 2, as described in the our Proxy Statement. CORPORATE GOVERNANCE
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Esther M. Alegria, PhD DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Joseph Carleone, PhD DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Nicholas S. Green DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Richard B. Hancock DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Catherine J. Mackey, PhD DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Gregory P. Sargen DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 Election of Directors: Jeanne A. Thoma DIRECTOR ELECTIONS
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2025. AUDIT-RELATED
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 To approve, by an advisory vote, a non-binding resolution approving the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 To approve an amendment to the Company's 2018 Omnibus Incentive Plan to increase the number of shares reserved thereunder. COMPENSATION
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Avid Bioservices, Inc. 05368M106 US05368M1062 - 10/16/2024 To approve an amendment to the Company's 2010 Employee Stock Purchase Plan to remove the expiration date. COMPENSATION
 - ISSUER 708.000000 0 FOR
 708.000000
 FOR
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Election of Directors: Howard W. Lutnick DIRECTOR ELECTIONS
 - ISSUER 1942.000000 0 WITHHOLD
 1942.000000
 AGAINST
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Election of Directors: Virginia S. Bauer DIRECTOR ELECTIONS
 - ISSUER 1942.000000 0 WITHHOLD
 1942.000000
 AGAINST
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Election of Directors: Kenneth A. McIntyre DIRECTOR ELECTIONS
 - ISSUER 1942.000000 0 WITHHOLD
 1942.000000
 AGAINST
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Election of Directors: Jay Itzkowitz DIRECTOR ELECTIONS
 - ISSUER 1942.000000 0 FOR
 1942.000000
 FOR
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Approval of the ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2024. AUDIT-RELATED
 - ISSUER 1942.000000 0 FOR
 1942.000000
 FOR
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Approval, on an advisory basis, of executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1942.000000 0 AGAINST
 1942.000000
 AGAINST
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Approval of the amendment and restatement of the Company's Amended and Restated Certificate of Incorporation to provide for officer exculpation to the extent permitted under Delaware law. CORPORATE GOVERNANCE
 - ISSUER 1942.000000 0 AGAINST
 1942.000000
 AGAINST
 - -
Newmark Group, Inc. 65158N102 US65158N1028 - 10/17/2024 Approval of the Amended and Restated Newmark Group, Inc. Long Term Incentive Plan. COMPENSATION
 - ISSUER 1942.000000 0 AGAINST
 1942.000000
 AGAINST
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Mark W. Adams DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Shankar Arumugavelu DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Prat S. Bhatt DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Judy Bruner DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Michael R. Cannon DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Richard L. Clemmer DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Yolanda L. Conyers DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Jay L. Geldmacher DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Dylan G. Haggart DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: William D. Mosley DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Election of Directors: Stephanie Tilenius DIRECTOR ELECTIONS
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Approve, in an Advisory, Non-binding Vote, the Compensation of the Company's Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 A Non-binding Ratification of the Appointment of Ernst & Young LLP as the Independent Auditors for the Fiscal Year Ending June 27, 2025 and Binding Authorization of the Audit and Finance Committee to Set Auditors' Remuneration. AUDIT-RELATED
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
Seagate Technology Holdings plc G7997R103 IE00BKVD2N49 - 10/19/2024 Determine the Price Range for the Re-allotment of Treasury Shares under Irish law. CAPITAL STRUCTURE
 - ISSUER 2826.000000 0 FOR
 2826.000000
 FOR
 - -
The First Bancshares, Inc. 318916103 US3189161033 - 10/22/2024 A proposal to approve the Agreement and Plan of Merger, dated as of July 29, 2024, by and between Renasant Corporation and The First Bancshares, Inc., and the transactions contemplated thereby, including the merger of The First Bancshares, Inc. with and into Renasant Corporation, with Renasant Corporation as the surviving corporation (the "merger"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
The First Bancshares, Inc. 318916103 US3189161033 - 10/22/2024 A proposal to approve, on an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of The First Bancshares, Inc. in connection with the merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 120.000000 0 AGAINST
 120.000000
 AGAINST
 - -
The First Bancshares, Inc. 318916103 US3189161033 - 10/22/2024 A proposal to approve one or more adjournments of the Special Meeting of The First Bancshares, Inc. shareholders, if necessary or appropriate, to solicit additional proxies in favor of approval of Proposal 1. CORPORATE GOVERNANCE
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Danimer Scientific, Inc. 236272407 US2362724070 - 10/23/2024 To approve an amendment and restatement of Danimer's Fifth Amended and Restated Certificate of Incorporation ("Charter") to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of the Company's Class A common stock, par value $0.0001 per share, into a lesser number of shares of Class A common stock at a ratio in a range of 1-for-20 to 1-for-40 ("Range"), with the ratio within such Range to be determined at the discretion of the Board of Directors without further approval or authorization of our stockholders and included in a public announcement. CAPITAL STRUCTURE
 - ISSUER 1055.000000 0 FOR
 1055.000000
 FOR
 - -
Glatfelter Corporation 55939A107 US55939A1079 - 10/23/2024 Share Issuance Proposal, To approve the issuance of shares of common stock of Glatfelter, par value $0.01 per share ("Glatfelter common stock"), to Spinco stockholders in the Merger as contemplated by the RMT Transaction Agreement; EXTRAORDINARY TRANSACTIONS
 - ISSUER 261.000000 0 FOR
 261.000000
 FOR
 - -
Glatfelter Corporation 55939A107 US55939A1079 - 10/23/2024 Charter Amendment Proposals. To approve the amendment of Glatfelter's Amended and Restated Articles of Incorporation: to increase the authorized shares of Glatfelter common stock from 120,000,000 shares to 240,000,000 shares (the "Common Stock Authorization proposal"); and CAPITAL STRUCTURE
 - ISSUER 261.000000 0 FOR
 261.000000
 FOR
 - -
Glatfelter Corporation 55939A107 US55939A1079 - 10/23/2024 to effect a reverse stock split of Glatfelter common stock at a ratio ranging from any whole number between 1-for-3 and 1-for-15, as determined by the Glatfelter Board of Directors in its discretion (the "Reverse Stock Split proposal"); CAPITAL STRUCTURE
 - ISSUER 261.000000 0 FOR
 261.000000
 FOR
 - -
Glatfelter Corporation 55939A107 US55939A1079 - 10/23/2024 Omnibus Plan Proposal. To approve the Magnera Corporation 2024 Omnibus Incentive Plan; and COMPENSATION
 - ISSUER 261.000000 0 AGAINST
 261.000000
 AGAINST
 - -
Glatfelter Corporation 55939A107 US55939A1079 - 10/23/2024 "Golden Parachute" Compensation Proposal. To approve, on an advisory (non-binding) basis, the "golden parachute" compensation payments that will or may be paid by Glatfelter to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 261.000000 0 FOR
 261.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To elect to the Board of Directors the three (3) nominees named in the attached Proxy Statement to serve until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: James R. Buch DIRECTOR ELECTIONS
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To elect to the Board of Directors the three (3) nominees named in the attached Proxy Statement to serve until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Steven D. Menneto DIRECTOR ELECTIONS
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To elect to the Board of Directors the three (3) nominees named in the attached Proxy Statement to serve until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Peter E. Murphy DIRECTOR ELECTIONS
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025. AUDIT-RELATED
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To approve, on a non-binding basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Malibu Boats, Inc. 56117J100 US56117J1007 - 10/23/2024 To approve the Company's 2024 Performance Incentive Plan. COMPENSATION
 - ISSUER 121.000000 0 FOR
 121.000000
 FOR
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 10/23/2024 Approval of an increase in the number of shares of our common stock available for issuance under our 2021 Equity and Incentive Plan by 5,500,000 shares. COMPENSATION
 - ISSUER 62.000000 0 AGAINST
 62.000000
 AGAINST
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 10/23/2024 Approval of the adjournment of the special meeting, if necessary, in the reasonable discretion of the Chairperson of the Board, to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve the plan amendment. CORPORATE GOVERNANCE
 - ISSUER 62.000000 0 AGAINST
 62.000000
 AGAINST
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 To set the number of Directors at nine. CORPORATE GOVERNANCE
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Robert V. Baumgartner DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Julie L. Bushman DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Judith Klimovsky DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: John L. Higgins DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Kim Kelderman DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Alpna Seth DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Rupert Vessey DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Joseph D. Keegan DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Election of Directors: Roeland Nusse DIRECTOR ELECTIONS
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Approve, on an advisory basis, the compensation of our executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Bio-Techne Corporation 09073M104 US09073M1045 - 10/24/2024 Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 5648.000000 0 FOR
 5648.000000
 FOR
 - -
Neogen Corporation 640491106 US6404911066 - 10/24/2024 Election of Directors: James C. Borel DIRECTOR ELECTIONS
 - ISSUER 1258.000000 0 FOR
 1258.000000
 FOR
 - -
Neogen Corporation 640491106 US6404911066 - 10/24/2024 Election of Directors: Jeffrey D. Capello DIRECTOR ELECTIONS
 - ISSUER 1258.000000 0 FOR
 1258.000000
 FOR
 - -
Neogen Corporation 640491106 US6404911066 - 10/24/2024 Election of Directors: Ronald D. Green, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1258.000000 0 FOR
 1258.000000
 FOR
 - -
Neogen Corporation 640491106 US6404911066 - 10/24/2024 To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1258.000000 0 AGAINST
 1258.000000
 AGAINST
 - -
Neogen Corporation 640491106 US6404911066 - 10/24/2024 Ratification of Appointment of BDO USA P.C. as the Company's Independent Registered Public Accounting Firm. AUDIT-RELATED
 - ISSUER 1258.000000 0 FOR
 1258.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 Election of Directors: James Bristol DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 Election of Directors: Dorothy Clarke DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 Election of Directors: Peter Cicala DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 Election of Directors: Sanjeev Luther DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 Election of Directors: William Wexler DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 WITHHOLD
 8.000000
 AGAINST
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 To ratify the appointment of Grant Thornton LLP as the company's independent registered public accounting firm for the 2024 fiscal year. AUDIT-RELATED
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Eterna Therapeutics, Inc. 114082308 US1140823089 - 10/29/2024 To approve, for the purpose of complying with the applicable Nasdaq listing rules, the issuance of shares of the company's common stock (a) pursuant to a securities purchase agreement dated September 24, 2024, (b) in exchange for outstanding convertible notes, (c) in exchange for outstanding warrants to purchase shares of common stock, and (d) upon conversion of 12% senior convertible notes, as further described in the accompanying proxy statement. CAPITAL STRUCTURE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Joseph Alvarado DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Sanjay Chowbey DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Cindy L. Davis DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: William J. Harvey DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: William M. Lambert DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Lorraine M. Martin DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Sagar A. Patel DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Paul Sternlieb DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Election of nine directors for terms expiring in 2025: Steven H. Wunning DIRECTOR ELECTIONS
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending June 30, 2025; AUDIT-RELATED
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Non-Binding (Advisory) Vote to Approve the Compensation Paid to the Company's Named Executive Officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Kennametal Inc. 489170100 US4891701009 - 10/29/2024 Approval of the Kennametal Inc. 2024 Stock and Incentive Plan. COMPENSATION
 - ISSUER 980.000000 0 FOR
 980.000000
 FOR
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Election of Directors: Jeffrey D. Buchanan DIRECTOR ELECTIONS
 - ISSUER 463.000000 0 FOR
 463.000000
 FOR
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Election of Directors: Keith B. Geeslin DIRECTOR ELECTIONS
 - ISSUER 463.000000 0 FOR
 463.000000
 FOR
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Election of Directors: James L. Whims DIRECTOR ELECTIONS
 - ISSUER 463.000000 0 FOR
 463.000000
 FOR
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Proposal to ratify the appointment of KPMG LLP, an independent registered public accounting firm, as the Company's independent auditor for the fiscal year ending June 28, 2025. AUDIT-RELATED
 - ISSUER 463.000000 0 FOR
 463.000000
 FOR
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Proposal to approve the Company's amended and restated 2019 Equity and Incentive Compensation Plan. COMPENSATION
 - ISSUER 463.000000 0 AGAINST
 463.000000
 AGAINST
 - -
Synaptics Incorporated 87157D109 US87157D1090 - 10/29/2024 Proposal to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 463.000000 0 FOR
 463.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Emma S. Battle DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Francis S. Blake DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Albert P. Carey DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Edmund M. Ingle DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Kenneth G. Langone DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Suzanne M. Present DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Rhonda L. Ramlo DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Election of directors: Eva T. Zlotnicka DIRECTOR ELECTIONS
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Advisory vote to approve UNIFI's named executive officer compensation in fiscal 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Unifi, Inc. 904677200 US9046772003 - 10/29/2024 Ratification of the appointment of KPMG LLP to serve as UNIFI's independent registered public accounting firm for fiscal 2025. AUDIT-RELATED
 - ISSUER 81.000000 0 FOR
 81.000000
 FOR
 - -
Tonix Pharmaceuticals Holding Corp. 890260839 US8902608392 - 10/30/2024 The approval of a proposal to authorize the Company's Board of Directors (the "Board"), in its discretion at any time within one year after shareholder approval is obtained, to effect a reverse stock split of then-outstanding shares of the Company's common stock, at a ratio of not less than one-for-two (1:2) and not greater than one-for-one hundred (1:100), with the exact ratio to be determined by the Board and included in a public announcement (the "Reverse Stock Split Proposal"). CAPITAL STRUCTURE
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Tonix Pharmaceuticals Holding Corp. 890260839 US8902608392 - 10/30/2024 To approve an amendment to the Company's Articles of Incorporation, as amended, to increase the Company's authorized shares of common stock to 1,000,000,000 in the event a reverse stock split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal. CAPITAL STRUCTURE
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Lockie Andrews DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Nancy Benacci DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Matthew Doctor DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Mark S. Light DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Michael Mansbach DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: Michael J. Merriman DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Election of Directors: M. Ann Rhoades DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Advisory vote on the compensation of the Company's named executive officers (the "Say-on-Pay Vote"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Regis Corporation 758932206 US7589322061 - 11/06/2024 Approval of the Amended and Restated 2018 Long Term Incentive Plan. COMPENSATION
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Lorinda A. Burgess DIRECTOR ELECTIONS
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Wesley E. Johnson, Jr. DIRECTOR ELECTIONS
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 Proposal to elect three Class III directors, for a term of three years: Karen A. Licitra DIRECTOR ELECTIONS
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2025. AUDIT-RELATED
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
AngioDynamics, Inc. 03475V101 US03475V1017 - 11/12/2024 Approval of an amendment to increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan. COMPENSATION
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 11/12/2024 To approve the issuance of shares of Class A Common Stock of Recursion Pharmaceuticals, Inc. ("Recursion") in connection with Recursion's acquisition of the entire issued and to be issued share capital of Exscientia plc pursuant to a scheme of arrangement under Part 26 of the United Kingdom Companies Act 2006, for purposes of complying with the applicable provisions of the Nasdaq Listing Rules (the "Recursion Share Issuance Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 11/12/2024 To approve any motion to adjourn the special meeting of stockholders of Recursion (the "Recursion Special Meeting") to another time or place, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Recursion Special Meeting to approve the Recursion Share Issuance Proposal. CORPORATE GOVERNANCE
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Talis Biomedical Corporation 87424L207 US87424L2079 - 11/12/2024 Approve Plan of Dissolution EXTRAORDINARY TRANSACTIONS
 - ISSUER 6.000000 0 AGAINST
 6.000000
 AGAINST
 - -
Bally's Corporation 05875B106 US05875B1061 - 11/19/2024 To adopt that certain Agreement and Plan of Merger, dated as of July 25, 2024, (as it has been or may be amended, supplemented or modified from time to time, the "Merger Agreement"), by and among SG Parent LLC, a Delaware limited liability company ("Parent"), The Queen Casino & Entertainment, Inc., a Delaware corporation and affiliate of Parent, Bally's Corporation, a Delaware corporation (the "Company"), Epsilon Sub I, Inc., a Delaware corporation and wholly owned subsidiary of the Company, Epsilon Sub II, Inc., a Delaware corporation and wholly owned subsidiary of the Company, and, solely for purposes of specified provisions of the Merger Agreement, SG CQ Gaming LLC, a Delaware limited liability company (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 191.000000 0 FOR
 191.000000
 FOR
 - -
Bally's Corporation 05875B106 US05875B1061 - 11/19/2024 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the transactions contemplated by the Merger Agreement (the "Advisory Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 191.000000 0 FOR
 191.000000
 FOR
 - -
Bally's Corporation 05875B106 US05875B1061 - 11/19/2024 To adjourn the Special Meeting, from time to time, to a later date or dates to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). CORPORATE GOVERNANCE
 - ISSUER 191.000000 0 FOR
 191.000000
 FOR
 - -
Pioneer Bancorp, Inc. 723561106 US7235611065 - 11/19/2024 Election of Directors: Thomas L. Amell DIRECTOR ELECTIONS
 - ISSUER 69.000000 0 FOR
 69.000000
 FOR
 - -
Pioneer Bancorp, Inc. 723561106 US7235611065 - 11/19/2024 Election of Directors: Shaun Mahoney DIRECTOR ELECTIONS
 - ISSUER 69.000000 0 WITHHOLD
 69.000000
 AGAINST
 - -
Pioneer Bancorp, Inc. 723561106 US7235611065 - 11/19/2024 Election of Directors: Charles Seifert DIRECTOR ELECTIONS
 - ISSUER 69.000000 0 FOR
 69.000000
 FOR
 - -
Pioneer Bancorp, Inc. 723561106 US7235611065 - 11/19/2024 Ratification of the appointment of Bonadio & Co., LLP as the independent registered public accounting firm for the six- month transition period ending December 31, 2024 AUDIT-RELATED
 - ISSUER 69.000000 0 FOR
 69.000000
 FOR
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Reappoint Dessislava Temperley to Cimpress' Board of Directors to serve for a term of three years. DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 AGAINST
 205.000000
 AGAINST
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Approve, on a non-binding, advisory basis, the compensation of Cimpress' named executive officers, as described in the company's proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Amend Cimpress' 2020 Equity Incentive Plan to increase the number of ordinary shares issuable under the plan. COMPENSATION
 - ISSUER 205.000000 0 AGAINST
 205.000000
 AGAINST
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Renew authority of Cimpress' Board of Directors to issue authorized but unissued ordinary shares of Cimpress plc. CAPITAL STRUCTURE
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Renew authority of Cimpress' Board of Directors to opt out of statutory preemption rights. CAPITAL STRUCTURE
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Reappoint PricewaterhouseCoopers Ireland as Cimpress' statutory auditor under Irish law. AUDIT-RELATED
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Cimpress Plc G2143T103 IE00BKYC3F77 - 11/20/2024 Authorize Cimpress' Board of Directors or Audit Committee to determine the remuneration of PricewaterhouseCoopers Ireland. AUDIT-RELATED
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 Election of Directors: James M. Hindman DIRECTOR ELECTIONS
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 Election of Directors: Suzanne Winter DIRECTOR ELECTIONS
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 To approve an amendment to our 2016 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan. COMPENSATION
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 To approve an amendment to our 2007 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance under such plan. COMPENSATION
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Accuray Incorporated 004397105 US0043971052 - 11/21/2024 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025. AUDIT-RELATED
 - ISSUER 550.000000 0 FOR
 550.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Carl T. Berquist DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 WITHHOLD
 278.000000
 AGAINST
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Jody L. Bilney DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Meg G. Crofton DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 WITHHOLD
 278.000000
 AGAINST
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Gilbert R. Davila DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: John Garratt DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Cheryl Henry DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Julie Masino DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Gisel Ruiz DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Company Nominees: COMPANY RECOMMENDED NOMINEE: Darryl L. Wade DIRECTOR ELECTIONS
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Recommended Biglari Nominee: NOMINEE RECOMMENDED BY THE COMPANY: Michael W. Goodwin DIRECTOR ELECTIONS
 - SECURITY HOLDER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Biglari Nominees OPPOSED by the Company NOMINEE OPPOSED BY THE COMPANY: Milena Alberti-Perez DIRECTOR ELECTIONS
 - SECURITY HOLDER 278.000000 0 WITHHOLD
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To elect ten (10) directors to serve on our Board of Directors - Vote "FOR" up to ten (10) nominees in total. You are permitted to vote "FOR" less than ten (10) nominees. If you vote "FOR" more than ten (10) nominees, all of your votes on Proposal 1 will be invalid and will not be counted. Biglari Nominees OPPOSED by the Company NOMINEE OPPOSED BY THE COMPANY: Sardar Biglari DIRECTOR ELECTIONS
 - SECURITY HOLDER 278.000000 0 WITHHOLD
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement that accompanies this notice. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To approve the Company's shareholder rights agreement, which was adopted by our Board of Directors on February 22, 2024 and effective as of February 27, 2024. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 278.000000 0 FOR
 278.000000
 FOR
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Shareholder proposal requesting the Company disclose targets for reducing greenhouse gas emissions. ENVIRONMENT OR CLIMATE
 - SECURITY HOLDER 278.000000 0 FOR
 278.000000
 AGAINST
 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. BIGLARI GROUP Nominees: Milena Alberti-Perez DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. BIGLARI GROUP Nominees: Sardar Biglari DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. BIGLARI GROUP Nominees: Michael W. Goodwin DIRECTOR ELECTIONS
 - SECURITY HOLDER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Jody L. Bilney DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Gilbert R. Davila DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: John Garratt DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Cheryl Henry DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Julie Masino DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Gisel Ruiz DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL Nominees UNOPPOSED BY THE BIGLARI GROUP: Darryl L. Wade DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL NOMINEES OPPOSED BY THE BILGARI GROUP: Carl T. Berquist DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Election of ten (10) nominees to serve as directors until the Company's 2025 annual meeting of shareholders and until their respective successors have been duly elected and qualified. CRACKER BARREL NOMINEES OPPOSED BY THE BILGARI GROUP: Meg G. Crofton DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 The Company's proposal to vote on a non-binding, advisory basis on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 The Company's proposal to approve the Company's shareholder rights agreement, which was adopted by the Board of Directors on February 22, 2024 and effective as of February 27, 2024: SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 The Company's proposal to ratify the appointment of Deloitte & Touche LLP as its independent registered public accounting firm for the 2025 fiscal year: AUDIT-RELATED
 - ISSUER 0.000000 0 - -
Cracker Barrel Old Country Store, Inc. 22410J106 US22410J1060 - 11/21/2024 Shareholder proposal requesting the Company disclose targets for reducing greenhouse gas emissions: ENVIRONMENT OR CLIMATE
 - SECURITY HOLDER 0.000000 0 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 11/21/2024 To elect the Board of Directors' nominees: Robert Connelly DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 11/21/2024 To elect the Board of Directors' nominees: Yekaterina (Katie) Chudnovsky DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 11/21/2024 To elect the Board of Directors' nominees: Allen R. Nissenson, M.D. DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 11/21/2024 To ratify the selection by the Audit Committee of the Board of Directors of Baker Tilly US, LLP as the independent registered public accounting firm of Elicio Therapeutics, Inc. for its fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 11/21/2024 To approve, for purposes of complying with Nasdaq Listing Rule 5635(b), the issuance of shares of common stock issuable upon the exercise of certain warrants and conversion of that certain convertible note. CAPITAL STRUCTURE
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
iBio, Inc. 451033708 US4510337086 - 11/21/2024 Election of Directors: Evert Schimmelpennink DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 WITHHOLD
 2.000000
 AGAINST
 - -
iBio, Inc. 451033708 US4510337086 - 11/21/2024 Election of Directors: Antonio Parada DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
iBio, Inc. 451033708 US4510337086 - 11/21/2024 Election of Directors: David Arkowitz DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
iBio, Inc. 451033708 US4510337086 - 11/21/2024 To ratify the appointment of Grassi & Co., CPAs, P.C. as our independent registered public accounting firm for our fiscal year ending on June 30, 2025. AUDIT-RELATED
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
iBio, Inc. 451033708 US4510337086 - 11/21/2024 To approve, on an advisory, non-binding basis, the compensation of our named executive officers ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Bradley T. Favreau DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Mary E. Gallagher DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Gregory J. Gluchowski DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Luis G. Marconi DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Barry M. Monheit DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 ELECTION OF DIRECTORS: To elect as directors each of the nominees listed below to serve until their successors are elected and qualified at the 2025 Annual Meeting of Stockholders, subject to their earlier death, resignation, disqualification, or removal: Brian D. Murphy DIRECTOR ELECTIONS
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 To ratify the appointment of Grant Thornton LLP, an independent registered public accounting firm, as the independent registered public accountant of our company for the fiscal year ending April 30, 2025. AUDIT-RELATED
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
American Outdoor Brands, Inc. 02875D109 US02875D1090 - 11/25/2024 To adopt amendments to our certificate of incorporation to eliminate the supermajority voting requirements. CORPORATE GOVERNANCE
 - ISSUER 84.000000 0 FOR
 84.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Election of two class III directors to serve until the 2027 Annual Meeting of Stockholders and until such director's successor shall have been duly elected and qualified. COMPANY NOMINEES: COMPANY RECOMMENDED NOMINEE: Karin-Joyce (K.J.) Tjon DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Election of two class III directors to serve until the 2027 Annual Meeting of Stockholders and until such director's successor shall have been duly elected and qualified. COMPANY NOMINEES: COMPANY RECOMMENDED NOMINEE: Dan Fletcher DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Ratification of the appointment of BDO USA, P.C. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Advisory approval of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Approval of the Company's Tax benefit Preservation Plan so that it may remain in effect through January 21, 2027 unless earlier terminated by the Company's Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 775.000000 0 AGAINST
 775.000000
 AGAINST
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Approval of an amendment and restatement of the 2019 Stock Incentive Plan, including to increase the number of shares available for issuance and to make certain other changes. COMPENSATION
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Approval of an amendment and restatement of the 2019 Employee Stock Purchase Plan, including to increase the number of shares available for issuance and to make certain other changes. COMPENSATION
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 11/25/2024 Approval of an amendment to the Company's fourth Amended and Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. CORPORATE GOVERNANCE
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To elect two Class II directors, Raj Mehra, Ph.D. and Brian Lian, Ph.D., nominated by our Board of Directors, to serve until our 2027 annual meeting of stockholders or until his successor is duly elected and qualified: Raj Mehra, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 WITHHOLD
 2.000000
 AGAINST
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To elect two Class II directors, Raj Mehra, Ph.D. and Brian Lian, Ph.D., nominated by our Board of Directors, to serve until our 2027 annual meeting of stockholders or until his successor is duly elected and qualified: Brian Lian, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 WITHHOLD
 2.000000
 AGAINST
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To approve, on an advisory basis, the compensation paid to the Company's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion within the section of the Company's Proxy Statement titled "Executive Compensation". SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company's issued and outstanding common stock, par value $0.001 per share, upon repayment or conversion of up to $1,492,844 of principal amount of that certain Convertible Promissory Note No. 1 in the initial principal amount of $22,000,000 and due November 23, 2024, issued by the Company to Lind Global Asset Management V, LLC on November 23, 2021, as amended on December 10, 2021, February 8, 2023, May 19, 2023, September 30, 2023, March 27, 2024, May 1, 2024, June 1, 2024 and July 16, 2024. CAPITAL STRUCTURE
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company's issued and outstanding common stock, par value $0.001 per share, upon exercise of (i) certain common stock purchase warrants to purchase up to an aggregate of 1,879,478 shares of common stock, issued by the Company, in a private placement, to certain accredited investors, pursuant to that certain Inducement Offer Letter Agreement, dated July 11, 2024, by and among the Company and the investors named on the signatory pages thereto, and (ii) placement agent warrants to purchase up to an aggregate of 65,782 shares of Common Stock, issued by the Company to H.C. Wainwright & Co., LLC. CAPITAL STRUCTURE
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Seelos Therapeutics, Inc. 81577F406 US81577F4063 - 11/25/2024 To approve the adjournment of the Annual Meeting, if necessary, to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 4 and Proposal No. 5. CORPORATE GOVERNANCE
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 11/25/2024 To adopt the Agreement and Plan of Merger, dated as of October 15, 2023 (as may be amended from time to time, the "Merger Agreement"), among Vista Outdoor Inc. ("Vista Outdoor"), Revelyst, Inc. ("Revelyst"), CSG Elevate II Inc. ("Merger Sub Parent"), CSG Elevate III Inc., a wholly owned subsidiary of Merger Sub Parent ("Merger Sub"), and, solely for the purposes of specific provisions therein, CZECHOSLOVAK GROUP a.s. ("CSG"), pursuant to which, on the terms and conditions set forth therein and in accordance with the Delaware General Corporation Law, Merger Sub will merge with and into Vista Outdoor with Vista Outdoor surviving the merger as a wholly owned subsidiary of Merger Sub Parent (the "Merger") (the "Merger Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 11/25/2024 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to Vista Outdoor's named executive officers in connection with the consummation of the Merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
Vista Outdoor Inc. 928377100 US9283771007 - 11/25/2024 To approve adjournments of the Special Meeting (i) to the extent necessary to ensure that any required supplement or amendment to the accompanying proxy statement/prospectus is provided to the Vista Outdoor stockholders within a reasonable amount of time in advance of the Special Meeting, (ii) to the extent required by a court of competent jurisdiction, (iii) if there are insufficient shares of common stock, par value $0.01 per share, of Vista Outdoor represented to constitute a quorum necessary to conduct the business of the Special Meeting or (iv) to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal. CORPORATE GOVERNANCE
 - ISSUER 330.000000 0 FOR
 330.000000
 FOR
 - -
TechTarget, Inc. 87874R100 US87874R1005 - 11/26/2024 Adopt the Agreement and Plan of Merger, dated as of January 10, 2024 (as it may be amended, modified or supplemented from time to time, the "Transaction Agreement"), among TechTarget, Inc. ("TechTarget"), Toro CombineCo, Inc., Toro Acquisition Sub, LLC ("Merger Sub"), Informa PLC, Informa US Holdings Limited, and Informa Intrepid Holdings Inc., that provides for, among other things, the merger of Merger Sub with and into TechTarget (collectively, the "Transactions"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 305.000000 0 FOR
 305.000000
 FOR
 - -
TechTarget, Inc. 87874R100 US87874R1005 - 11/26/2024 Approve, on a non-binding, advisory basis, the compensation that will be or may become payable to TechTarget's named executive officers in connection with the Transactions. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 305.000000 0 FOR
 305.000000
 FOR
 - -
TechTarget, Inc. 87874R100 US87874R1005 - 11/26/2024 Adopt the proposed TechTarget, Inc. 2024 Incentive Plan. COMPENSATION
 - ISSUER 305.000000 0 FOR
 305.000000
 FOR
 - -
TechTarget, Inc. 87874R100 US87874R1005 - 11/26/2024 Adopt the proposed TechTarget, Inc. 2024 Employee Stock Purchase Plan. COMPENSATION
 - ISSUER 305.000000 0 FOR
 305.000000
 FOR
 - -
TechTarget, Inc. 87874R100 US87874R1005 - 11/26/2024 Approve the adjournment of the special meeting if TechTarget determines that it is necessary to permit further solicitation of proxies in the event there are not sufficient votes at the time of the special meeting to adopt the Transaction Agreement. CORPORATE GOVERNANCE
 - ISSUER 305.000000 0 FOR
 305.000000
 FOR
 - -
Aptiv Plc - - - 12/02/2024 Authorize the directors of Aptiv PLC to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect; to amend the articles of association of Aptiv PLC so that any Company Shares that are issued on or after the Voting Record Time to persons other than New Aptiv or its nominees will either be subject to the terms of the Scheme or immediately and automatically acquired by New Aptiv and/or its nominee(s) for the Scheme consideration of ordinary shares in New Aptiv; subject to and conditional upon the Scheme becoming effective, to change the name and status of Aptiv. EXTRAORDINARY TRANSACTIONS
 - ISSUER 4627.000000 0 FOR
 4627.000000
 FOR
 - -
Aptiv Plc - - - 12/02/2024 Subject to and conditional upon the Scheme becoming effective, the Merger Agreement proposed to be entered into between Aptiv PLC and Aptiv Swiss Holdings Limited be hereby approved all purposes, including (without limitation) for the purposes of Article 127F(1) of the Companies Law; and the directors of Aptiv PLC (or a duly authorized committee thereof) be and are authorized to take all such action as they may consider necessary or desirable for the implementation of the Merger pursuant to the terms and subject to the conditions contained in the Merger Agreement. EXTRAORDINARY TRANSACTIONS
 - ISSUER 4627.000000 0 FOR
 4627.000000
 FOR
 - -
Aptiv Plc G3265R107 JE00BTDN8H13 - 12/02/2024 That the Scheme in its original form or with or subject to any modification(s), addition(s) of condition(s) approved or imposed by the Royal Court of Jersey to be agreed to. EXTRAORDINARY TRANSACTIONS
 - ISSUER 4627.000000 0 FOR
 4627.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 Election of Class II Directors: John O. Agwunobi DIRECTOR ELECTIONS
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 Election of Class II Directors: Elisabeth Leiderman DIRECTOR ELECTIONS
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 Election of Class II Directors: Andrew Obenshain DIRECTOR ELECTIONS
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 The approval, on a non-binding, advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 The approval of an amendment to our Amended and Restated Certificate of Incorporation to provide for the exculpation of officers for certain breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware. CORPORATE GOVERNANCE
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 The approval of amendments to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio ranging from any whole number between 1-for-15 and 1-for-20, as determined by our Board of Directors in its discretion. CAPITAL STRUCTURE
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 The approval of an amendment and restatement of our 2023 Incentive Award Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder. COMPENSATION
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 Ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
bluebird bio, Inc. 09609G209 US09609G2093 - 12/04/2024 The approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal 3, Proposal 4 and/or Proposal 5. CORPORATE GOVERNANCE
 - ISSUER 402.000000 0 FOR
 402.000000
 FOR
 - -
Molecular Templates, Inc. 608550208 US6085502085 - 12/04/2024 To adopt and approve the dissolution of the Company in accordance with Section 275 of the Delaware General Corporation Law and the Plan of Liquidation and Dissolution which will authorize the Board of Directors of the Company to liquidate the Company in accordance with the terms thereof (the "Dissolution Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 14.000000 0 FOR
 14.000000
 FOR
 - -
Molecular Templates, Inc. 608550208 US6085502085 - 12/04/2024 To approve an adjournment of the special meeting, from time to time, if deemed necessary or advisable by the Board of Directors or a committee thereof, including to solicit additional proxies if there are not sufficient votes at the time of the special meeting to approve the Dissolution Proposal. CORPORATE GOVERNANCE
 - ISSUER 14.000000 0 FOR
 14.000000
 FOR
 - -
Outbrain Inc. 69002R103 US69002R1032 - 12/05/2024 To approve, for the purposes of complying with Nasdaq Listing Rule 5635(a) and (b), the issuance of 35 million shares of common stock, par value $0.001 per share, of Outbrain Inc. (the "Common Stock") and 10.5 million Series A Convertible Preferred Shares, par value $0.001 per share, of Outbrain Inc., which are convertible into Common Stock, in connection with the acquisition by Outbrain Inc., directly and via certain of its subsidiaries, of all of the issued and outstanding equity interests of Teads S.A., a public limited liability company (societe anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg ("Teads"), from Altice Teads S.A., a public limited liability company (societe anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, after which Teads will become a wholly owned subsidiary of Outbrain Inc.; and EXTRAORDINARY TRANSACTIONS
 - ISSUER 127.000000 0 FOR
 127.000000
 FOR
 - -
Outbrain Inc. 69002R103 US69002R1032 - 12/05/2024 To postpone or adjourn the special meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the special meeting to approve Proposal 1. CORPORATE GOVERNANCE
 - ISSUER 127.000000 0 FOR
 127.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To elect directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified: Tommy G. Thompson DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To elect directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified: Cooper C. Collins DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To elect directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified: Gail K. Naughton, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To elect directors to serve until the next annual meeting of stockholders or until their successors are duly elected and qualified: Justin Roberts DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To approve, on a non-binding advisory basis, the compensation of our named executive officers for the fiscal year ended December 31, 2023. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
TherapeuticsMD, Inc. 88338N206 US88338N2062 - 12/05/2024 To ratify the appointment of Berkowitz Pollack Brant Advisors + CPAs, LLP, an independent registered public accounting firm, as the independent auditor of the company for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve an amendment to our Articles of Incorporation, as amended, to effect a reverse stock split of our outstanding common stock at a ratio between 1-for-2 and 1-for-250, to be determined at the discretion of our board of directors (the "Reverse Split"), for the purpose of complying with the Nasdaq Listing Rules, subject to the Board's discretion to abandon such amendment (Proposal 1). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the issuance of shares of common stock upon exercise of the warrants dated September 29, 2024 (the "Inducement Warrants") in accordance with Nasdaq Listing Rules (Proposal 2). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the issuance of shares of common stock upon exercise of the warrants dated August 27, 2024 (the "August Warrants") in accordance with Nasdaq Listing Rules (Proposal 3). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the issuance of shares of common stock upon exercise of the warrants dated September 13, 2024 (the "September 13 Warrants") in accordance with Nasdaq Listing Rules (Proposal 4). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the issuance of shares of common stock upon exercise of the warrants dated September 27, 2024 (the "September 27 Warrants") in accordance with Nasdaq Listing Rules (Proposal 5). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the issuance of shares of common stock upon exercise of the warrants dated October 11. 2024 (the October 11 Warrants) in accordance with Nasdaq Listing Rules (Proposal 6). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve an amendment to the outstanding convertible Debentures (the "JGB Amendment") pursuant to Rules 5635(b) and 5635(d) of the Nasdaq Stock Market (Proposal 7). CAPITAL STRUCTURE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
22nd Century Group, Inc. 90137F509 US90137F5098 - 12/06/2024 To approve the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of Proposals 1, 2, 3, 4, 5, 6 and/or 7 (Proposal 8). CORPORATE GOVERNANCE
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 Election of Directors: Debra von Storch DIRECTOR ELECTIONS
 - ISSUER 55.000000 0 WITHHOLD
 55.000000
 AGAINST
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 Election of Directors: James Chen DIRECTOR ELECTIONS
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 Election of Directors: Foster Chiang DIRECTOR ELECTIONS
 - ISSUER 55.000000 0 WITHHOLD
 55.000000
 AGAINST
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve, by an advisory vote, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 55.000000 0 AGAINST
 55.000000
 AGAINST
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve, pursuant to Nasdaq Rule 5635, the issuance of shares of our common stock, par value $0.0001 per share ("Common Stock"), to YA II PN, Ltd. ("Yorkville") pursuant to our Prepaid Advance Agreement entered into with Yorkville on July 19, 2024 (as amended and supplemented from time to time, the "July PPA"), in excess of 20% of the number of shares of our Common Stock outstanding on June 13, 2024. CAPITAL STRUCTURE
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve an amendment to the July PPA with Yorkville to lower the minimum floor price at which shares of Common Stock may be sold by us under the July PPA to $0.20 per share. CAPITAL STRUCTURE
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve an amendment to our Prepaid Advance Agreement entered into with Yorkville on July 20, 2022 (as amended and supplemented from time to time, the "2022 PPA"), to lower the minimum floor price at which shares of Common Stock may be sold by us under the 2022 PPA to $0.20 per share. CAPITAL STRUCTURE
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To grant discretionary authority to the Company's board of directors to amend our Second Amended and Restated Certificate of Incorporation, as amended, to effect one or more consolidations of the issued and outstanding shares of our Common Stock with each reverse stock split ratio ranging from 1:2 up to 1:30 (each, a "Reverse Stock Split"); provided that (i) the Company shall not effect Reverse Stock Splits that, in the aggregate, exceed 1:60 and (ii) any Reverse Stock Split is completed prior to the one-year anniversary of the date on which the Reverse Stock Split Proposal is approved by the Company's stockholders. CAPITAL STRUCTURE
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve, pursuant to Nasdaq Rule 5635, the issuance of shares of our Common Stock to certain special purpose vehicles managed by entities affiliated with Tony Aquila, our Chief Executive Officer and Executive Chairman (collectively, the "Series C Purchasers"), upon (i) conversion of the Company's 7.5% Series C Cumulative Perpetual Redeemable Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") pursuant to certain securities purchase agreements entered into with the Series C Purchasers, (ii) election by the Series C Purchasers for payment of dividends on their respective Series C Preferred Stock to be paid in Common Stock and (iii) exercise of warrants to purchase our Common Stock issued in connection with the securities purchase agreements entered into with the Series C Purchasers, in each case, in excess of 20% of the number of shares of our Common Stock outstanding on April 9, 2024. CAPITAL STRUCTURE
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve an amendment to our 2020 Equity Incentive Plan (the "2020 EIP") to increase the number of shares of our Common Stock available and reserved for issuance under the 2020 EIP by an additional 45,000,000 shares of Common Stock. COMPENSATION
 - ISSUER 55.000000 0 AGAINST
 55.000000
 AGAINST
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To approve an amendment to our 2020 Employee Stock Purchase Plan (the "ESPP") to increase the number of shares of our Common Stock available and reserved for issuance under the ESPP by an additional 1,000,000 shares of Common Stock. COMPENSATION
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Canoo Inc. 13803R300 US13803R3003 - 12/06/2024 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 55.000000 0 FOR
 55.000000
 FOR
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 12/10/2024 Nasdaq Proposal. Approval, for purposes of Nasdaq listing rule 5635(b), of the issuance by the Company of that number of shares of Company common stock, par value $0.001 per share (the "Common Stock") that would cause William W. Smith, Jr. to beneficially own twenty percent (20%) or more of the Common Stock or voting power of the Company, through the exercise of that certain warrant to purchase up to 2,575,107 shares of Common Stock (the "Common Warrant"), which was acquired by a trust for which William W. Smith, Jr., our Chairman, President and Chief Executive Officer, serves as co-trustee. CAPITAL STRUCTURE
 - ISSUER 34.000000 0 FOR
 34.000000
 FOR
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 12/10/2024 Approval of an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal 1. CORPORATE GOVERNANCE
 - ISSUER 34.000000 0 FOR
 34.000000
 FOR
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Celia R. Brown DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: James A. Cannavino DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 FOR
 317.000000
 FOR
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Dina Colombo DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 FOR
 317.000000
 FOR
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Eugene F. DeMark DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 FOR
 317.000000
 FOR
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Leonard J. Elmore DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Adam Hanft DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 FOR
 317.000000
 FOR
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Stephanie Redish Hofmann DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Christopher G. McCann DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: James F. McCann DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Christina Shim DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 Election of Directors: Larry Zarin DIRECTOR ELECTIONS
 - ISSUER 317.000000 0 WITHHOLD
 317.000000
 AGAINST
 - -
1-800-FLOWERS.COM, Inc. 68243Q106 US68243Q1067 - 12/11/2024 To ratify the appointment of BDO USA, PC as our independent registered public accounting firm for the fiscal year ending June 29, 2025. AUDIT-RELATED
 - ISSUER 317.000000 0 FOR
 317.000000
 FOR
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Election of Directors: Eric F. Cosentino DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 AGAINST
 85.000000
 AGAINST
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Election of Directors: Howard S. Jonas DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 AGAINST
 85.000000
 AGAINST
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Election of Directors: Irwin Katsof DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Election of Directors: Judah Schorr DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 AGAINST
 85.000000
 AGAINST
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Election of Directors: Elaine S. Yatzkan DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 AGAINST
 85.000000
 AGAINST
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
IDT Corporation 448947507 US4489475073 - 12/12/2024 Advisory vote on frequency of future advisory votes on executive compensation SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 85.000000 0 ONE YEAR
 85.000000
 AGAINST
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Election of Directors: Katrina Lake DIRECTOR ELECTIONS
 - ISSUER 949.000000 0 FOR
 949.000000
 FOR
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Election of Directors: Sharon McCollam DIRECTOR ELECTIONS
 - ISSUER 949.000000 0 WITHHOLD
 949.000000
 AGAINST
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Election of Directors: Elizabeth Williams DIRECTOR ELECTIONS
 - ISSUER 949.000000 0 FOR
 949.000000
 FOR
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Advisory vote on the frequency of solicitation of advisory stockholder approval of executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 949.000000 0 ONE YEAR
 949.000000
 FOR
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 949.000000 0 FOR
 949.000000
 FOR
 - -
Stitch Fix, Inc. 860897107 US8608971078 - 12/12/2024 Ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending August 2, 2025. AUDIT-RELATED
 - ISSUER 949.000000 0 FOR
 949.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Hila Karah DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Dennis Matheis DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Dennis M. McGrath DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Erez Raphael DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Yoav Shaked DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Jon Kaplan DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 Election of Hila Karah, Dennis Matheis, Dennis M. McGrath, Erez Raphael, Jon Kaplan, Yoav Shaked and Adam K. Stern to hold office until the 2025 Annual Meeting of Stockholders or their successors are elected and qualified or until their earlier resignation or removal: Adam K. Stern DIRECTOR ELECTIONS
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 12/18/2024 To ratify the appointment by the Audit Committee of the Company's Board of Kost Forer Gabbay & Kasierer as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Election of Directors Nominees: David B. McWilliams DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 WITHHOLD
 24.000000
 AGAINST
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Election of Directors Nominees: Snehal S. Patel DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 WITHHOLD
 24.000000
 AGAINST
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Election of Directors Nominees: Eric Rothe DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 WITHHOLD
 24.000000
 AGAINST
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Election of Directors Nominees: F. Joseph Daugherty, M.D. DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 WITHHOLD
 24.000000
 AGAINST
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Election of Directors Nominees: Kenneth Hallock DIRECTOR ELECTIONS
 - ISSUER 24.000000 0 WITHHOLD
 24.000000
 AGAINST
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Proposal to ratify RBSM LLP as the Company's independent registered public accountants for fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 24.000000 0 FOR
 24.000000
 FOR
 - -
Greenwich LifeSciences, Inc. 396879108 US3968791083 - 12/19/2024 Proposal to approve an amendment to the Greenwich Life Sciences, Inc. 2019 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance under such plan to 4,000,000 shares from 1,500,000 shares. COMPENSATION
 - ISSUER 24.000000 0 AGAINST
 24.000000
 AGAINST
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified: Ben Errez DIRECTOR ELECTIONS
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified: Fredi Nisan DIRECTOR ELECTIONS
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified: Genevieve Baer DIRECTOR ELECTIONS
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified: David Montoya DIRECTOR ELECTIONS
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified: Ezra Laniado DIRECTOR ELECTIONS
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To ratify the appointment of Simon & Edward, LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To approve, under Nasdaq Listing Rule 5635(d), the issuance to an institutional investor of shares of our common stock in excess of 20% of the number of shares of our common stock outstanding. CAPITAL STRUCTURE
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
RYVYL Inc. 39366L307 US39366L3078 - 12/19/2024 To approve the Company's amendment to the 2023 Equity Incentive Plan. COMPENSATION
 - ISSUER 11.000000 0 AGAINST
 11.000000
 AGAINST
 - -
Grid Dynamics Holdings, Inc. 39813G109 US39813G1094 - 12/23/2024 Election of Class II Directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected and qualified: Lloyd Carney DIRECTOR ELECTIONS
 - ISSUER 530.000000 0 WITHHOLD
 530.000000
 AGAINST
 - -
Grid Dynamics Holdings, Inc. 39813G109 US39813G1094 - 12/23/2024 Election of Class II Directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected and qualified: Michael Southworth DIRECTOR ELECTIONS
 - ISSUER 530.000000 0 FOR
 530.000000
 FOR
 - -
Grid Dynamics Holdings, Inc. 39813G109 US39813G1094 - 12/23/2024 Election of Class II Directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected and qualified: Yueou Wang DIRECTOR ELECTIONS
 - ISSUER 530.000000 0 FOR
 530.000000
 FOR
 - -
Grid Dynamics Holdings, Inc. 39813G109 US39813G1094 - 12/23/2024 The ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 530.000000 0 FOR
 530.000000
 FOR
 - -
Grid Dynamics Holdings, Inc. 39813G109 US39813G1094 - 12/23/2024 The approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 530.000000 0 FOR
 530.000000
 FOR
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Michael S. Weiss DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 WITHHOLD
 28.000000
 AGAINST
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Adam J. Chill DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Neil Herskowitz DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: David Jin DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 WITHHOLD
 28.000000
 AGAINST
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Manuel Litchman, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 WITHHOLD
 28.000000
 AGAINST
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Lindsay A. Rosenwald, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 WITHHOLD
 28.000000
 AGAINST
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Election of Directors: Michael J. Zelefsky, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Mustang Bio, Inc. 62818Q302 US62818Q3020 - 12/26/2024 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024. AUDIT-RELATED
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Eaton Vance Limited Duration Income Fund 27828H105 US27828H1059 - 01/08/2025 Election of three Class I Trustees: Cynthia E. Frost DIRECTOR ELECTIONS
 - ISSUER 309597.000000 0 WITHHOLD
FOR
 6501.388260
303095.611740
 AGAINST
FOR
 - -
Eaton Vance Limited Duration Income Fund 27828H105 US27828H1059 - 01/08/2025 Election of three Class I Trustees: Valerie A. Mosley DIRECTOR ELECTIONS
 - ISSUER 309597.000000 0 WITHHOLD
FOR
 10947.949570
298649.050430
 AGAINST
FOR
 - -
Eaton Vance Limited Duration Income Fund 27828H105 US27828H1059 - 01/08/2025 Election of three Class I Trustees: Scott E. Wennerholm DIRECTOR ELECTIONS
 - ISSUER 309597.000000 0 WITHHOLD
FOR
 6574.332540
303022.667460
 AGAINST
FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Kamran S. Cheema DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Steven P. DenBaars DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Jill K. Frizzley DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Arthur E. Geiss DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Matthew R. Kahn DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Election of Directors: Jerry D. Neal DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Proposal to approve, on a non-binding, advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 287.000000 0 AGAINST
 287.000000
 AGAINST
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Proposal to approve amendments to the Certificate of Incorporation effecting reverse stock splits of the Company's common stock at ratios between 1-for-50 and 1-for-250 inclusive, one of which amendments (and therefore one of which reverse stock split ratios) will be chosen by the Board of Directors in its sole discretion on or prior to the one year anniversary of the state of the Annual Meeting, and the rest of which amendments (and therefore the rest of the reverse stock split ratios) will be abandoned. CAPITAL STRUCTURE
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Akoustis Technologies, Inc. 00973N102 US00973N1028 - 01/09/2025 Proposal to ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2025. AUDIT-RELATED
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
AlloVir, Inc. 482929106 US4829291065 - 01/09/2025 To approve an amendment to our Third Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of our Board of Directors (the "Board"), effect a reverse stock split with respect to our issued and outstanding shares of Common Stock, including any Common Stock held by us as treasury shares, at any time prior to January 10, 2026, at a ratio of not less than 1-for-15 and not greater than 1-for-35 (the "Range"), with the ratio within the Range to be determined at the discretion of the Board without further approval or authorization of our stockholders (the "Reverse Stock Split Proposal") and included in a public announcement. CAPITAL STRUCTURE
 - ISSUER 175.000000 0 FOR
 175.000000
 FOR
 - -
AlloVir, Inc. 482929106 US4829291065 - 01/09/2025 To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal. CORPORATE GOVERNANCE
 - ISSUER 175.000000 0 FOR
 175.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 Election of Directors: Susan Y. Bernstein DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 Election of Directors: Stephen M. Greenberg DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 AGAINST
 60.000000
 AGAINST
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 Election of Directors: Howard S. Jonas DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 AGAINST
 60.000000
 AGAINST
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 Election of Directors: Mark N. Stein DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 Election of Directors: Michael J. Weiss DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 AGAINST
 60.000000
 AGAINST
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 To ratify the appointment of CohnReznick LLP as the Company's independent registered public accounting firm for the Fiscal Year ending July 31, 2025. AUDIT-RELATED
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 01/09/2025 To approve an amendment to the Rafael Holdings, Inc. 2021 Equity Incentive that will increase the number of shares of the Company's Class B common stock available for the grant of awards thereunder by 750,000. COMPENSATION
 - ISSUER 60.000000 0 AGAINST
 60.000000
 AGAINST
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 01/10/2025 Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of our common stock (with a proportionate reduction in the authorized number of shares of common stock) at a ratio in the range of 1-for-25 to 1-for-50. CAPITAL STRUCTURE
 - ISSUER 5152.000000 0 FOR
 5152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Wendi B. Carpenter DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Bruce T. Crawford DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Michael J. Hildebrandt DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Mark R. Quinlan DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: John Ratigan DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Kenneth Traub DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Election of Directors: Lawrence J. Waldman DIRECTOR ELECTIONS
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Approval, on an advisory basis, of the compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2025. AUDIT-RELATED
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
Comtech Telecommunications Corp. 205826209 US2058262096 - 01/13/2025 Approval of an amendment to the Company's 2023 Equity and Incentive Plan (the "2023 Plan") to increase the number of shares of Common Stock available under the 2023 Plan. COMPENSATION
 - ISSUER 152.000000 0 FOR
 152.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 01/15/2025 Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Exchange Agreement. CAPITAL STRUCTURE
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 01/15/2025 Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Securities Purchase Agreement CAPITAL STRUCTURE
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 01/15/2025 Approval of an amendment to the Company's certificate of incorporation, as amended, to increase the total number of shares of common stock the Company is authorized to issue by 200,000,000 shares, from 50,000,000 shares to 250,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 01/15/2025 Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the special meeting to approve the foregoing proposals. CORPORATE GOVERNANCE
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Vincerx Pharma, Inc. 92731L304 US92731L3042 - 01/16/2025 Approval of an amendment to the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the issued shares of our common stock at a ratio ranging from 1 share-for-10 shares up to a ratio of 1 share-for-20 shares, which ratio will be selected by the Board of Directors CAPITAL STRUCTURE
 - ISSUER 95.000000 0 FOR
 95.000000
 FOR
 - -
MiNK Therapeutics, Inc. 603693201 US6036932019 - 01/17/2025 To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued outstanding common stock at a ratio of 1 - for - 10. CAPITAL STRUCTURE
 - ISSUER 11.000000 0 FOR
 11.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 01/24/2025 The approval of an amended and restated 2021 Equity Incentive Plan. COMPENSATION
 - ISSUER 2.000000 0 AGAINST
 2.000000
 AGAINST
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 01/27/2025 To approve, for purposes of complying with NYSE American LLC listing standards and requirements, the issuance of the Company's common shares and common warrants pursuant to the terms of the securities purchase agreement, dated November 19, 2024, between the Company and Broadwood Partners, L.P., the Company's common shares issuable upon exercise of such common warrants. CAPITAL STRUCTURE
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 01/27/2025 To approve the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposal if there are not sufficient votes to approve such proposal at the time of the Meeting or any adjournment or postponement thereof. CORPORATE GOVERNANCE
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Brightcove Inc. 10921T101 US10921T1016 - 01/30/2025 Adoption of the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of November 24, 2024, by and among Bending Spoons US Inc., a Delaware corporation, Bending Spoons S.p.A., an Italian societa per azioni (solely for the purposes of Section 6.11, Section 6.13 and Section 9.15), Blossom Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Bending Spoons US Inc., and Brightcove Inc. ("Brightcove"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Brightcove Inc. 10921T101 US10921T1016 - 01/30/2025 Approval of, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Brightcove's named executive officers in connection with the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Brightcove Inc. 10921T101 US10921T1016 - 01/30/2025 Approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
MEI Pharma, Inc. 55279B301 US55279B3015 - 01/30/2025 To elect two directors to our Board of Directors, to serve until the expiration of their terms in fiscal year 2028 and until their successor is elected and qualified: Frederick W. Driscoll DIRECTOR ELECTIONS
 - ISSUER 33.000000 0 WITHHOLD
 33.000000
 AGAINST
 - -
MEI Pharma, Inc. 55279B301 US55279B3015 - 01/30/2025 To elect two directors to our Board of Directors, to serve until the expiration of their terms in fiscal year 2028 and until their successor is elected and qualified: Nicholas R. Glover, Ph.D DIRECTOR ELECTIONS
 - ISSUER 33.000000 0 FOR
 33.000000
 FOR
 - -
MEI Pharma, Inc. 55279B301 US55279B3015 - 01/30/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 33.000000 0 FOR
 33.000000
 FOR
 - -
MEI Pharma, Inc. 55279B301 US55279B3015 - 01/30/2025 To ratify the appointment of Deloitte & Touche LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending June 30, 2025. AUDIT-RELATED
 - ISSUER 33.000000 0 FOR
 33.000000
 FOR
 - -
Kirkland's, Inc. 497498105 US4974981056 - 02/05/2025 To approve, subject to certain conditions, the issuance of shares of common stock to Beyond, Inc. pursuant to Nasdaq Listing Rules 5635(b) and 5635(d). CAPITAL STRUCTURE
 - ISSUER 74.000000 0 FOR
 74.000000
 FOR
 - -
Kirkland's, Inc. 497498105 US4974981056 - 02/05/2025 To approve one or more adjournments of the Special Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposal. CORPORATE GOVERNANCE
 - ISSUER 74.000000 0 FOR
 74.000000
 FOR
 - -
Kirkland's, Inc. 497498105 US4974981056 - 02/05/2025 To approve an amendment to the Amended and Restated Charter of the Company to reduce the number of authorized shares of common stock from 100,000,000 to 80,000,000. CAPITAL STRUCTURE
 - ISSUER 74.000000 0 FOR
 74.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Arun Sarin DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Brian Krzanich DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Marianne Budnik DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Douglas Davis DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Marcy Klevorn DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Kristi Ann Matus DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Election of seven directors named in the proxy statement, each to serve for a one-year term and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal: Alfred Nietzel DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Ratification of the appointment of BDO USA PC as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025; and AUDIT-RELATED
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Cerence Inc. 156727109 US1567271093 - 02/13/2025 Approval of an amendment to the Company's amended and restated certificate of incorporation to limit the liability of certain officers of the Company in certain circumstances as permitted pursuant to recent amendments to the Delaware General Corporation Law. CORPORATE GOVERNANCE
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 02/19/2025 To approve an amendment to our Restated Articles of Incorporation to increase the number of shares of common stock authorized for issuance from 500,000,000 shares to 800,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 1115.000000 0 FOR
 1115.000000
 FOR
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 02/19/2025 To approve one or more adjournments of the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if we conclude that there are insufficient votes to approve Proposal No. 1 at the time of the Special Meeting (or any adjournment thereof). CORPORATE GOVERNANCE
 - ISSUER 1115.000000 0 FOR
 1115.000000
 FOR
 - -
Singular Genomics Systems, Inc. 82933R308 US82933R3084 - 02/19/2025 To approve the adoption of the Agreement and Plan of Merger, dated as of December 22, 2024, by and among Singular Genomics Systems, Inc., Singular Genomics Parent, LLC, a Delaware limited liability company ("Parent") and Saturn Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent, as it may be amended from time to time (the "Merger Agreement"), and the transactions contemplated by the Merger Agreement, including the Merger. EXTRAORDINARY TRANSACTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Singular Genomics Systems, Inc. 82933R308 US82933R3084 - 02/19/2025 To approve the adoption of any proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
EMCORE Corporation 290846401 US2908464017 - 02/27/2025 Approval of the Agreement and Plan of Merger, dated as of November 7, 2024, by and among EMCORE Corporation ("EMCORE"), Velocity One Holdings, LP, Aerosphere Power Inc., and Velocity Merger Sub, Inc. ("Merger Sub") (as it may be amended from time to time, the "Merger Agreement") and the transactions contemplated by the Merger Agreement, including the merger of Merger Sub with and into EMCORE. EXTRAORDINARY TRANSACTIONS
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
EMCORE Corporation 290846401 US2908464017 - 02/27/2025 Approval of, on an advisory (non-binding) basis, the "golden parachute" compensation that will or may be paid or become payable to EMCORE's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
EMCORE Corporation 290846401 US2908464017 - 02/27/2025 Approval of the adjournment of the special meeting of shareholders, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve Proposal 1 at the time of such special meeting. CORPORATE GOVERNANCE
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
Stronghold Digital Mining, Inc. 86337R202 US86337R2022 - 02/27/2025 Approve and adopt the merger agreement and approve of the transactions contemplated thereby, including the merger, as set forth in our proxy statement. EXTRAORDINARY TRANSACTIONS
 - ISSUER 5.000000 0 FOR
 5.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 03/05/2025 Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of, or in excess of, 20% of the Company's outstanding common stock upon conversion of the Series A Preferred Stock at less than the "minimum price and which may be deemed a "change of control" under Nasdaq Listing Rule 5635; CAPITAL STRUCTURE
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 03/05/2025 Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of the Company's Series A Preferred Stock to certain of the Company's directors, officers and employees and any shares of the Company's common stock issuable upon the conversion thereof; CAPITAL STRUCTURE
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 03/05/2025 Approval of an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-15, inclusive, as determined by the Company's board of directors in its discretion, subject to the Company's board of directors' authority to abandon such amendments; and CAPITAL STRUCTURE
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 03/05/2025 Approval of the adjournment of the Special Meeting, if necessary in the reasonable discretion of the Company's board of directors, the Chair of the Board, the President or the Corporate Secretary to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve any of the other proposals. CORPORATE GOVERNANCE
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 03/11/2025 To approve the Transaction, the Asset Purchase Agreement and the other transactions and ancillary documents contemplated by the Asset Purchase Agreement. EXTRAORDINARY TRANSACTIONS
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
AlloVir, Inc. 482929106 US4829291065 - 03/12/2025 To approve (i) the issuance of shares of common stock, par value $0.0001 per share, of AlloVir ("AlloVir common stock"), which will represent more than 20% of the shares of AlloVir common stock outstanding immediately prior to the merger, to stockholders of Kalaris Therapeutics, Inc. ("Kalaris"), pursuant to the terms of the Agreement and Plan of Merger among AlloVir, Kalaris and Aurora Merger Sub, Inc. ("Merger Sub"), dated as of November 7, 2024 (the "merger agreement"), a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, and (ii) the change of control resulting from the merger, pursuant to Nasdaq Listing Rules 5635(a) and 5635(b), respectively (the "Nasdaq stock issuance proposal"); EXTRAORDINARY TRANSACTIONS
 - ISSUER 7.000000 0 AGAINST
 7.000000
 AGAINST
 - -
AlloVir, Inc. 482929106 US4829291065 - 03/12/2025 To approve an amendment to the AlloVir 2020 Stock Option and Grant Plan (the "2020 plan") to (i) increase the number of shares of AlloVir common stock reserved and available for future issuance under the 2020 plan by a number of shares of AlloVir common stock equal to five percent of the total number of shares of AlloVir common stock that are issued and outstanding immediately following the closing of the merger, (ii) establish a new maximum aggregate number of shares of AlloVir common stock that may be granted as incentive stock options, and (iii) extend the term of the 2020 plan to the tenth (10th) anniversary of the closing of the merger (the "2020 plan amendment proposal"); COMPENSATION
 - ISSUER 7.000000 0 AGAINST
 7.000000
 AGAINST
 - -
AlloVir, Inc. 482929106 US4829291065 - 03/12/2025 To approve an adjournment of the AlloVir special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the Nasdaq stock issuance proposal (the "adjournment proposal"); and CORPORATE GOVERNANCE
 - ISSUER 7.000000 0 AGAINST
 7.000000
 AGAINST
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Election of Directors: R. Matthew Neff DIRECTOR ELECTIONS
 - ISSUER 99.000000 0 WITHHOLD
 99.000000
 AGAINST
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Election of Directors: Robert W. Leasure, Jr. DIRECTOR ELECTIONS
 - ISSUER 99.000000 0 FOR
 99.000000
 FOR
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal 2025 AUDIT-RELATED
 - ISSUER 99.000000 0 FOR
 99.000000
 FOR
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Say on Pay - An advisory vote on the approval of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 99.000000 0 FOR
 99.000000
 FOR
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Say on Frequency - An advisory vote on the frequency of future advisory votes on the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 99.000000 0 ONE YEAR
 99.000000
 AGAINST
 - -
Inotiv, Inc. 45783Q100 US45783Q1004 - 03/13/2025 Approve an amendment to the Inotiv, Inc. 2024 Equity Incentive Plan COMPENSATION
 - ISSUER 99.000000 0 FOR
 99.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 03/13/2025 Coliseum Transactions Proposal CAPITAL STRUCTURE
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 03/13/2025 Adjournment Proposal CORPORATE GOVERNANCE
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
Scilex Holding Company - - - 03/19/2025 Proposal to approve any amendment to the Company's Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, $0.0001 par value per share (the "Common Stock"), within a range of 1-for-14 to 1-for-50 (or any number in between), without reducing the authorized number of shares of the Common Stock, and the filing of a final amendment with the ratio within such range to be determined in the sole discretion of the Board of Directors of the Company (the "Board") at any time on or before March 19, 2026, without further approval or authorization of our stockholders (the "Reverse Stock Split Proposal"). CAPITAL STRUCTURE
 - ISSUER 3971.000000 0 FOR
 3971.000000
 FOR
 - -
Scilex Holding Company - - - 03/19/2025 Proposal to consider and vote upon an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Reverse Stock Split Proposal. CORPORATE GOVERNANCE
 - ISSUER 3971.000000 0 FOR
 3971.000000
 FOR
 - -
Cyclo Therapeutics, Inc. 23254X201 US23254X2018 - 03/20/2025 To adopt the Agreement and Plan of Merger, dated as of August 21, 2024, as amended as of December 18, 2024, among Cyclo, Rafael Holdings, Inc. ("Rafael"), Tandem Therapeutics, Inc., a wholly owned subsidiary of Rafael ("First Merger Sub"), and Tandem Therapeutics, LLC, a wholly owned subsidiary of Rafael ("Second Merger Sub"), as may be amended from time to time (the "Merger Agreement"), pursuant to which, at the First Effective Time (as defined therein), First Merger Sub will merge with and into Cyclo (the "First Merger"), and First Merger Sub will cease to exist, and Cyclo will become a wholly owned subsidiary of Rafael, and (ii) immediately following the First Merger, Cyclo will merge with and into Second Merger Sub, with Second Merger Sub being the Surviving Entity (as defined herein) of the subsequent merger (the "Second Merger" and together with the First Merger, the "Merger"), and all related transactions contemplated thereby. A copy of the Merger Agreement is attached as Annex A to the joint proxy statement/prospectus accompanying this notice. This proposal is referred to as the "Cyclo Merger Proposal." EXTRAORDINARY TRANSACTIONS
 - ISSUER 19.000000 0 FOR
 19.000000
 FOR
 - -
Cyclo Therapeutics, Inc. 23254X201 US23254X2018 - 03/20/2025 To approve the adjournment from time to time of the Cyclo Special Meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Cyclo Special Meeting to approve the Cyclo Merger Proposal or if there are insufficient shares of Cyclo Common Stock present or represented by proxy at the Cyclo Special Meeting to constitute a quorum at the Cyclo Special Meeting or any adjournment or postponement thereof. This proposal is referred to as the "Cyclo Adjournment Proposal." CORPORATE GOVERNANCE
 - ISSUER 19.000000 0 FOR
 19.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 03/20/2025 To consider and vote upon a proposal to approve the issuance of shares of Rafael Class B Common Stock in exchange for shares of common stock of Cyclo Therapeutics, Inc., a Nevada corporation ("Cyclo"), in connection with a merger transaction with Cyclo (the "Rafael Share Issuance Proposal"); and EXTRAORDINARY TRANSACTIONS
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Rafael Holdings, Inc. 75062E106 US75062E1064 - 03/20/2025 To consider and vote upon a proposal to approve the adjournment of the Rafael Special Meeting to a later date or dates, if necessary, to permit further solicitation of proxies in the event there are insufficient votes present in person or by proxy for, or otherwise in connection with, the approval of the Rafael Share Issuance Proposal ("Rafael Adjournment Proposal"). CORPORATE GOVERNANCE
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 03/27/2025 To adopt the Agreement and Plan of Merger (as it may be amended from time to time), dated January 8, 2025 (the "Merger Agreement"), by and among Accolade, Inc., a Delaware corporation ("Accolade"), Transcarent, Inc., a Delaware corporation ("Parent"), and Acorn Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub will merge with and into Accolade (the "Merger"), and approve the Merger and the transactions contemplated by the Merger Agreement (the "Merger Agreement Proposal"). EXTRAORDINARY TRANSACTIONS
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 03/27/2025 To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Accolade to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
Accolade, Inc. 00437E102 US00437E1029 - 03/27/2025 To approve the adjournment of the special meeting of stockholders of Accolade (the "Special Meeting"), from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the Merger Agreement Proposal at the time of the Special Meeting. CORPORATE GOVERNANCE
 - ISSUER 601.000000 0 FOR
 601.000000
 FOR
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve the issuance of shares of Cara common stock pursuant to the Merger, which (i) will represent more than 20% of the shares of Cara common stock outstanding immediately prior to the Merger and (ii) result in the change of control of Cara, pursuant to Rules 5635(a) and 5635(b) of Nasdaq, respectively, referred to as the Stock Issuance Proposal. EXTRAORDINARY TRANSACTIONS
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve the Tvardi Therapeutics, Inc. 2025 Equity Incentive Plan, referred to as the Equity Plan Proposal. COMPENSATION
 - ISSUER 22.000000 0 AGAINST
 22.000000
 AGAINST
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve the Tvardi Therapeutics, Inc. 2025 Employee Stock Purchase Plan, referred to as the ESPP Proposal. COMPENSATION
 - ISSUER 22.000000 0 AGAINST
 22.000000
 AGAINST
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve an amendment to the amended and restated certificate of incorporation of Cara to effect a reverse stock split of Cara common stock at a ratio within the range between, 1-for-2 to 1-for-4 (with such ratio to be mutually agreed upon by the Cara Board and the Tvardi Board prior to the effectiveness of the Merger or, if the Stock Issuance Proposal is not approved by Cara stockholders, determined solely by the Cara Board), referred to as the Reverse Stock Split Proposal. CAPITAL STRUCTURE
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve an amendment to the Cara amended and restated certificate of incorporation to increase the number of authorized shares of Cara common stock from 16,666,667 shares to 150,000,000 shares, referred to as the Authorized Share Proposal. CAPITAL STRUCTURE
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve, on a non-binding, advisory basis, the compensation that will or may become payable by Cara to its named executive officers in connection with the Merger, referred to as the Compensation Proposal. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
CARA Therapeutics, Inc. 140755307 US1407553072 - 04/01/2025 Approve a postponement or adjournment of the Cara special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Stock Issuance Proposal, the Reverse Stock Split Proposal and/or the Authorized Share Proposal, referred to as the Adjournment Proposal. CORPORATE GOVERNANCE
 - ISSUER 22.000000 0 FOR
 22.000000
 FOR
 - -
Nevro Corp. 64157F103 US64157F1030 - 04/02/2025 To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 6, 2025, by and among Globus Medical, Inc., a Delaware corporation ("Globus"), Palmer Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Globus ("Merger Sub"), and Nevro Corp., a Delaware corporation ("Nevro"), pursuant to which Merger Sub will be merged with and into Nevro, with Nevro surviving as a wholly owned subsidiary of Globus (the "Merger"); EXTRAORDINARY TRANSACTIONS
 - ISSUER 405.000000 0 FOR
 405.000000
 FOR
 - -
Nevro Corp. 64157F103 US64157F1030 - 04/02/2025 To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or otherwise relates to the Merger; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 405.000000 0 AGAINST
 405.000000
 AGAINST
 - -
Nevro Corp. 64157F103 US64157F1030 - 04/02/2025 To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting. CORPORATE GOVERNANCE
 - ISSUER 405.000000 0 FOR
 405.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Election of Directors: Dennis A. Ausiello DIRECTOR ELECTIONS
 - ISSUER 414.000000 0 WITHHOLD
 414.000000
 AGAINST
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Election of Directors: Willard H. Dere DIRECTOR ELECTIONS
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Election of Directors: Eric D. Shaff DIRECTOR ELECTIONS
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval of the Seres Therapeutics, Inc. 2025 Incentive Award Plan as an amendment and restatement of the Seres Therapeutics, Inc. 2015 Incentive Award Plan, which is scheduled to expire in 2025. COMPENSATION
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split. CAPITAL STRUCTURE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to clarify voting requirements to amend the number of shares of authorized common stock and preferred stock. CAPITAL STRUCTURE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval of amendments to our Restated Certificate of Incorporation, as amended, to eliminate supermajority voting requirements. CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Seres Therapeutics, Inc. 81750R201 US81750R2013 - 04/10/2025 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposals 5, 6 or 7. CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 04/17/2025 Approve, for purposes of Nasdaq Listing Rule 5635(b), the issuance by PLBY Group, Inc. of 16,956, 842 shares of its common stock, par value $0.0001 per share, at a sale price of $1.50 per share to The Million S.a.r.l., pursuant to the terms of the Securities Purchase Agreement, dated December 14, 2024, by and between PLBY Group, Inc. and The Million S.a.r.l. CAPITAL STRUCTURE
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 04/17/2025 Approve the adjournment of the Special Meeting, if necessary, to continue to solicit votes in favor of Proposal 1 above. CORPORATE GOVERNANCE
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
Blackstone Strategic Credit 2027 Term Fund 09257R101 US09257R1014 - 04/23/2025 Election of one Nominee for Trustee: Daniel Leiter DIRECTOR ELECTIONS
 - ISSUER 91382.000000 0 FOR
 91382.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Jane H. Hsiao, Ph.D., MBA DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Elias A. Zerhouni, M.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven D. Rubin DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Gary J. Nabel, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard M. Krasno, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Prem A. Lachman, M.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Roger J. Medel, M.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: John A. Paganelli DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 AGAINST
 2343.000000
 AGAINST
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Richard C. Pfenniger, Jr DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2026 annual meeting of stockholders or until their respective successors are duly elected and qualified: Alice Lin-Tsing Yu, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 To approve a non-binding resolution regarding the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
OPKO Health, Inc. 68375N103 US68375N1037 - 04/23/2025 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 2343.000000 0 FOR
 2343.000000
 FOR
 - -
Liberty TripAdvisor Holdings, Inc. 531465102 US5314651028 - 04/24/2025 A proposal to approve the adoption of the Agreement and Plan of Merger, dated December 18, 2024 (as may be amended from time to time, the "merger agreement"), by and among Tripadvisor, Inc., a Delaware corporation ("Tripadvisor"), Liberty TripAdvisor Holdings, Inc., a Delaware corporation ("Liberty TripAdvisor"), and Telluride Merger Sub Corp., a Delaware corporation and an indirect wholly owned subsidiary of Tripadvisor ("Merger Sub"), pursuant to which Merger Sub will merge with and into Liberty TripAdvisor (the "merger"), with Liberty TripAdvisor surviving the merger as the surviving corporation and becoming an indirect wholly owned subsidiary of Tripadvisor (the "merger proposal"); EXTRAORDINARY TRANSACTIONS
 - ISSUER 434.000000 0 FOR
 434.000000
 FOR
 - -
Liberty TripAdvisor Holdings, Inc. 531465102 US5314651028 - 04/24/2025 A proposal to approve the adoption of an amendment to the Liberty TripAdvisor certificate of incorporation, which amends certain provisions of the certificate of designations to provide that, in connection with the merger all shares of Liberty TripAdvisor preferred stock issued and outstanding immediately prior to the effective time of the merger (other than the excluded treasury shares) will be converted into the right to receive the preferred share merger consideration (the "charter amendment proposal"); CAPITAL STRUCTURE
 - ISSUER 434.000000 0 FOR
 434.000000
 FOR
 - -
Liberty TripAdvisor Holdings, Inc. 531465102 US5314651028 - 04/24/2025 A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Liberty TripAdvisor's named executive officers that is based on or related to the merger agreement and the transactions contemplated thereby; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 434.000000 0 AGAINST
 434.000000
 AGAINST
 - -
Liberty TripAdvisor Holdings, Inc. 531465102 US5314651028 - 04/24/2025 A proposal to approve the adjournment of the special meeting from time to time to solicit additional proxies in favor of the merger proposal or the charter amendment proposal, as applicable, if there are insufficient votes at the time of such adjournment to approve the merger proposal or the charter amendment proposal, as applicable, or if otherwise determined by the chairperson of the meeting to be necessary or appropriate. CORPORATE GOVERNANCE
 - ISSUER 434.000000 0 FOR
 434.000000
 FOR
 - -
DarioHealth Corp. 23725P209 US23725P2092 - 04/28/2025 To approve, for purposes of Nasdaq Listing Rule 5635(d) (A) (i) the conversion of 25,605 shares of the Company's Series D, D-1, D-2 and D-3 Preferred Stock into an aggregate of 33,956,850 shares of common stock, $0.0001 par value per share (the "Common Stock"), which were issued pursuant to private placement transactions that closed on December 18, 2024 and January 14, 2025 (the "Private Placement"), (ii) the issuance of up to 13,582,740 shares of Common Stock issuable as dividends to the shares of the Company's Series D, D-1, D-2 and D-3 Preferred Stock; and (iii) to approve the issuance of up to 4,175,070 shares of Common Stock issuable as share consideration provided under the lock up agreements executed between the Company and certain purchasers in the Private Placement that are holders of the Company's Series B Preferred Stock and Series C Preferred Stock, pursuant to which the Company agreed to issue, up to forty percent (40%) of the shares of Common Stock underlying the Series B Preferred Stock and the Series C Preferred Stock held by such purchaser, including dividend shares of Common Stock due upon conversion of these shares into shares of Common Stock, over the course of twelve (12) months, and (B) (i) reduce the exercise price of certain warrants to purchase 584,882 shares of Common Stock issued to Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P. (collectively "Avenue") to $0.7208 per share, and (ii) to permit the conversion of up to two million dollars of the principal amount of the loan issued by Avenue to the Company at a conversion price of $0.8650 per share. CAPITAL STRUCTURE
 - ISSUER 80.000000 0 FOR
 80.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to approve the voting cutback proposal, being the amendment of Bye-Law 1.1. and Bye-Law 33 of the Bye-Laws of Maiden Holdings, Ltd. ("Maiden") to remove the 9.5% voting limitation contained therein; CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to approve the first merger approval bye-law proposal, being the amendment of Bye-Law 87 of the Bye-Laws of Maiden to require that the first merger resolution (as defined below) shall be approved by a simple majority of votes cast at the Maiden special meeting; CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to approve the statutory merger agreement required by Section 105 of the Bermuda Companies Act, in the form attached as Exhibit B to the combination agreement (the "Statutory Merger Agreement") and the merger of Ranger Bermuda Merger Sub Ltd with and into Maiden, pursuant to and in accordance with the terms of the combination agreement and the Statutory Merger Agreement, with Maiden surviving as a direct wholly owned subsidiary of Ranger U.S. Newco LLC and an indirect wholly owned subsidiary of Bermuda NewCo (as defined below) (the "first merger resolution"); EXTRAORDINARY TRANSACTIONS
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to authorize the adjournment of the special meeting by Maiden to permit further solicitation of proxies if a quorum is present and sufficient votes are not represented at the special meeting to approve the first merger resolution or to ensure that any supplement or amendment to the proxy statement/prospectus is timely provided to Maiden shareholders; CORPORATE GOVERNANCE
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to approve the equity incentive plan for service providers of Ranger Bermuda Topco Ltd ("Bermuda NewCo") and its subsidiaries; and COMPENSATION
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Maiden Holdings, Ltd. G5260K102 BMG5260K1027 - 04/29/2025 A proposal to approve, by a non-binding, advisory vote, the compensation that may be paid or become payable to Maiden's named executive officers in connection with the mergers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 414.000000 0 FOR
 414.000000
 FOR
 - -
Emergent BioSolutions Inc. 29089Q105 US29089Q1058 - 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Keith Katkin DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Emergent BioSolutions Inc. 29089Q105 US29089Q1058 - 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Ronald Richard DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Emergent BioSolutions Inc. 29089Q105 US29089Q1058 - 04/30/2025 To elect three Class I directors to hold office for a term expiring at our 2028 Annual Meeting of Stockholders, each to serve until their respective successors are duly elected and qualified: Kathryn Zoon Ph.D. DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Emergent BioSolutions Inc. 29089Q105 US29089Q1058 - 04/30/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Emergent BioSolutions Inc. 29089Q105 US29089Q1058 - 04/30/2025 To hold, on an advisory basis, a vote to approve the 2024 compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
The E.W. Scripps Company 811054402 US8110544025 - 05/05/2025 Election of Directors: Burton F. Jablin DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 FOR
 335.000000
 FOR
 - -
The E.W. Scripps Company 811054402 US8110544025 - 05/05/2025 Election of Directors: Nishat A. Mehta DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 FOR
 335.000000
 FOR
 - -
The E.W. Scripps Company 811054402 US8110544025 - 05/05/2025 Election of Directors: Kim Williams DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 WITHHOLD
 335.000000
 AGAINST
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Heather L. Mason DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sravan K. Emany DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sigurd C. Kirk DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: William T. McKee DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Brendan P. O'Grady DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Mark L. Reisenauer DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To elect the seven directors named in the Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: David M. Stark DIRECTOR ELECTIONS
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To approve an amendment and restatement of the Company's Amended and Restated 2014 Omnibus Incentive Plan to increase the number of shares available for issuance thereunder. COMPENSATION
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To approve an amendment to the Company's Certificate of Incorporation to effect a reverse stock split at a ratio of not less than 1-for-2 and not greater than 1-for-15, inclusive. CAPITAL STRUCTURE
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
Assertio Holdings, Inc. 04546C205 US04546C2052 - 05/07/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 173.000000 0 FOR
 173.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Turki Saleh A. AlRajhi DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Hussan Arshad DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Douglas Edwards DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Muhammad Asif Seemab DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Rhys Summerton DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 Election of Directors: Muhammad Umair DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 To ratify the appointment of BDO USA LLP as the independent registered public accounting firm of The Children's Place, Inc. for fiscal 2025. AUDIT-RELATED
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 To approve an amendment to the Company's Charter to eliminate the prohibition against stockholders acting by written consent without a stockholder meeting. CORPORATE GOVERNANCE
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 To approve an amendment to the Company's Charter to provide stockholders the right to fill vacancies on the Board in any circumstance. CORPORATE GOVERNANCE
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 To approve an amendment to the Company's Charter to make certain housekeeping amendments. CORPORATE GOVERNANCE
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
The Children's Place, Inc. 168905107 US1689051076 - 05/07/2025 To approve, by non-binding vote, executive compensation as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 161.000000 0 AGAINST
 161.000000
 AGAINST
 - -
1stdibs.com, Inc. 320551104 US3205511047 - 05/08/2025 The election of three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: David S. Rosenblatt DIRECTOR ELECTIONS
 - ISSUER 106.000000 0 FOR
 106.000000
 FOR
 - -
1stdibs.com, Inc. 320551104 US3205511047 - 05/08/2025 The election of three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Everette Taylor DIRECTOR ELECTIONS
 - ISSUER 106.000000 0 WITHHOLD
 106.000000
 AGAINST
 - -
1stdibs.com, Inc. 320551104 US3205511047 - 05/08/2025 The election of three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Paula J. Volent DIRECTOR ELECTIONS
 - ISSUER 106.000000 0 WITHHOLD
 106.000000
 AGAINST
 - -
1stdibs.com, Inc. 320551104 US3205511047 - 05/08/2025 The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 106.000000 0 FOR
 106.000000
 FOR
 - -
GrafTech International Ltd. 384313508 US3843135084 - 05/08/2025 Election of Directors: Michel J. Dumas DIRECTOR ELECTIONS
 - ISSUER 2345.000000 0 FOR
 2345.000000
 FOR
 - -
GrafTech International Ltd. 384313508 US3843135084 - 05/08/2025 Election of Directors: Eric. V. Roegner DIRECTOR ELECTIONS
 - ISSUER 2345.000000 0 FOR
 2345.000000
 FOR
 - -
GrafTech International Ltd. 384313508 US3843135084 - 05/08/2025 Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED
 - ISSUER 2345.000000 0 FOR
 2345.000000
 FOR
 - -
GrafTech International Ltd. 384313508 US3843135084 - 05/08/2025 Approve, on an advisory basis, our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2345.000000 0 FOR
 2345.000000
 FOR
 - -
GrafTech International Ltd. 384313508 US3843135084 - 05/08/2025 To vote, on an advisory basis, on the frequency of the advisory vote on our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2345.000000 0 ONE YEAR
 2345.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: John B. Wood DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: David Borland DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: Maj. Gen. (ret) John W. Maluda DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: Bonnie Carroll DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: Derrick D. Dockery DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: Brad Jacobs DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors are elected and qualified: Fredrick D. Schaufeld DIRECTOR ELECTIONS
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM: To ratify the selection of PricewaterhouseCoopers LLP to serve as the Company's independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 AMENDMENT TO THE AMENDED AND RESTATED 2016 OMNIBUS LONG-TERM INCENTIVE PLAN: To approve Amendment No. 1 to the Amended and Restated 2016 Omnibus Long-Term Incentive Plan of the Company, substantially in the form attached hereto as Exhibit A (the "Plan Amendment"). COMPENSATION
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Telos Corporation 87969B101 US87969B1017 - 05/08/2025 ADVISORY VOTE ON EXECUTIVE COMPENSATION: To approve, on an advisory basis, the compensation of the Company's named executive officers or "say-on-pay". SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 238.000000 0 FOR
 238.000000
 FOR
 - -
Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 - 05/09/2025 To elect the three Class I director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2028 Annual Meeting of the Company's stockholders: Victor F. Ganzi DIRECTOR ELECTIONS
 - ISSUER 235.000000 0 FOR
 235.000000
 FOR
 - -
Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 - 05/09/2025 To elect the three Class I director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2028 Annual Meeting of the Company's stockholders: Devin O'Reilly DIRECTOR ELECTIONS
 - ISSUER 235.000000 0 WITHHOLD
 235.000000
 AGAINST
 - -
Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 - 05/09/2025 To elect the three Class I director nominees identified in the accompanying Proxy Statement to the Board of Directors of the Company, each to serve a three-year term expiring at the 2028 Annual Meeting of the Company's stockholders: Robert M. Williams, Jr. DIRECTOR ELECTIONS
 - ISSUER 235.000000 0 WITHHOLD
 235.000000
 AGAINST
 - -
Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 - 05/09/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending January 3, 2026. AUDIT-RELATED
 - ISSUER 235.000000 0 FOR
 235.000000
 FOR
 - -
Aveanna Healthcare Holdings Inc. 05356F105 US05356F1057 - 05/09/2025 To approve, on an advisory, non-binding basis, the compensation paid to the Company's Named Executive Officers identified in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 235.000000 0 FOR
 235.000000
 FOR
 - -
Retractable Technologies, Inc. 76129W105 US76129W1053 - 05/09/2025 Election of Three Class 1 Directors: Marco Laterza DIRECTOR ELECTIONS
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Retractable Technologies, Inc. 76129W105 US76129W1053 - 05/09/2025 Election of Three Class 1 Directors: Darren E. Findley DIRECTOR ELECTIONS
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Retractable Technologies, Inc. 76129W105 US76129W1053 - 05/09/2025 Election of Three Class 1 Directors: Amy Mack DIRECTOR ELECTIONS
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Retractable Technologies, Inc. 76129W105 US76129W1053 - 05/09/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Retractable Technologies, Inc. 76129W105 US76129W1053 - 05/09/2025 Advisory vote on the frequency of executive compensation advisory votes. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 103.000000 0 ONE YEAR
 103.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: Monty J. Bennett DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: Amish Gupta DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: J. Robison Hays, III DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: David W. Johnson DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: Frederick J. Kleisner DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: Sheri L. Pantermuehl DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 Election of Directors: Davinder "Sonny" Sra DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 To obtain advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 To ratify the appointment of BDO USA, P.C., a national public accounting firm, as the Company's independent auditors for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ashford Hospitality Trust, Inc. 044103794 US0441037944 - 05/13/2025 To approve Amendment No. 5 to the Ashford Hospitality Trust, Inc. 2021 Stock Incentive Plan. COMPENSATION
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Robert W. Pittman DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: James A. Rasulo DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Richard J. Bressler DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Samuel E. Englebardt DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Robert B. Millard DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Cheryl Mills DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Graciela Monteagudo DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The election of the following eight director nominees, each for a one-year term ending at the 2026 Annual Meeting of Stockholders: Kamakshi Sivaramakrishnan DIRECTOR ELECTIONS
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1313.000000 0 FOR
 1313.000000
 FOR
 - -
iHeartMedia, Inc. 45174J509 US45174J5092 - 05/13/2025 The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1313.000000 0 AGAINST
 1313.000000
 AGAINST
 - -
Aemetis, Inc. 00770K202 US00770K2024 - 05/14/2025 To elect Eric A. McAfee and Francis P. Barton as Class I Directors, each to hold office for a three-year term, until their successors are duly elected and qualified: Eric A. McAfee DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
Aemetis, Inc. 00770K202 US00770K2024 - 05/14/2025 To elect Eric A. McAfee and Francis P. Barton as Class I Directors, each to hold office for a three-year term, until their successors are duly elected and qualified: Francis P. Barton DIRECTOR ELECTIONS
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
Aemetis, Inc. 00770K202 US00770K2024 - 05/14/2025 To ratify the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
Aemetis, Inc. 00770K202 US00770K2024 - 05/14/2025 To hold a non-binding advisory vote to approve our executive compensation, as disclosed in this proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission (the "SEC"); and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 161.000000 0 FOR
 161.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 Election of three Class III directors: Thomas Lynch DIRECTOR ELECTIONS
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 Election of three Class III directors: Elisa Schreiber DIRECTOR ELECTIONS
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 Election of three Class III directors: Britain Peakes DIRECTOR ELECTIONS
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 Advisory (non-binding) vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 Advisory (non-binding) vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 242.000000 0 ONE YEAR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 30, 2025. AUDIT-RELATED
 - ISSUER 242.000000 0 FOR
 242.000000
 FOR
 - -
Noodles & Company 65540B105 US65540B1052 - 05/14/2025 To vote on a stockholder proposal regarding simple majority voting requirements. CORPORATE GOVERNANCE
 - SECURITY HOLDER 242.000000 0 FOR
 242.000000
 AGAINST
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 Election of Directors: John Gerber DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 Election of Directors: Scott Bibaud DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 Election of Directors: Steve Shevick DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 Election of Directors: Duy-Loan Le DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 Election of Directors: Suja Ramnath DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 To ratify the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Atomera Incorporated 04965B100 US04965B1008 - 05/15/2025 To approve Amendment No.1 to the Company's 2023 Stock Incentive Plan. COMPENSATION
 - ISSUER 120.000000 0 AGAINST
 120.000000
 AGAINST
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Marcus A. Lemonis DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Joanna C. Burkey DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Barclay F. Corbus DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: William B. Nettles, Jr. DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Debra G. Perelman DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Dr. Robert J. Shapiro DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 Election of Directors: Joseph J. Tabacco, Jr. DIRECTOR ELECTIONS
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 The approval, on an advisory (non-binding) basis, of the compensation paid by the Company to its named executive officers (the "Say on Pay Vote"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 The approval of an amendment and restatement of the Company's Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"). COMPENSATION
 - ISSUER 504.000000 0 AGAINST
 504.000000
 AGAINST
 - -
Beyond, Inc. 690370101 US6903701018 - 05/15/2025 The approval of an amendment to the 2005 Plan to increase the individual award limits for purposes of the issuance of the awards granted to Marcus A. Lemonis, the Company's Executive Chairman that exceed such limits (the "Contingent Awards"). COMPENSATION
 - ISSUER 504.000000 0 FOR
 504.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Election of Directors: Alex Dimitrief DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 AGAINST
 259.000000
 AGAINST
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Election of Directors: Joe Mastrangelo DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Election of Directors: Joseph Nigro DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Ratification of selection of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Non-binding advisory vote to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Eos Energy Enterprises, Inc. 29415C101 US29415C1018 - 05/15/2025 Amendment to our Amended and Restated 2020 Equity Compensation Plan. COMPENSATION
 - ISSUER 259.000000 0 AGAINST
 259.000000
 AGAINST
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: George J. Carter DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: Georgia Murray DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: John N. Burke DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: Dennis J. McGillicuddy DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: Bruce J. Schanzer DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To elect six Directors, each to serve for a term expiring at the 2026 Annual Meeting of Stockholders: Milton P. Wilkins, Jr. DIRECTOR ELECTIONS
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To ratify the Audit Committee's appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
Franklin Street Properties Corp. 35471R106 US35471R1068 - 05/15/2025 To approve, by non-binding vote, our executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 595.000000 0 FOR
 595.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Dr. Kenneth D. Eichenbaum, MD, MSE DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Paul A. Gendron DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Ronald Hundzinski DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Beverly A. Huss DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Carrie Lachance DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Scott Shuda DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Election of Directors: Dr. John J. Sviokla DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Approval, on advisory basis, of the Company's Executive Compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Approval of an amendment increasing the number of shares reserved under the InfuSystem Holdings, Inc. 2021 Equity Incentive Plan. COMPENSATION
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Approval to amend the Company's Amended and Restated Certificate of Incorporation to remove blank check company business combination provisions. CORPORATE GOVERNANCE
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Approval to amend the Company's Amended and Restated Certificate of Incorporation to provide an exclusive forum provision. SHAREHOLDER RIGHTS AND DEFENSES
CORPORATE GOVERNANCE
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Approval to amend the Company's Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
InfuSystem Holdings, Inc. 45685K102 US45685K1025 - 05/15/2025 Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Mark A. Beck DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Gwendolyn M. Bingham DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Kenneth Gardner-Smith DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Robert J. Henkel DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Rita F. Johnson-Mills DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Stephen W. Klemash DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Teresa L. Kline DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Edward A. Pesicka DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Election of nine Directors, each for a one-year term and until their respective successors are elected and qualified: Carissa L. Rollins DIRECTOR ELECTIONS
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Owens & Minor, Inc. 690732102 US6907321029 - 05/15/2025 Advisory vote to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 718.000000 0 FOR
 718.000000
 FOR
 - -
Stereotaxis, Inc. 85916J409 US85916J4094 - 05/15/2025 To elect each of the following directors to serve a three-year term as a Class III director until the 2028 Annual Meeting and until their respective successors are duly elected and qualified: Dr. Nathan Fischel DIRECTOR ELECTIONS
 - ISSUER 295.000000 0 FOR
 295.000000
 FOR
 - -
Stereotaxis, Inc. 85916J409 US85916J4094 - 05/15/2025 To elect each of the following directors to serve a three-year term as a Class III director until the 2028 Annual Meeting and until their respective successors are duly elected and qualified: Mr. Ross B. Levin DIRECTOR ELECTIONS
 - ISSUER 295.000000 0 FOR
 295.000000
 FOR
 - -
Stereotaxis, Inc. 85916J409 US85916J4094 - 05/15/2025 To ratify the appointment of Ernst & Young, LLP as the Corporation's independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED
 - ISSUER 295.000000 0 FOR
 295.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 AGAINST
 1453.000000
 AGAINST
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy DIRECTOR ELECTIONS
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The approval, on an advisory basis, of the compensation paid to our named executive officers in 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
3D Systems Corporation 88554D205 US88554D2053 - 05/16/2025 The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED
 - ISSUER 1453.000000 0 FOR
 1453.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Brian L. Libman DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 WITHHOLD
 10.000000
 AGAINST
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Norma C. Corio DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Andrew Essex DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Cory S. Gardner DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Tyson A. Pratcher DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 Election of Directors: Lance N. West DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 An advisory vote to approve the compensation of the named executive officers of the Company; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Finance of America Companies Inc. 31738L206 US31738L2060 - 05/16/2025 The ratification of the appointment of BDO USA, P.C. as the Independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Elect two (2) Class II directors, nominated by the board of directors, each to serve for a three-year term, and until his successor has been duly elected and qualified or until his earlier death, resignation or removal: Neal Goldman DIRECTOR ELECTIONS
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Elect two (2) Class II directors, nominated by the board of directors, each to serve for a three-year term, and until his successor has been duly elected and qualified or until his earlier death, resignation or removal: Julien Mininberg DIRECTOR ELECTIONS
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's Independent registered public accounting firm for the current fiscal year. AUDIT-RELATED
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve amendments to our amended and restated certificate of incorporation ("Existing Certificate") to eliminate supermajority voting requirements. CORPORATE GOVERNANCE
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve amendments to our Existing Certificate to declassify the board of directors. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve amendments to our Existing Certificate to eliminate the prohibition on stockholders' ability to call a special meeting. CORPORATE GOVERNANCE
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve amendments to our Existing Certificate to limit the liability of certain officers in certain circumstances as permitted by the Delaware General Corporation Law. CORPORATE GOVERNANCE
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved for issuance under the 2018 Plan. COMPENSATION
 - ISSUER 315.000000 0 AGAINST
 315.000000
 AGAINST
 - -
iRobot Corporation 462726100 US4627261005 - 05/16/2025 Approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 315.000000 0 FOR
 315.000000
 FOR
 - -
Personalis, Inc. 71535D106 US71535D1063 - 05/16/2025 Election of Directors: A. Blaine Bowman DIRECTOR ELECTIONS
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
Personalis, Inc. 71535D106 US71535D1063 - 05/16/2025 Election of Directors: Karin Eastham DIRECTOR ELECTIONS
 - ISSUER 214.000000 0 WITHHOLD
 214.000000
 AGAINST
 - -
Personalis, Inc. 71535D106 US71535D1063 - 05/16/2025 Ratification of the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
Personalis, Inc. 71535D106 US71535D1063 - 05/16/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To elect the persons who shall constitute CEL-SCI's Board of Directors for the ensuing year: Geert R. Kersten DIRECTOR ELECTIONS
 - ISSUER 214.000000 0 WITHHOLD
 214.000000
 AGAINST
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To elect the persons who shall constitute CEL-SCI's Board of Directors for the ensuing year: Bruno Baillavoine DIRECTOR ELECTIONS
 - ISSUER 214.000000 0 WITHHOLD
 214.000000
 AGAINST
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To elect the persons who shall constitute CEL-SCI's Board of Directors for the ensuing year: Robert Watson DIRECTOR ELECTIONS
 - ISSUER 214.000000 0 WITHHOLD
 214.000000
 AGAINST
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To approve the adoption of CEL-SCI's 2025 Non-Qualified Stock Option Plan. COMPENSATION
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To approve the adoption of CEL-SCI's 2025 Stock Bonus Plan. COMPENSATION
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To approve a combination of CEL-SCI's outstanding shares of common stock. CAPITAL STRUCTURE
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
CEL-SCI Corporation 150837706 US1508377066 - 05/19/2025 To ratify the appointment of BDO USA, P.C. as CEL-SCI's independent registered public accounting firm for the fiscal year ending September 30, 2025. AUDIT-RELATED
 - ISSUER 214.000000 0 FOR
 214.000000
 FOR
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 05/19/2025 To elect the Board of Directors' nominees: Karen Wilson DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 05/19/2025 To elect the Board of Directors' nominees: Robert R. Ruffolo, Jr., Ph.D., FCPP DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Elicio Therapeutics, Inc. 28657F103 US28657F1030 - 05/19/2025 To ratify the selection by the Audit Committee of the Board of Directors of Baker Tilly US, LLP as the independent registered public accounting firm of Elicio Therapeutics, Inc. for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Biodesix, Inc. 09075X108 US09075X1081 - 05/20/2025 To elect the two Class II directors named in this proxy statement to hold office until the 2028 annual meeting of stockholders: Lawrence T. Kennedy, Jr. DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Biodesix, Inc. 09075X108 US09075X1081 - 05/20/2025 To elect the two Class II directors named in this proxy statement to hold office until the 2028 annual meeting of stockholders: Matthew Strobeck, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 WITHHOLD
 75.000000
 AGAINST
 - -
Biodesix, Inc. 09075X108 US09075X1081 - 05/20/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Biodesix, Inc. 09075X108 US09075X1081 - 05/20/2025 To approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's Common Stock at a ratio ranging from any whole number between 1-for-2 and 1-for-20 inclusive, as determined by our board of directors in its discretion, subject to our board of directors' authority to abandon such amendments; CAPITAL STRUCTURE
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Biodesix, Inc. 09075X108 US09075X1081 - 05/20/2025 To approve the Company's Amended and Restated Employee Stock Purchase Plan to increase the available shares of the Company's Common Stock under the plan by 1,451,500 and to increase the maximum number of shares of the Company's Common Stock that may be provided as the result of the plan's annual automatic increase to 3,000,000; and COMPENSATION
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 Election of Directors: Scott Hill DIRECTOR ELECTIONS
 - ISSUER 382.000000 0 FOR
 382.000000
 FOR
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 Election of Directors: Alex Mishurov DIRECTOR ELECTIONS
 - ISSUER 382.000000 0 WITHHOLD
 382.000000
 AGAINST
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 Election of Directors: Jon Francis DIRECTOR ELECTIONS
 - ISSUER 382.000000 0 FOR
 382.000000
 FOR
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 The ratification of the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 382.000000 0 FOR
 382.000000
 FOR
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. COMPENSATION
 - ISSUER 382.000000 0 AGAINST
 382.000000
 AGAINST
 - -
Cardlytics, Inc. 14161W105 US14161W1053 - 05/20/2025 Advisory vote to approve compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 382.000000 0 AGAINST
 382.000000
 AGAINST
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 Election of two Class II Directors: John A. Hohneker, M.D. DIRECTOR ELECTIONS
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 Election of two Class II Directors: Marc Rubin, M.D. DIRECTOR ELECTIONS
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 To approve an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 To approve Amendment No. 1 to the Fifth Amended and Restated 2010 Stock Incentive Plan to reserve up to an additional 1,255,000 shares of common stock for issuance under the plan. COMPENSATION
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 To adopt and approve an amendment to our Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 39,171,875 to 73,343,750 and the number of authorized shares of our common stock from 34,171,875 to 68,343,750. CAPITAL STRUCTURE
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Curis, Inc. 231269309 US2312693094 - 05/20/2025 To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of up to 8,316,882 shares of our common stock upon the exercise of certain warrants issued on March 31, 2025 in a private placement. CAPITAL STRUCTURE
 - ISSUER 25.000000 0 FOR
 25.000000
 FOR
 - -
Hyliion Holdings Corp. 449109107 US4491091074 - 05/20/2025 Election of Directors: Jeffrey Craig DIRECTOR ELECTIONS
 - ISSUER 698.000000 0 WITHHOLD
 698.000000
 AGAINST
 - -
Hyliion Holdings Corp. 449109107 US4491091074 - 05/20/2025 Election of Directors: Richard Freeland DIRECTOR ELECTIONS
 - ISSUER 698.000000 0 FOR
 698.000000
 FOR
 - -
Hyliion Holdings Corp. 449109107 US4491091074 - 05/20/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the 2025 fiscal year ended December 31, 2025. AUDIT-RELATED
 - ISSUER 698.000000 0 FOR
 698.000000
 FOR
 - -
Hyliion Holdings Corp. 449109107 US4491091074 - 05/20/2025 To approve, on an advisory basis, compensation for the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 698.000000 0 FOR
 698.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Jacqueline E. Shea, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Simon X. Benito DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Roger D. Dansey, M.D. DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Ann C. Miller, M.D. DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Jay P. Shepard DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: David B. Weiner, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Wendy L. Yarno DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To elect the following directors to serve for a term ending upon the 2026 Annual Meeting of Stockholders and until their successors are elected and qualified: Lota S. Zoth DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To approve, on a non-binding advisory basis, the resolution regarding compensation of our named executive officers described in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Inovio Pharmaceuticals, Inc. 45773H409 US45773H4092 - 05/20/2025 To approve an amendment and restatement of our 2023 Omnibus Incentive Plan. COMPENSATION
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
MaxLinear, Inc. 57776J100 US57776J1007 - 05/20/2025 Election of the nominee for Class I Director named in the proxy statement, to hold office until the 2028 annual meeting of stockholders and until his successor is duly elected and qualified: Daniel A. Artusi DIRECTOR ELECTIONS
 - ISSUER 829.000000 0 FOR
 829.000000
 FOR
 - -
MaxLinear, Inc. 57776J100 US57776J1007 - 05/20/2025 To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2024, as set forth in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 829.000000 0 AGAINST
 829.000000
 AGAINST
 - -
MaxLinear, Inc. 57776J100 US57776J1007 - 05/20/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 829.000000 0 FOR
 829.000000
 FOR
 - -
MaxLinear, Inc. 57776J100 US57776J1007 - 05/20/2025 To approve an amendment of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan to increase the number of shares reserved thereunder by 3,657,565. COMPENSATION
 - ISSUER 829.000000 0 AGAINST
 829.000000
 AGAINST
 - -
The ONE Group Hospitality, Inc. 88338K103 US88338K1034 - 05/20/2025 Election of three Class III Directors: Emanuel Hilario DIRECTOR ELECTIONS
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
The ONE Group Hospitality, Inc. 88338K103 US88338K1034 - 05/20/2025 Election of three Class III Director: Scott Ross DIRECTOR ELECTIONS
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
The ONE Group Hospitality, Inc. 88338K103 US88338K1034 - 05/20/2025 Election of three Class III Director: Jonathan Segal DIRECTOR ELECTIONS
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
The ONE Group Hospitality, Inc. 88338K103 US88338K1034 - 05/20/2025 Proposal to ratify the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 28, 2025. AUDIT-RELATED
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
The ONE Group Hospitality, Inc. 88338K103 US88338K1034 - 05/20/2025 Proposal to approve, by an advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 Election of Class III Directors: William H. Baum DIRECTOR ELECTIONS
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 Election of Class III Directors: Mary Kathryn Ellet DIRECTOR ELECTIONS
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 Election of Class III Directors: Gary W. Mize DIRECTOR ELECTIONS
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 To approve an amendment of the Gevo, Inc. Amended and Restated 2010 Stock Incentive Plan. COMPENSATION
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Gevo, Inc. 374396406 US3743964062 - 05/21/2025 To cast an advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1167.000000 0 FOR
 1167.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 05/21/2025 Election of Director: Kathryn E. Falberg DIRECTOR ELECTIONS
 - ISSUER 1852.000000 0 WITHHOLD
 1852.000000
 AGAINST
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 05/21/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Nuvation Bio Inc. 67080N101 US67080N1019 - 05/21/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1852.000000 0 FOR
 1852.000000
 FOR
 - -
Sensei Biotherapeutics, Inc. 81728A207 US81728A2078 - 05/21/2025 To elect the Board's two nominees to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: William Ringo DIRECTOR ELECTIONS
 - ISSUER 124.000000 0 WITHHOLD
 124.000000
 AGAINST
 - -
Sensei Biotherapeutics, Inc. 81728A207 US81728A2078 - 05/21/2025 To elect the Board's two nominees to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: John Celebi DIRECTOR ELECTIONS
 - ISSUER 124.000000 0 FOR
 124.000000
 FOR
 - -
Sensei Biotherapeutics, Inc. 81728A207 US81728A2078 - 05/21/2025 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 124.000000 0 FOR
 124.000000
 FOR
 - -
Sensei Biotherapeutics, Inc. 81728A207 US81728A2078 - 05/21/2025 To approve an amendment to the Company's amended and restated certificate of incorporation to effect, at the discretion of the Board of Directors, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-10 to 1-for-30, inclusive, and a corresponding proportionate reduction in the total number of authorized shares of the Company's common stock, such ratio to be determined at the discretion of the Board of Directors. CAPITAL STRUCTURE
 - ISSUER 124.000000 0 FOR
 124.000000
 FOR
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Election of directors: Stephen P. DeFalco DIRECTOR ELECTIONS
 - ISSUER 5152.000000 0 WITHHOLD
 5152.000000
 AGAINST
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Election of directors: Brian Hansen DIRECTOR ELECTIONS
 - ISSUER 5152.000000 0 FOR
 5152.000000
 FOR
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Election of directors: Douglas S. Prince DIRECTOR ELECTIONS
 - ISSUER 5152.000000 0 WITHHOLD
 5152.000000
 AGAINST
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Election of directors: Douglas A. Roeder DIRECTOR ELECTIONS
 - ISSUER 5152.000000 0 WITHHOLD
 5152.000000
 AGAINST
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Advisory approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 5152.000000 0 FOR
 5152.000000
 FOR
 - -
Senseonics Holdings, Inc. 81727U105 US81727U1051 - 05/21/2025 Ratification of the selection of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 5152.000000 0 FOR
 5152.000000
 FOR
 - -
Star Holdings 85512G106 US85512G1067 - 05/21/2025 Election of Trustees: Nina Matis DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 WITHHOLD
 60.000000
 AGAINST
 - -
Star Holdings 85512G106 US85512G1067 - 05/21/2025 Election of Trustees: Clifford De Souza DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 WITHHOLD
 60.000000
 AGAINST
 - -
Star Holdings 85512G106 US85512G1067 - 05/21/2025 Election of Trustees: Richard Lieb DIRECTOR ELECTIONS
 - ISSUER 60.000000 0 WITHHOLD
 60.000000
 AGAINST
 - -
Star Holdings 85512G106 US85512G1067 - 05/21/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 60.000000 0 FOR
 60.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Deirdre P. Connelly DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Ellen G. Cooper DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: William H. Cunningham DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Reginald E. Davis DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Eric G. Johnson DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Gary C. Kelly DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: M. Leanne Lachman DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Dale LeFebvre DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: James Morris DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The election of ten directors for a one-year term expiring at the 2026 Annual Meeting: Owen Ryan DIRECTOR ELECTIONS
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025. AUDIT-RELATED
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The approval of an advisory resolution on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 750000.000000 0 FOR
 750000.000000
 FOR
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 The approval of an amendment to the Lincoln National Corporation 2020 Incentive Compensation Plan. COMPENSATION
 - ISSUER 750000.000000 0 AGAINST
 750000.000000
 AGAINST
 - -
Lincoln National Corporation 534187BR9 US534187BR92 - 05/22/2025 Shareholder proposal to amend our governing documents to provide for an independent chairman of the board. CORPORATE GOVERNANCE
 - SECURITY HOLDER 750000.000000 0 FOR
 750000.000000
 AGAINST
 - -
Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 - 05/22/2025 To elect two Class I Directors to serve until the 2028 Annual Meeting of Stockholders: Inese Lowenstein DIRECTOR ELECTIONS
 - ISSUER 86.000000 0 WITHHOLD
 86.000000
 AGAINST
 - -
Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 - 05/22/2025 To elect two Class I Directors to serve until the 2028 Annual Meeting of Stockholders: Dafni Bika, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
Rapid Micro Biosystems, Inc. 75340L104 US75340L1044 - 05/22/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 86.000000 0 FOR
 86.000000
 FOR
 - -
The Cato Corporation 149205106 US1492051065 - 05/22/2025 ELECTION OF DIRECTORS: Theresa J. Drew DIRECTOR ELECTIONS
 - ISSUER 117.000000 0 FOR
 117.000000
 FOR
 - -
The Cato Corporation 149205106 US1492051065 - 05/22/2025 ELECTION OF DIRECTORS: D. Harding Stowe DIRECTOR ELECTIONS
 - ISSUER 117.000000 0 WITHHOLD
 117.000000
 AGAINST
 - -
The Cato Corporation 149205106 US1492051065 - 05/22/2025 To consider and vote upon a proposal to amend and restate The Cato Corporation 2013 Employee Stock Purchase Plan, as amended in 2021. COMPENSATION
 - ISSUER 117.000000 0 FOR
 117.000000
 FOR
 - -
The Cato Corporation 149205106 US1492051065 - 05/22/2025 To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2026. AUDIT-RELATED
 - ISSUER 117.000000 0 FOR
 117.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Kenneth D. Tuchman DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Steven J. Anenen DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Tracy L. Bahl DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Gregory A. Conley DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Robert N. Frerichs DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Marc L. Holtzman DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Election of Director Nominees: Gina L. Loften DIRECTOR ELECTIONS
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
TTEC Holdings, Inc. 89854H102 US89854H1023 - 05/22/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as TTEC's Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED
 - ISSUER 108.000000 0 FOR
 108.000000
 FOR
 - -
Verastem, Inc. 92337C203 US92337C2035 - 05/22/2025 Election of Directors: Michael Kauffman DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
Verastem, Inc. 92337C203 US92337C2035 - 05/22/2025 Election of Directors: Eric Rowinsky DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
Verastem, Inc. 92337C203 US92337C2035 - 05/22/2025 Election of Directors: John Johnson DIRECTOR ELECTIONS
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
Verastem, Inc. 92337C203 US92337C2035 - 05/22/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
Verastem, Inc. 92337C203 US92337C2035 - 05/22/2025 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 85.000000 0 FOR
 85.000000
 FOR
 - -
Vor Biopharma Inc. 929033108 US9290331084 - 05/22/2025 To elect each of the two Class I director nominees, each to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Matthew Patterson DIRECTOR ELECTIONS
 - ISSUER 113.000000 0 WITHHOLD
 113.000000
 AGAINST
 - -
Vor Biopharma Inc. 929033108 US9290331084 - 05/22/2025 To elect each of the two Class I director nominees, each to serve until the 2028 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal: Daniella Beckman DIRECTOR ELECTIONS
 - ISSUER 113.000000 0 WITHHOLD
 113.000000
 AGAINST
 - -
Vor Biopharma Inc. 929033108 US9290331084 - 05/22/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 400,000,000 to 800,000,000. CAPITAL STRUCTURE
 - ISSUER 113.000000 0 FOR
 113.000000
 FOR
 - -
Vor Biopharma Inc. 929033108 US9290331084 - 05/22/2025 To ratify the selection by the audit committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 113.000000 0 FOR
 113.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 Re-elect two (2) Class I Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Robert Anderson, Jr. DIRECTOR ELECTIONS
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 Re-elect two (2) Class I Directors to serve for three-year terms as of the date of the Annual Meeting of Stockholders and until their successors are duly elected and qualified: Michael J. O'Donnell DIRECTOR ELECTIONS
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 To approve an amendment to the Company's Non-employee Director Compensation Program. COMPENSATION
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to reduce the Company's Board classification from three to two. CORPORATE GOVERNANCE
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Cassava Sciences, Inc. 14817C107 US14817C1071 - 05/23/2025 To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 448.000000 0 FOR
 448.000000
 FOR
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Election of Directors: John P. Larson DIRECTOR ELECTIONS
 - ISSUER 71.000000 0 FOR
 71.000000
 FOR
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Election of Directors: Andrea K. Tarbox DIRECTOR ELECTIONS
 - ISSUER 71.000000 0 WITHHOLD
 71.000000
 AGAINST
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Election of Directors: Elisabeth Vanzura DIRECTOR ELECTIONS
 - ISSUER 71.000000 0 FOR
 71.000000
 FOR
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Ratification of the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 71.000000 0 FOR
 71.000000
 FOR
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for exculpation of officers from breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware. CORPORATE GOVERNANCE
 - ISSUER 71.000000 0 AGAINST
 71.000000
 AGAINST
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Approval of amendments to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its Class A common stock and Class B common stock at a ratio ranging from any whole number between. 1-for-10 and 1-for-100, as determined by the Board of Directors in its discretion. CAPITAL STRUCTURE
 - ISSUER 71.000000 0 FOR
 71.000000
 FOR
 - -
Solo Brands, Inc. 83425V203 US83425V2034 - 05/23/2025 Approval of an adjournment of the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposals 3 or 4. CORPORATE GOVERNANCE
 - ISSUER 71.000000 0 AGAINST
 71.000000
 AGAINST
 - -
a.k.a. Brands Holding Corp. 00152K200 US00152K2006 - 05/27/2025 Elect Class I directors to serve on the Board until the 2028 Annual Meeting and until their successors are duly elected and qualified: Christopher Dean DIRECTOR ELECTIONS
 - ISSUER 4.000000 0 WITHHOLD
 4.000000
 AGAINST
 - -
a.k.a. Brands Holding Corp. 00152K200 US00152K2006 - 05/27/2025 Elect Class I directors to serve on the Board until the 2028 Annual Meeting and until their successors are duly elected and qualified: Ilene Eskenazi DIRECTOR ELECTIONS
 - ISSUER 4.000000 0 WITHHOLD
 4.000000
 AGAINST
 - -
a.k.a. Brands Holding Corp. 00152K200 US00152K2006 - 05/27/2025 Elect Class I directors to serve on the Board until the 2028 Annual Meeting and until their successors are duly elected and qualified: Matthew Hamilton DIRECTOR ELECTIONS
 - ISSUER 4.000000 0 WITHHOLD
 4.000000
 AGAINST
 - -
a.k.a. Brands Holding Corp. 00152K200 US00152K2006 - 05/27/2025 Ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 4.000000 0 FOR
 4.000000
 FOR
 - -
Bolt Biotherapeutics, Inc. 097702203 US0977022039 - 05/27/2025 To elect our two nominees for Class I directors to serve until our 2028 Annual Meeting of Stockholders: Laura Berner DIRECTOR ELECTIONS
 - ISSUER 136.000000 0 WITHHOLD
 136.000000
 AGAINST
 - -
Bolt Biotherapeutics, Inc. 097702203 US0977022039 - 05/27/2025 To elect our two nominees for Class I directors to serve until our 2028 Annual Meeting of Stockholders: Brian O'Callaghan DIRECTOR ELECTIONS
 - ISSUER 136.000000 0 FOR
 136.000000
 FOR
 - -
Bolt Biotherapeutics, Inc. 097702203 US0977022039 - 05/27/2025 To ratify the selection by the audit committee of the Board of Directors of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 136.000000 0 FOR
 136.000000
 FOR
 - -
Bolt Biotherapeutics, Inc. 097702203 US0977022039 - 05/27/2025 Approval of an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock; and CAPITAL STRUCTURE
 - ISSUER 136.000000 0 FOR
 136.000000
 FOR
 - -
Universal Electronics Inc. 913483103 US9134831034 - 05/27/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 74.000000 0 FOR
 74.000000
 FOR
 - -
Universal Electronics Inc. 913483103 US9134831034 - 05/27/2025 Ratification of the appointment of Grant Thornton LLP, a firm of Independent Registered Public Accountants as the Company's auditors for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 74.000000 0 FOR
 74.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To elect five Class II directors from the nominees described in the proxy statement: James M. Kilts DIRECTOR ELECTIONS
 - ISSUER 455.000000 0 FOR
 455.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To elect five Class II directors from the nominees described in the proxy statement: Jody L. Macedonio DIRECTOR ELECTIONS
 - ISSUER 455.000000 0 FOR
 455.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To elect five Class II directors from the nominees described in the proxy statement: Robin Manherz DIRECTOR ELECTIONS
 - ISSUER 455.000000 0 FOR
 455.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To elect five Class II directors from the nominees described in the proxy statement: Adam Nebesar DIRECTOR ELECTIONS
 - ISSUER 455.000000 0 WITHHOLD
 455.000000
 AGAINST
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To elect five Class II directors from the nominees described in the proxy statement: Deborah Poole DIRECTOR ELECTIONS
 - ISSUER 455.000000 0 FOR
 455.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To ratify the appointment of PricewaterhouseCoopers LLP as Advantage Solution Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 455.000000 0 FOR
 455.000000
 FOR
 - -
Advantage Solutions Inc. 00791N102 US00791N1028 - 05/28/2025 To approve, on a advisory (non-binding) basis, the compensation of Advantage Solution Inc's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 455.000000 0 AGAINST
 455.000000
 AGAINST
 - -
Passage Bio, Inc. 702712209 US7027122099 - 05/28/2025 To elect two Class II directors, each to serve a three-year term through the third Annual Meeting of Stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Maxine Gowen, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 220.000000 0 WITHHOLD
 220.000000
 AGAINST
 - -
Passage Bio, Inc. 702712209 US7027122099 - 05/28/2025 To elect two Class II directors, each to serve a three-year term through the third Annual Meeting of Stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Dolan Sondhi, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 220.000000 0 WITHHOLD
 220.000000
 AGAINST
 - -
Passage Bio, Inc. 702712209 US7027122099 - 05/28/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
Passage Bio, Inc. 702712209 US7027122099 - 05/28/2025 To approve an amendment to the Company's Restated Certificate of Incorporation to effect a reverse stock split of the Company's outstanding shares of common stock at a ratio of any whole number between 1-for-5 and 1-for-50, with the exact ratio determined by the Board of Directors in its discretion, subject to the Board of Directors' authority to abandon such amendment. CAPITAL STRUCTURE
 - ISSUER 220.000000 0 FOR
 220.000000
 FOR
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Election of Class III Directors: Kevin J. Buehler DIRECTOR ELECTIONS
 - ISSUER 9.000000 0 WITHHOLD
 9.000000
 AGAINST
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Election of Class III Directors: Shari Lisa Pire DIRECTOR ELECTIONS
 - ISSUER 9.000000 0 WITHHOLD
 9.000000
 AGAINST
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Ratification of the appointment of Deloitte & Touche LLP as Precision's independent registered public accounting firm for 2025. AUDIT-RELATED
 - ISSUER 9.000000 0 FOR
 9.000000
 FOR
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers (commonly referred to as the "say-on-pay vote"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 9.000000 0 FOR
 9.000000
 FOR
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Approval, on an advisory (non-binding) basis, of the frequency of future say-on-pay votes. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 9.000000 0 ONE YEAR
 9.000000
 FOR
 - -
Precision BioSciences, Inc. 74019P207 US74019P2074 - 05/28/2025 Approval of an amendment to our Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation. CORPORATE GOVERNANCE
 - ISSUER 9.000000 0 FOR
 9.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Election of Directors: Linda A. Findley DIRECTOR ELECTIONS
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Election of Directors: Deborah L. Kilpatrick, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Election of Directors: Hilary A. Schneider DIRECTOR ELECTIONS
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Approve Amendments to the Company's Articles and Bylaws to Declassify the Board SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Approve an Amendment to the Company's Articles to Eliminate the Supermajority Voting Requirement in Article XIV Related to Directors CORPORATE GOVERNANCE
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Approve an Amendment to the Company's Articles to Eliminate the Supermajority Voting Requirements in Article XV Related to Approval of Certain Transactions CORPORATE GOVERNANCE
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Ratification of Appointment of Independent Registered Public Accounting Firm AUDIT-RELATED
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Advisory Vote to Approve Executive Compensation (Say on Pay) SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 260.000000 0 FOR
 260.000000
 FOR
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 500,000 shares COMPENSATION
 - ISSUER 260.000000 0 AGAINST
 260.000000
 AGAINST
 - -
Sleep Number Corporation 83125X103 US83125X1037 - 05/28/2025 Approve the Adjournment of the Annual Meeting to a Later Date or Dates, if Necessary and Appropriate CORPORATE GOVERNANCE
 - ISSUER 260.000000 0 AGAINST
 260.000000
 AGAINST
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Election of Directors: Steven R. Becker DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Election of Directors: Martha Bejar DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Election of Directors: Richard McBee DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Election of Directors: Steven W. Sansom DIRECTOR ELECTIONS
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Sportsman's Warehouse Holdings, Inc. 84920Y106 US84920Y1064 - 05/28/2025 Ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2026 (fiscal year 2025). AUDIT-RELATED
 - ISSUER 259.000000 0 FOR
 259.000000
 FOR
 - -
Tenaya Therapeutics, Inc. 87990A106 US87990A1060 - 05/28/2025 To elect three Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: David Goeddel, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 WITHHOLD
 153.000000
 AGAINST
 - -
Tenaya Therapeutics, Inc. 87990A106 US87990A1060 - 05/28/2025 To elect three Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Jeffrey T. Walsh, M.B.A. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 WITHHOLD
 153.000000
 AGAINST
 - -
Tenaya Therapeutics, Inc. 87990A106 US87990A1060 - 05/28/2025 To elect three Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: R. Sanders Williams, M.D. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 WITHHOLD
 153.000000
 AGAINST
 - -
Tenaya Therapeutics, Inc. 87990A106 US87990A1060 - 05/28/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 153.000000 0 FOR
 153.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To re-elect as a director, Ali Behbahani, who retires by rotation in accordance with the Articles of Association. DIRECTOR ELECTIONS
 - ISSUER 273.000000 0 AGAINST
 273.000000
 AGAINST
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To re-elect as a director, John Furey, who retires by rotation in accordance with the Articles of Association. DIRECTOR ELECTIONS
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To re-elect as a director, Adrian Rawcliffe, who retires by rotation in accordance with the Articles of Association. DIRECTOR ELECTIONS
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To re-appoint KPMG LLP as auditors of the Company, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To authorize the Audit Committee to determine our auditors' remuneration for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To adopt the U.K. statutory annual accounts and reports for the fiscal year ended December 31, 2024 and to note that the Directors do not recommend the payment of any dividend for the year ended December 31, 2024. CORPORATE GOVERNANCE
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To approve our U.K. statutory directors' remuneration report for the year ended December 31, 2024 COMPENSATION
 - ISSUER 273.000000 0 FOR
 273.000000
 FOR
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To approve our 2025 employee share option scheme, which, if approved, will take effect upon the conclusion of the Annual General Meeting. COMPENSATION
 - ISSUER 273.000000 0 AGAINST
 273.000000
 AGAINST
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To approve our 2025 non-employee share option scheme, which, if approved, will take effect upon the conclusion of the Annual General Meeting. COMPENSATION
 - ISSUER 273.000000 0 AGAINST
 273.000000
 AGAINST
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To authorize the Directors under Section 551 of the U.K. Companies Act 2006 (the "2006 Act") to allot shares or to grant rights to subscribe for or to convert any security into shares. CAPITAL STRUCTURE
 - ISSUER 273.000000 0 AGAINST
 273.000000
 AGAINST
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To empower the Directors to allot equity securities for cash pursuant to Section 570(1) of the 2006 Act as if Section 561(1) of the 2006 Act did not apply to that allotment. CAPITAL STRUCTURE
 - ISSUER 273.000000 0 AGAINST
 273.000000
 AGAINST
 - -
Adaptimmune Therapeutics Plc 00653A107 US00653A1079 - 05/29/2025 To approve, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 273.000000 0 ONE YEAR
 273.000000
 FOR
 - -
Athira Pharma, Inc. 04746L104 US04746L1044 - 05/29/2025 Election of Class II Directors: Joseph Edelman DIRECTOR ELECTIONS
 - ISSUER 192.000000 0 WITHHOLD
 192.000000
 AGAINST
 - -
Athira Pharma, Inc. 04746L104 US04746L1044 - 05/29/2025 Election of Class II Directors: John M. Fluke, Jr. DIRECTOR ELECTIONS
 - ISSUER 192.000000 0 FOR
 192.000000
 FOR
 - -
Athira Pharma, Inc. 04746L104 US04746L1044 - 05/29/2025 Election of Class II Directors: Grant Pickering DIRECTOR ELECTIONS
 - ISSUER 192.000000 0 FOR
 192.000000
 FOR
 - -
Athira Pharma, Inc. 04746L104 US04746L1044 - 05/29/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 192.000000 0 FOR
 192.000000
 FOR
 - -
Athira Pharma, Inc. 04746L104 US04746L1044 - 05/29/2025 To approve proposed amendments to our amended and restated certificate of incorporation to effect a reverse stock split and reduce the total number of authorized shares of common stock. CAPITAL STRUCTURE
 - ISSUER 192.000000 0 FOR
 192.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: John Dionne DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Lisa Hammitt DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Andrew Hobson DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Timothy (Tim) P. Jones DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Thomas C. King DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Joe Marchese DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: W. Benjamin Moreland DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Scott R. Wells DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Raymond (Ted) T. White DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Election of each of the following director nominees: John Dionne, Lisa Hammitt, Andrew Hobson, Timothy (Tim) P. Jones, Thomas C. King, Joe Marchese, W. Benjamin Moreland, Scott R. Wells, Raymond (Ted) T. White, and Jinhy Yoon: Jinhy Yoon DIRECTOR ELECTIONS
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Approval of the advisory (non-binding) resolution on executive compensation SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
Clear Channel Outdoor Holdings, Inc. 18453H106 US18453H1068 - 05/29/2025 Ratification of Ernst & Young LLP as the independent accounting firm for the year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 4259.000000 0 FOR
 4259.000000
 FOR
 - -
CoreCard Corporation 45816D100 US45816D1000 - 05/29/2025 Election of Two Directors. Nominees: Philip H. Moise DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 AGAINST
 43.000000
 AGAINST
 - -
CoreCard Corporation 45816D100 US45816D1000 - 05/29/2025 Election of Two Directors. Nominees: Kathryn Petralia DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 AGAINST
 43.000000
 AGAINST
 - -
CoreCard Corporation 45816D100 US45816D1000 - 05/29/2025 Approval, by a non-binding advisory vote, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
CoreCard Corporation 45816D100 US45816D1000 - 05/29/2025 Approval of the CoreCard Corporation 2025 Employee Stock Incentive Plan. COMPENSATION
 - ISSUER 43.000000 0 AGAINST
 43.000000
 AGAINST
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Stephen L. Schlecht DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 WITHHOLD
 72.000000
 AGAINST
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: David C. Finch DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 WITHHOLD
 72.000000
 AGAINST
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Janet H. Kennedy DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Brett L. Paschke DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 WITHHOLD
 72.000000
 AGAINST
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Stephanie L Pugliese DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Susan J. Riley DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Ronald Robinson DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 Election of Directors: Scott K. Williams DIRECTOR ELECTIONS
 - ISSUER 72.000000 0 WITHHOLD
 72.000000
 AGAINST
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 To approve, by an advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Duluth Holdings Inc. 26443V101 US26443V1017 - 05/29/2025 To ratify the appointment of KPMG LLP as our independent registered public accountants for fiscal 2025. AUDIT-RELATED
 - ISSUER 72.000000 0 FOR
 72.000000
 FOR
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: Jessica Hopfield, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 801.000000 0 WITHHOLD
 801.000000
 AGAINST
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: David T. Scadden, M.D. DIRECTOR ELECTIONS
 - ISSUER 801.000000 0 FOR
 801.000000
 FOR
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 801.000000 0 AGAINST
 801.000000
 AGAINST
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 To approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 801.000000 0 ONE YEAR
 801.000000
 FOR
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. COMPENSATION
 - ISSUER 801.000000 0 AGAINST
 801.000000
 AGAINST
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 To adopt and approve an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock from 195,000,000 to 390,000,000. CAPITAL STRUCTURE
 - ISSUER 801.000000 0 FOR
 801.000000
 FOR
 - -
Editas Medicine, Inc. 28106W103 US28106W1036 - 05/29/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 801.000000 0 FOR
 801.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Paul Anton Zevnik DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Gilbert R. Vasquez DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Martha Elena Diaz DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Fehmi Zeko DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Thomas Strickler DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Brad Bender DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Michael Christenson DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 Election of Directors to serve for a term ending at the 2026 Annual Meeting of Stockholders and until a successor is duly elected and qualified: Lara Sweet DIRECTOR ELECTIONS
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 To ratify the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Entravision Communications Corporation 29382R107 US29382R1077 - 05/29/2025 To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 358.000000 0 FOR
 358.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 Election of Class III Directors: Dr. Shefali Agarwal DIRECTOR ELECTIONS
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 Election of Class III Directors: Dr. Bahram Valamehr DIRECTOR ELECTIONS
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 Election of Class III Directors: Matthew C. Abernethy DIRECTOR ELECTIONS
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To approve the ratification of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To recommend, on a non-binding advisory basis, the frequency of future non-binding stockholder advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 948.000000 0 ONE YEAR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To approve the amendment of our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 250,000,000 to 350,000,000. CAPITAL STRUCTURE
 - ISSUER 948.000000 0 FOR
 948.000000
 FOR
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. COMPENSATION
 - ISSUER 948.000000 0 AGAINST
 948.000000
 AGAINST
 - -
Fate Therapeutics, Inc. 31189P102 US31189P1021 - 05/29/2025 To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. CORPORATE GOVERNANCE
 - ISSUER 948.000000 0 AGAINST
 948.000000
 AGAINST
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 05/29/2025 The election of three (3) Class II directors to hold office until our 2028 annual meeting of stockholders and until his successor is elected and qualified: Richard Vincent DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 05/29/2025 The election of three (3) Class II directors to hold office until our 2028 annual meeting of stockholders and until his successor is elected and qualified: Shiv Kapoor DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 05/29/2025 The election of three (3) Class II directors to hold office until our 2028 annual meeting of stockholders and until his successor is elected and qualified: David Gryska DIRECTOR ELECTIONS
 - ISSUER 2.000000 0 WITHHOLD
 2.000000
 AGAINST
 - -
Forte Biosciences, Inc. 34962G208 US34962G2084 - 05/29/2025 The ratification of the appointment of KPMG LLP P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 2.000000 0 FOR
 2.000000
 FOR
 - -
GRAIL, Inc. 384747101 US3847471014 - 05/29/2025 Election of Class I Director to serve until the 2028 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: William (Bill) Chase DIRECTOR ELECTIONS
 - ISSUER 274.000000 0 FOR
 274.000000
 FOR
 - -
GRAIL, Inc. 384747101 US3847471014 - 05/29/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 274.000000 0 FOR
 274.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 Election of Directors: James Bristol DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 Election of Directors: Peter Cicala DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 Election of Directors: Sanjeev Luther DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 Election of Directors: Elena Ratner DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 Election of Directors: William Wexler DIRECTOR ELECTIONS
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To approve, by non-binding vote, the compensation disclosed in the Proxy Statement of the Company's executive officers, who are named in the Proxy Statement Summary Compensation Table. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To recommend, by non-binding vote, the frequency of advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 8.000000 0 ONE YEAR
 8.000000
 AGAINST
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To approve an amendment to our Restated Certificate of Incorporation, as amended (the "Restated Certificate") to effect a reverse stock split (the "Reverse Stock Split") with respect to our issued and outstanding common stock, at a ratio of 1-for-10 to 1-for-15 (the "Range"), with the ratio within such Range to be determined at the discretion of our Board of Directors. CAPITAL STRUCTURE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To approve an amendment to our Restated Certificate to allow for action required or permitted to be taken by stockholders of the company to be effected by written consent of such stockholders in addition to duly called annual or special meetings of such stockholders. CORPORATE GOVERNANCE
 - ISSUER 8.000000 0 AGAINST
 8.000000
 AGAINST
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To approve an amendment to our Restated Certificate to increase the Company's authorized shares of common stock from 100,000,000 to 150,000,000. CAPITAL STRUCTURE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Ernexa Therapeutics Inc. 114082308 US1140823089 - 06/02/2025 To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the potential issuance and sale of more than 20% of the Company's issued and outstanding common stock, pursuant to our securities purchase agreement, dated March 31, 2025, with certain investors. CAPITAL STRUCTURE
 - ISSUER 8.000000 0 FOR
 8.000000
 FOR
 - -
Harvard Bioscience, Inc. 416906105 US4169061052 - 06/02/2025 Election of Director: James W. Green DIRECTOR ELECTIONS
 - ISSUER 234.000000 0 FOR
 234.000000
 FOR
 - -
Harvard Bioscience, Inc. 416906105 US4169061052 - 06/02/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 234.000000 0 FOR
 234.000000
 FOR
 - -
Harvard Bioscience, Inc. 416906105 US4169061052 - 06/02/2025 Approval, by a non-binding advisory vote, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 234.000000 0 FOR
 234.000000
 FOR
 - -
Harvard Bioscience, Inc. 416906105 US4169061052 - 06/02/2025 Approval of the Harvard Bioscience, Inc. Amended and Restated 2021 Incentive Plan to increase the number of authorized shares of Common Stock available for issuance thereunder. COMPENSATION
 - ISSUER 234.000000 0 FOR
 234.000000
 FOR
 - -
Kodiak Sciences Inc. 50015M109 US50015M1099 - 06/02/2025 Elect two Class I directors nominated by our board and named in this proxy statement: Richard S. Levy, M.D. DIRECTOR ELECTIONS
 - ISSUER 399.000000 0 WITHHOLD
 399.000000
 AGAINST
 - -
Kodiak Sciences Inc. 50015M109 US50015M1099 - 06/02/2025 Elect two Class I directors nominated by our board and named in this proxy statement: Robert A. Profusek, J.D. DIRECTOR ELECTIONS
 - ISSUER 399.000000 0 WITHHOLD
 399.000000
 AGAINST
 - -
Kodiak Sciences Inc. 50015M109 US50015M1099 - 06/02/2025 Approve, on an advisory basis, the compensation of Kodiak's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 399.000000 0 FOR
 399.000000
 FOR
 - -
Kodiak Sciences Inc. 50015M109 US50015M1099 - 06/02/2025 Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 399.000000 0 FOR
 399.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Election of Directors: Raymond Debbane DIRECTOR ELECTIONS
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Election of Directors: Ivan H. Cheung DIRECTOR ELECTIONS
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan COMPENSATION
 - ISSUER 408.000000 0 AGAINST
 408.000000
 AGAINST
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Ratification and approval of the amendment to the Company's 2017 Non-Employee Directors' Equity Incentive Plan COMPENSATION
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Approval of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to effect, at the discretion of the Company's board of directors, a reverse split of its common stock, at a ratio within a range of 1-for-10 to 1-for-50, at any time prior to the Company's 2026 annual meeting of stockholders and with the actual ratio to be determined within that range at the discretion of the Company's board of directors CAPITAL STRUCTURE
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Advisory vote to approve the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Lexicon Pharmaceuticals, Inc. 528872302 US5288723027 - 06/02/2025 Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 408.000000 0 FOR
 408.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 Election of Class II Directors: D. Keith Grossman DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 WITHHOLD
 36.000000
 AGAINST
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 Election of Class II Directors: Patrick T. Hackett DIRECTOR ELECTIONS
 - ISSUER 36.000000 0 WITHHOLD
 36.000000
 AGAINST
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 To approve, on a non-binding basis, the 2024 compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 36.000000 0 AGAINST
 36.000000
 AGAINST
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 To approve an amendment to our 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares COMPENSATION
 - ISSUER 36.000000 0 AGAINST
 36.000000
 AGAINST
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 To approve an amendment to our Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 255,000 shares COMPENSATION
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Outset Medical, Inc. 690145206 US6901452069 - 06/02/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025 AUDIT-RELATED
 - ISSUER 36.000000 0 FOR
 36.000000
 FOR
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 Election of Directors: Paul Friedman DIRECTOR ELECTIONS
 - ISSUER 129.000000 0 FOR
 129.000000
 FOR
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 Election of Directors: Mary Haggerty DIRECTOR ELECTIONS
 - ISSUER 129.000000 0 WITHHOLD
 129.000000
 AGAINST
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 Election of Directors: Daniel Hoffman DIRECTOR ELECTIONS
 - ISSUER 129.000000 0 WITHHOLD
 129.000000
 AGAINST
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 Election of Directors: Michael Nierenberg DIRECTOR ELECTIONS
 - ISSUER 129.000000 0 FOR
 129.000000
 FOR
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 To approve the issuance of up to 7,700,000 shares of Common Stock to RCM GA Manager LLC, the external manager of Rithm Property Trust Inc. ("RPT") as payment of fees under the Management Agreement (as defined in the accompanying materials). CAPITAL STRUCTURE
 - ISSUER 129.000000 0 FOR
 129.000000
 FOR
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for RPT for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 129.000000 0 FOR
 129.000000
 FOR
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 To approve (on a non-binding advisory basis) the compensation of the named executive officers as described in the accompanying materials. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 129.000000 0 AGAINST
 129.000000
 AGAINST
 - -
Rithm Property Trust Inc. 38983D300 US38983D3008 - 06/02/2025 To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 129.000000 0 ONE YEAR
 129.000000
 FOR
 - -
Taysha Gene Therapies, Inc. 877619106 US8776191061 - 06/02/2025 To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Phillip B. Donenberg, CPA DIRECTOR ELECTIONS
 - ISSUER 133.000000 0 WITHHOLD
 133.000000
 AGAINST
 - -
Taysha Gene Therapies, Inc. 877619106 US8776191061 - 06/02/2025 To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Sukumar Nagendran, MD DIRECTOR ELECTIONS
 - ISSUER 133.000000 0 WITHHOLD
 133.000000
 AGAINST
 - -
Taysha Gene Therapies, Inc. 877619106 US8776191061 - 06/02/2025 To ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 133.000000 0 FOR
 133.000000
 FOR
 - -
Taysha Gene Therapies, Inc. 877619106 US8776191061 - 06/02/2025 To approve a proposed amendment to the Company's Amended and Restated Certificate of Incorporation, as amended to date, to increase the number of authorized shares of common stock from 400,000,000 to 700,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 133.000000 0 FOR
 133.000000
 FOR
 - -
Cerus Corporation 157085101 US1570851014 - 06/03/2025 The election of the two nominees for director named in the Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders: Jami Dover Nachtsheim DIRECTOR ELECTIONS
 - ISSUER 986.000000 0 FOR
 986.000000
 FOR
 - -
Cerus Corporation 157085101 US1570851014 - 06/03/2025 The election of the two nominees for director named in the Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders: Hua Shan, MD, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 986.000000 0 FOR
 986.000000
 FOR
 - -
Cerus Corporation 157085101 US1570851014 - 06/03/2025 The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. COMPENSATION
 - ISSUER 986.000000 0 AGAINST
 986.000000
 AGAINST
 - -
Cerus Corporation 157085101 US1570851014 - 06/03/2025 The approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 986.000000 0 FOR
 986.000000
 FOR
 - -
Cerus Corporation 157085101 US1570851014 - 06/03/2025 The ratification of the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 986.000000 0 FOR
 986.000000
 FOR
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Nicholas Woodman DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 WITHHOLD
 755.000000
 AGAINST
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Tyrone Ahmad-Taylor DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 WITHHOLD
 755.000000
 AGAINST
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Emily S. Culp Hogue DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 FOR
 755.000000
 FOR
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Michael C. Dennison DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 FOR
 755.000000
 FOR
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Shaz Kahng DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 WITHHOLD
 755.000000
 AGAINST
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Miguel A. Lopez Ben DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 FOR
 755.000000
 FOR
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Election of Directors: Susan Lyne DIRECTOR ELECTIONS
 - ISSUER 755.000000 0 WITHHOLD
 755.000000
 AGAINST
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 755.000000 0 FOR
 755.000000
 FOR
 - -
GoPro, Inc. 38268T103 US38268T1034 - 06/03/2025 Approval of the non-binding, advisory resolution on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 755.000000 0 FOR
 755.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Election of Directors: Xi "Felix" Lin DIRECTOR ELECTIONS
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Election of Directors: Maria Ross DIRECTOR ELECTIONS
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Election of Directors: Richard Diaz DIRECTOR ELECTIONS
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Election of Directors: Lisa Lim DIRECTOR ELECTIONS
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Election of Directors: Charlotte Westfall DIRECTOR ELECTIONS
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Ratification of the appointment of BDO USA, P.C. as the independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 217.000000 0 FOR
 217.000000
 FOR
 - -
HF Foods Group Inc. 40417F109 US40417F1093 - 06/03/2025 Approval, on an advisory basis, of the compensation of our executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 217.000000 0 AGAINST
 217.000000
 AGAINST
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Nicolas Brien DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Angela Courtin DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 AGAINST
 1659.000000
 AGAINST
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Manuel A. Diaz DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Michael J. Dominguez DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Peter Mathes DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Election of Director Nominees: Susan M. Tolson DIRECTOR ELECTIONS
 - ISSUER 1659.000000 0 AGAINST
 1659.000000
 AGAINST
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Ratification of the appointment of PricewaterhouseCoopers LLP to serve as OUTFRONT Media Inc.'s independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
OUTFRONT Media Inc. 69007J304 US69007J3041 - 06/03/2025 Approval, on a non-binding advisory basis, of the compensation of OUTFRONT Media Inc.'s named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1659.000000 0 FOR
 1659.000000
 FOR
 - -
Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 - 06/03/2025 To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: Heidi Kunz DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 - 06/03/2025 To elect two class II directors to hold office until the 2026 Annual Meeting of Stockholders: James Topper, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 120.000000 0 WITHHOLD
 120.000000
 AGAINST
 - -
Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 - 06/03/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 - 06/03/2025 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 120.000000 0 FOR
 120.000000
 FOR
 - -
Phathom Pharmaceuticals, Inc. 71722W107 US71722W1071 - 06/03/2025 To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 120.000000 0 ONE YEAR
 120.000000
 FOR
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Election of Directors. To elect two (2) directors to serve for a three-year term ending at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Andrew Arno DIRECTOR ELECTIONS
 - ISSUER 34.000000 0 FOR
 34.000000
 FOR
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Election of Directors. To elect two (2) directors to serve for a three-year term ending at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Samuel Gulko DIRECTOR ELECTIONS
 - ISSUER 34.000000 0 WITHHOLD
 34.000000
 AGAINST
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Non-binding advisory vote to approve the compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 34.000000 0 AGAINST
 34.000000
 AGAINST
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Ratification of the appointment of SingerLewak LLP as the independent registered public accounting firm of Smith Micro Software, Inc. for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 34.000000 0 FOR
 34.000000
 FOR
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Approval of an amendment to the Smith Micro Software, Inc. Amended and Restated Omnibus Equity Incentive Plan. COMPENSATION
 - ISSUER 34.000000 0 AGAINST
 34.000000
 AGAINST
 - -
Smith Micro Software, Inc. 832154405 US8321544053 - 06/03/2025 Approval of an amendment to the Smith Micro Software, Inc. Amended and Restated Employee Stock Purchase Plan. COMPENSATION
 - ISSUER 34.000000 0 FOR
 34.000000
 FOR
 - -
Ameresco, Inc. 02361E108 US02361E1082 - 06/04/2025 Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified: Jennifer Miller DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 WITHHOLD
 362.000000
 AGAINST
 - -
Ameresco, Inc. 02361E108 US02361E1082 - 06/04/2025 Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified: Nickolas Stavropoulos DIRECTOR ELECTIONS
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Ameresco, Inc. 02361E108 US02361E1082 - 06/04/2025 To ratify the selection by the Audit Committee of RSM US LLP as Ameresco's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 362.000000 0 FOR
 362.000000
 FOR
 - -
Ameresco, Inc. 02361E108 US02361E1082 - 06/04/2025 To approve an amendment to Ameresco's restated certificate of incorporation to limit the liability of certain officers in Certain circumstances as permitted pursuant to amendments to Delaware law. CORPORATE GOVERNANCE
 - ISSUER 362.000000 0 AGAINST
 362.000000
 AGAINST
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Election of Director Nominees: Ellen Beausang DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Election of Director Nominees: Jeffrey Cohen, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Election of Director Nominees: John Fraser DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Election of Director Nominees: Cynthia Hundorfean DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Election of Director Nominees: Winfred Parnell, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Proposal to approve, the issuance of warrants to purchase 27,778 shares of common stock to certain related parties pursuant to the terms of the private placement financing transaction set forth in the Securities Purchase Agreement dated as of June 30, 2024. CAPITAL STRUCTURE
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Proposal to approve an amendment to the Aspira Women's Health Inc. 2019 Stock Incentive Plan. COMPENSATION
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Aspira Women's Health Inc. 04537Y208 US04537Y2081 - 06/04/2025 Proposal to ratify the selection of BDO USA PC as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Climb Bio, Inc. 28658R106 US28658R1068 - 06/04/2025 The election of two directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Judith Dunn, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 41.000000 0 WITHHOLD
 41.000000
 AGAINST
 - -
Climb Bio, Inc. 28658R106 US28658R1068 - 06/04/2025 The election of two directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Stephen Thomas, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 41.000000 0 WITHHOLD
 41.000000
 AGAINST
 - -
Climb Bio, Inc. 28658R106 US28658R1068 - 06/04/2025 The ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 41.000000 0 FOR
 41.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 To adopt and approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 210,000,000 to 310,000,000 and increase the number of authorized shares of our common stock from 200,000,000 to 300,000,000. CAPITAL STRUCTURE
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Daniel R. Passeri DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Peter A. Kiener DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 WITHHOLD
 183.000000
 AGAINST
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Frank Morich DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 WITHHOLD
 183.000000
 AGAINST
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Pamela Garzone DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Patrick Verheyen DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The election of six nominees to the Board of Directors: Pasha Sarraf DIRECTOR ELECTIONS
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The ratification of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Cue Biopharma, Inc. 22978P106 US22978P1066 - 06/04/2025 The approval of the Cue Biopharma, Inc. 2025 Stock Incentive Plan. COMPENSATION
 - ISSUER 183.000000 0 FOR
 183.000000
 FOR
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Election of three Class II directors to our board of directors, each to serve until the 2028 Annual Meeting of Stockholders: Ron Cooper DIRECTOR ELECTIONS
 - ISSUER 522.000000 0 WITHHOLD
 522.000000
 AGAINST
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Election of three Class II directors to our board of directors, each to serve until the 2028 Annual Meeting of Stockholders: Anthony Quinn, M.B. Ch. N., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 522.000000 0 FOR
 522.000000
 FOR
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Election of three Class II directors to our board of directors, each to serve until the 2028 Annual Meeting of Stockholders: Jason Rhodes DIRECTOR ELECTIONS
 - ISSUER 522.000000 0 WITHHOLD
 522.000000
 AGAINST
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 522.000000 0 FOR
 522.000000
 FOR
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 522.000000 0 FOR
 522.000000
 FOR
 - -
Generation Bio Co. 37148K209 US37148K2096 - 06/04/2025 Adoption and approval of an amendment to our restated certificate of incorporation to effect a reverse stock split of our issued shares of common stock at a ratio within the range of not less than 1-for-10 and not greater than 1-for-30, without reducing the authorized number of shares of our common stock, with the exact ratio within such range and the implementation and timing of such reverse stock split to be determined at the sole discretion of our board of directors, without further approval or authorization of our stockholders. CAPITAL STRUCTURE
 - ISSUER 522.000000 0 FOR
 522.000000
 FOR
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 Election of Directors: William Ericson DIRECTOR ELECTIONS
 - ISSUER 2271.000000 0 FOR
 2271.000000
 FOR
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 Election of Directors: Kathy Ordonez DIRECTOR ELECTIONS
 - ISSUER 2271.000000 0 FOR
 2271.000000
 FOR
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 Election of Directors: Christopher M. Smith DIRECTOR ELECTIONS
 - ISSUER 2271.000000 0 FOR
 2271.000000
 FOR
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 2271.000000 0 FOR
 2271.000000
 FOR
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2271.000000 0 AGAINST
 2271.000000
 AGAINST
 - -
Pacific Biosciences of California, Inc. 69404D108 US69404D1081 - 06/04/2025 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION
 - ISSUER 2271.000000 0 AGAINST
 2271.000000
 AGAINST
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To elect three Class III nominees for directors to hold office until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified: June Bray DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To elect three Class III nominees for directors to hold office until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Christopher J. Senner DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To elect three Class III nominees for directors to hold office until the 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Rajiv Patni, M.D. DIRECTOR ELECTIONS
 - ISSUER 118.000000 0 WITHHOLD
 118.000000
 AGAINST
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To approve an amendment to our certificate of incorporation to increase the total number of authorized shares of our common stock from 100,000,000 to 250,000,000 shares. CAPITAL STRUCTURE
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To approve an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio of one-for-ten. CAPITAL STRUCTURE
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To ratify the selection of BDO USA, P.C. as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Quince Therapeutics, Inc. 22053A107 US22053A1079 - 06/04/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 118.000000 0 FOR
 118.000000
 FOR
 - -
Redfin Corporation 75737F108 US75737F1084 - 06/04/2025 To adopt the Agreement and Plan of Merger, dated March 9, 2025, among Rocket Companies, Inc. ("Rocket"), Neptune Merger Sub, Inc., a wholly owned subsidiary of Rocket ("Merger Sub"), and Redfin Corporation ("Redfin"), as may be amended from time to time, pursuant to which Merger Sub will merge with and into Redfin (the "Merger"), with Redfin surviving the Merger as a wholly owned subsidiary of Rocket. EXTRAORDINARY TRANSACTIONS
 - ISSUER 1216.000000 0 FOR
 1216.000000
 FOR
 - -
Redfin Corporation 75737F108 US75737F1084 - 06/04/2025 To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Redfin's named executive officers in connection with the proposed Merger. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1216.000000 0 FOR
 1216.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To elect the two Class I director nominees for terms expiring in 2028: Krishna Shivram DIRECTOR ELECTIONS
 - ISSUER 1328.000000 0 FOR
 1328.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To elect the two Class I director nominees for terms expiring in 2028: Laura D'Andrea Tyson DIRECTOR ELECTIONS
 - ISSUER 1328.000000 0 FOR
 1328.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To approve an amendment and restatement of the Stem, Inc. 2024 Equity Incentive Plan to increase the number of shares available for issuance by 7,500,000 shares and to extend the plan term. COMPENSATION
 - ISSUER 1328.000000 0 AGAINST
 1328.000000
 AGAINST
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1328.000000 0 AGAINST
 1328.000000
 AGAINST
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1328.000000 0 FOR
 1328.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To approve an amendment to our Certificate of Incorporation to effect a reverse stock split of our common stock at a reverse stock split ratio ranging from 10:1 to 20:1, inclusive. CAPITAL STRUCTURE
 - ISSUER 1328.000000 0 FOR
 1328.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To approve an amendment to our Certificate of Incorporation to effect a reduction in the total number of authorized shares of our common stock (which is conditioned on approval and implementation of Proposal 5). CAPITAL STRUCTURE
 - ISSUER 1328.000000 0 FOR
 1328.000000
 FOR
 - -
Stem, Inc. 85859N300 US85859N3008 - 06/04/2025 To approve an adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies. CORPORATE GOVERNANCE
 - ISSUER 1328.000000 0 AGAINST
 1328.000000
 AGAINST
 - -
Torrid Holdings Inc. 89142B107 US89142B1070 - 06/04/2025 DIRECTOR NOMINEES TO SERVE FOR A THREE-YEAR TERM EXPIRING AT THE FISCAL YEAR 2028 ANNUAL MEETING: Lisa M. Harper DIRECTOR ELECTIONS
 - ISSUER 103.000000 0 WITHHOLD
 103.000000
 AGAINST
 - -
Torrid Holdings Inc. 89142B107 US89142B1070 - 06/04/2025 DIRECTOR NOMINEES TO SERVE FOR A THREE-YEAR TERM EXPIRING AT THE FISCAL YEAR 2028 ANNUAL MEETING: Stefan L. Kaluzny DIRECTOR ELECTIONS
 - ISSUER 103.000000 0 WITHHOLD
 103.000000
 AGAINST
 - -
Torrid Holdings Inc. 89142B107 US89142B1070 - 06/04/2025 ADVISORY VOTE ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Torrid Holdings Inc. 89142B107 US89142B1070 - 06/04/2025 RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING JANUARY 31, 2026. AUDIT-RELATED
 - ISSUER 103.000000 0 FOR
 103.000000
 FOR
 - -
Upland Software, Inc. 91544A109 US91544A1097 - 06/04/2025 Election of three Class II Directors: David Chung DIRECTOR ELECTIONS
 - ISSUER 172.000000 0 FOR
 172.000000
 FOR
 - -
Upland Software, Inc. 91544A109 US91544A1097 - 06/04/2025 Election of three Class II Directors: Timothy W. Mattox DIRECTOR ELECTIONS
 - ISSUER 172.000000 0 FOR
 172.000000
 FOR
 - -
Upland Software, Inc. 91544A109 US91544A1097 - 06/04/2025 Election of three Class II Directors: David D. May DIRECTOR ELECTIONS
 - ISSUER 172.000000 0 FOR
 172.000000
 FOR
 - -
Upland Software, Inc. 91544A109 US91544A1097 - 06/04/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 172.000000 0 FOR
 172.000000
 FOR
 - -
Upland Software, Inc. 91544A109 US91544A1097 - 06/04/2025 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 172.000000 0 FOR
 172.000000
 FOR
 - -
Ocugen, Inc. 67577C105 US67577C1053 - 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Uday Kompella, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2201.000000 0 WITHHOLD
 2201.000000
 AGAINST
 - -
Ocugen, Inc. 67577C105 US67577C1053 - 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Blaise Coleman DIRECTOR ELECTIONS
 - ISSUER 2201.000000 0 FOR
 2201.000000
 FOR
 - -
Ocugen, Inc. 67577C105 US67577C1053 - 06/05/2025 The election of (i) Uday Kompella, Ph.D. and Blaise Coleman as Class II Directors to hold office until the 2028 Annual Meeting and (ii) Satish Chandran, Ph.D. as a Class III Director to hold office until the 2026 Annual Meeting: Satish Chandran, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 2201.000000 0 FOR
 2201.000000
 FOR
 - -
Ocugen, Inc. 67577C105 US67577C1053 - 06/05/2025 Ratification of Appointment of PricewaterhouseCoopers LLP as Ocugen, Inc.'s Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED
 - ISSUER 2201.000000 0 FOR
 2201.000000
 FOR
 - -
Ocugen, Inc. 67577C105 US67577C1053 - 06/05/2025 Approval, on an advisory basis, of the compensation of Ocugen, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2201.000000 0 FOR
 2201.000000
 FOR
 - -
PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 - 06/05/2025 Election of Class II Directors: Arnold Levine, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 156.000000 0 FOR
 156.000000
 FOR
 - -
PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 - 06/05/2025 Election of Class II Directors: Charles M. Baum, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 156.000000 0 WITHHOLD
 156.000000
 AGAINST
 - -
PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 - 06/05/2025 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 156.000000 0 AGAINST
 156.000000
 AGAINST
 - -
PMV Pharmaceuticals, Inc. 69353Y103 US69353Y1038 - 06/05/2025 Ratification of the appointment of Ernst & Young LLP as our independent public accounting firm. AUDIT-RELATED
 - ISSUER 156.000000 0 FOR
 156.000000
 FOR
 - -
Sana Biotechnology, Inc. 799566104 US7995661045 - 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Steven D. Harr, M.D. DIRECTOR ELECTIONS
 - ISSUER 1029.000000 0 FOR
 1029.000000
 FOR
 - -
Sana Biotechnology, Inc. 799566104 US7995661045 - 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert L. Rosiello DIRECTOR ELECTIONS
 - ISSUER 1029.000000 0 FOR
 1029.000000
 FOR
 - -
Sana Biotechnology, Inc. 799566104 US7995661045 - 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Michelle Seitz, CFA DIRECTOR ELECTIONS
 - ISSUER 1029.000000 0 FOR
 1029.000000
 FOR
 - -
Sana Biotechnology, Inc. 799566104 US7995661045 - 06/05/2025 To elect three Class I directors to our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Patrick Y. Yang, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1029.000000 0 WITHHOLD
 1029.000000
 AGAINST
 - -
Sana Biotechnology, Inc. 799566104 US7995661045 - 06/05/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1029.000000 0 FOR
 1029.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Martin S.J. Burvill DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Rodolpho C. Cardenuto DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Gregory M. Fischer DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Saar Gillai DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Hong Q. Hou DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Ye Jane Li DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paula LuPriore DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Julie G. Ruehl DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Elect nine directors nominated by the Company's Board of Directors and named in this Proxy Statement to hold office until the next annual meeting and until their respective successors are duly elected and qualified or until their earlier resignation or removal: Paul V. Walsh, Jr. DIRECTOR ELECTIONS
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for fiscal year 2026. AUDIT-RELATED
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Semtech Corporation 816850101 US8168501018 - 06/05/2025 Approve the amendment and restatement of the Semtech Corporation 2017 Long-Term Equity Incentive Plan. COMPENSATION
 - ISSUER 756.000000 0 FOR
 756.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Jacqueline Ardrey DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Ian Bickley DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Kristina Cashman DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Robert J. Hall DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Andrew Meslow DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Jessica Rodriguez DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To elect seven Directors for a one-year term to expire at the 2026 Annual Meeting of Shareholders: Carrie M. Tharp DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026. AUDIT-RELATED
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Vera Bradley, Inc. 92335C106 US92335C1062 - 06/05/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Linda Baddour DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Daniel Hancock DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Robert Hariri, MD, PhD DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Ram M. Jagannath DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Ramkumar Mandalam, PhD DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To elect six directors: Jerrell W. Shelton DIRECTOR ELECTIONS
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company and its subsidiaries for the year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 476.000000 0 FOR
 476.000000
 FOR
 - -
Cryoport, Inc. 229050307 US2290503075 - 06/06/2025 To approve, on an advisory basis, the preferred frequency of future advisory votes on the compensation of named executive officers; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 476.000000 0 ONE YEAR
 476.000000
 FOR
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 Election of Class I Directors: Heidi Hunter DIRECTOR ELECTIONS
 - ISSUER 517.000000 0 WITHHOLD
 517.000000
 AGAINST
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 Election of Class I Directors: Jon Wigginton, M.D. DIRECTOR ELECTIONS
 - ISSUER 517.000000 0 WITHHOLD
 517.000000
 AGAINST
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 Election of Class I Directors: Michael Dybbs, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 517.000000 0 WITHHOLD
 517.000000
 AGAINST
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 517.000000 0 FOR
 517.000000
 FOR
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 517.000000 0 FOR
 517.000000
 FOR
 - -
Sutro Biopharma, Inc. 869367102 US8693671021 - 06/06/2025 To approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a ratio of any whole number between 1-for-5 and 1-for-25, with the exact ratio determined by the board of directors in its discretion, subject to the board of directors authority to abandon such amendment. CAPITAL STRUCTURE
 - ISSUER 517.000000 0 FOR
 517.000000
 FOR
 - -
Tectonic Therapeutic, Inc. 878972108 US8789721086 - 06/06/2025 Election of Directors: Alise Reicin, M.D. DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 WITHHOLD
 18.000000
 AGAINST
 - -
Tectonic Therapeutic, Inc. 878972108 US8789721086 - 06/06/2025 Election of Directors: Praveen Tipirneni, M.D. DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 WITHHOLD
 18.000000
 AGAINST
 - -
Tectonic Therapeutic, Inc. 878972108 US8789721086 - 06/06/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Tectonic Therapeutic, Inc. 878972108 US8789721086 - 06/06/2025 Advisory approval of the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Tectonic Therapeutic, Inc. 878972108 US8789721086 - 06/06/2025 Advisory vote on the frequency of stockholder advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 18.000000 0 ONE YEAR
 18.000000
 FOR
 - -
WW International, Inc. 98262P101 US98262P1012 - 06/06/2025 Election of Directors: The election of three nominees as members of the Board of Directors to serve for a three-year term as Class III directors: Steven M. Altschuler, M.D. DIRECTOR ELECTIONS
 - ISSUER 627.000000 0 WITHHOLD
 627.000000
 AGAINST
 - -
WW International, Inc. 98262P101 US98262P1012 - 06/06/2025 Election of Directors: The election of three nominees as members of the Board of Directors to serve for a three-year term as Class III directors: Julie Bornstein DIRECTOR ELECTIONS
 - ISSUER 627.000000 0 WITHHOLD
 627.000000
 AGAINST
 - -
WW International, Inc. 98262P101 US98262P1012 - 06/06/2025 Election of Directors: The election of three nominees as members of the Board of Directors to serve for a three-year term as Class III directors: Thilo Semmelbauer DIRECTOR ELECTIONS
 - ISSUER 627.000000 0 FOR
 627.000000
 FOR
 - -
WW International, Inc. 98262P101 US98262P1012 - 06/06/2025 The ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2025. AUDIT-RELATED
 - ISSUER 627.000000 0 FOR
 627.000000
 FOR
 - -
WW International, Inc. 98262P101 US98262P1012 - 06/06/2025 The advisory vote to approve the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 627.000000 0 AGAINST
 627.000000
 AGAINST
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 Election of Director: Teena Lerner DIRECTOR ELECTIONS
 - ISSUER 105.000000 0 AGAINST
 105.000000
 AGAINST
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year 2025. AUDIT-RELATED
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 105.000000 0 ONE YEAR
 105.000000
 FOR
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to combine the outstanding shares of our common stock, par value $0.0001 per share, into a lesser number of outstanding shares, by a ratio of not less than one-for-5 and not more than one-for-40, with the exact ratio to be set within this range by our board of directors in its sole discretion (the "Reverse Stock Split Proposal"). CAPITAL STRUCTURE
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
Applied Therapeutics, Inc. 03828A101 US03828A1016 - 06/09/2025 To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient votes in favor of the Reverse Stock Split Proposal. CORPORATE GOVERNANCE
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
Hydrofarm Holdings Group, Inc. 44888K407 US44888K4076 - 06/09/2025 To elect two (2) class II directors to serve three-year terms expiring in 2028: Melisa Denis DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
Hydrofarm Holdings Group, Inc. 44888K407 US44888K4076 - 06/09/2025 To elect two (2) class II directors to serve three-year terms expiring in 2028: Renah Persofsky DIRECTOR ELECTIONS
 - ISSUER 46.000000 0 WITHHOLD
 46.000000
 AGAINST
 - -
Hydrofarm Holdings Group, Inc. 44888K407 US44888K4076 - 06/09/2025 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
Hydrofarm Holdings Group, Inc. 44888K407 US44888K4076 - 06/09/2025 To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 46.000000 0 FOR
 46.000000
 FOR
 - -
Big 5 Sporting Goods Corporation 08915P101 US08915P1012 - 06/10/2025 Election of Two Class B Directors: Lily W. Chang DIRECTOR ELECTIONS
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Big 5 Sporting Goods Corporation 08915P101 US08915P1012 - 06/10/2025 Election of Two Class B Directors: Van B. Honeycutt DIRECTOR ELECTIONS
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Big 5 Sporting Goods Corporation 08915P101 US08915P1012 - 06/10/2025 Approval of the compensation of the Company's named executive officers as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Big 5 Sporting Goods Corporation 08915P101 US08915P1012 - 06/10/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Big 5 Sporting Goods Corporation 08915P101 US08915P1012 - 06/10/2025 Approval of the Company's Amended and Restated 2019 Equity Incentive Plan. COMPENSATION
 - ISSUER 123.000000 0 FOR
 123.000000
 FOR
 - -
Exagen, Inc. 30068X103 US30068X1037 - 06/10/2025 To elect two directors to serve as Class III directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: John Aballi DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Exagen, Inc. 30068X103 US30068X1037 - 06/10/2025 To elect two directors to serve as Class III directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Bruce C. Robertson, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 WITHHOLD
 61.000000
 AGAINST
 - -
Exagen, Inc. 30068X103 US30068X1037 - 06/10/2025 To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Exagen, Inc. 30068X103 US30068X1037 - 06/10/2025 To approve by an advisory vote the compensation of our named executive officers, as disclosed in the proxy statement; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Exagen, Inc. 30068X103 US30068X1037 - 06/10/2025 To approve by an advisory vote the frequency of holding an advisory vote on compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 61.000000 0 ONE YEAR
 61.000000
 FOR
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 To approve an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), to declassify the Board of Directors; SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 127.000000 0 FOR
 127.000000
 FOR
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 Election of Directors: Laura Angelini DIRECTOR ELECTIONS
 - ISSUER 127.000000 0 WITHHOLD
 127.000000
 AGAINST
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 Election of Directors: James E. Ousley DIRECTOR ELECTIONS
 - ISSUER 127.000000 0 WITHHOLD
 127.000000
 AGAINST
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation and make other non-substantive, ministerial changes; CORPORATE GOVERNANCE
 - ISSUER 127.000000 0 FOR
 127.000000
 FOR
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 To approve the compensation of the Company's named executive officers, on a non-binding advisory basis; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 127.000000 0 AGAINST
 127.000000
 AGAINST
 - -
Identiv, Inc. 45170X205 US45170X2053 - 06/10/2025 To ratify the appointment of BPM LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 127.000000 0 FOR
 127.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: S. Hoby Darling DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Robert T. DeMartini DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Gary T. DiCamillo DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Neil Fiske DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Adam L. Gray DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Claudia Hollingsworth DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: R. Carter Pate DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: D. Scott Peterson DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Election of Directors: Erika Serow DIRECTOR ELECTIONS
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Approve, on an advisory basis, the compensation of the Company's Named Executive Officers as set forth in our Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Purple Innovation, Inc. 74640Y106 US74640Y1064 - 06/10/2025 Ratification of the appointment of BDO USA, LLP as our independent registered public accounting firm to audit our financial statements for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 343.000000 0 FOR
 343.000000
 FOR
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Election of Directors: Jaime Leverton DIRECTOR ELECTIONS
 - ISSUER 1226.000000 0 FOR
 1226.000000
 FOR
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Election of Directors: Douglas Mouton DIRECTOR ELECTIONS
 - ISSUER 1226.000000 0 FOR
 1226.000000
 FOR
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Ratification on a non-binding advisory basis of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1226.000000 0 FOR
 1226.000000
 FOR
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Approval, on a non-binding an advisory basis, of the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1226.000000 0 AGAINST
 1226.000000
 AGAINST
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Approval, on a non-binding advisory basis, of the frequency at which future Say-on-Pay votes will be held. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1226.000000 0 ONE YEAR
 1226.000000
 FOR
 - -
Riot Platforms, Inc. 767292105 US7672921050 - 06/10/2025 Approve, in a non-binding vote, D. E. Shaw's proposal, if properly presented at the Annual Meeting, requesting that the Board take all necessary steps in its power, including amending the Company's bylaws, to declassify the Board so that all directors are elected on an annual basis. SHAREHOLDER RIGHTS AND DEFENSES
 - SECURITY HOLDER 1226.000000 0 FOR
 1226.000000
 FOR
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To elect each of the Class I directors nominated by our Board of Directors to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified: Rene Russo, Pharm.D. DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To elect each of the Class I directors nominated by our Board of Directors to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified: Sara M. Bonstein DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To elect each of the Class I directors nominated by our Board of Directors to serve for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified: James Shannon, M.D. DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 WITHHOLD
 43.000000
 AGAINST
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to 600,000,000. CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To approve an amendment to our certificate of incorporation to reflect Delaware law provisions regarding officer exculpation. CORPORATE GOVERNANCE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Xilio Therapeutics, Inc. 98422T100 US98422T1007 - 06/10/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Absci Corporation 00091E109 US00091E1091 - 06/11/2025 The election of the Class I directors nominated by the Board of Directors and named in our Proxy Statement to hold office for a three-year term expiring at our 2028 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Frans van Houten DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 WITHHOLD
 287.000000
 AGAINST
 - -
Absci Corporation 00091E109 US00091E1091 - 06/11/2025 The election of the Class I directors nominated by the Board of Directors and named in our Proxy Statement to hold office for a three-year term expiring at our 2028 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Karen McGinnis DIRECTOR ELECTIONS
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Absci Corporation 00091E109 US00091E1091 - 06/11/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm to audit our financial statements for our fiscal ending December 31, 2025. AUDIT-RELATED
 - ISSUER 287.000000 0 FOR
 287.000000
 FOR
 - -
Alector, Inc. 014442107 US0144421072 - 06/11/2025 ELECTION OF DIRECTORS: Arnon Rosenthal, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 695.000000 0 FOR
 695.000000
 FOR
 - -
Alector, Inc. 014442107 US0144421072 - 06/11/2025 ELECTION OF DIRECTORS: Paula Hammond, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 695.000000 0 WITHHOLD
 695.000000
 AGAINST
 - -
Alector, Inc. 014442107 US0144421072 - 06/11/2025 Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 695.000000 0 FOR
 695.000000
 FOR
 - -
Alector, Inc. 014442107 US0144421072 - 06/11/2025 Advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 695.000000 0 FOR
 695.000000
 FOR
 - -
ALX Oncology Holdings Inc. 00166B105 US00166B1052 - 06/11/2025 Election of Directors: Scott Garland DIRECTOR ELECTIONS
 - ISSUER 105.000000 0 WITHHOLD
 105.000000
 AGAINST
 - -
ALX Oncology Holdings Inc. 00166B105 US00166B1052 - 06/11/2025 Election of Directors: Barbara Klencke, M.D. DIRECTOR ELECTIONS
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
ALX Oncology Holdings Inc. 00166B105 US00166B1052 - 06/11/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 105.000000 0 AGAINST
 105.000000
 AGAINST
 - -
ALX Oncology Holdings Inc. 00166B105 US00166B1052 - 06/11/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 105.000000 0 FOR
 105.000000
 FOR
 - -
American Well Corporation 03044L204 US03044L2043 - 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Mr. Stephen Schlegel DIRECTOR ELECTIONS
 - ISSUER 109.000000 0 WITHHOLD
 109.000000
 AGAINST
 - -
American Well Corporation 03044L204 US03044L2043 - 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Dr. Delos (Toby) Cosgrove DIRECTOR ELECTIONS
 - ISSUER 109.000000 0 WITHHOLD
 109.000000
 AGAINST
 - -
American Well Corporation 03044L204 US03044L2043 - 06/11/2025 To elect three Class II directors to serve until the 2028 annual meeting of stockholders: Ms. Rivka Goldwasser DIRECTOR ELECTIONS
 - ISSUER 109.000000 0 WITHHOLD
 109.000000
 AGAINST
 - -
American Well Corporation 03044L204 US03044L2043 - 06/11/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 109.000000 0 FOR
 109.000000
 FOR
 - -
American Well Corporation 03044L204 US03044L2043 - 06/11/2025 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the compensation discussion and analysis and the related compensation tables and narrative disclosure in the Company's proxy statement SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 109.000000 0 FOR
 109.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jill O'Donnell-Tormey, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Michael Ryan DIRECTOR ELECTIONS
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To elect three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Ali J. Satvat DIRECTOR ELECTIONS
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 806.000000 0 AGAINST
 806.000000
 AGAINST
 - -
Coherus BioSciences, Inc. 19249H103 US19249H1032 - 06/11/2025 To approve the amendment to the Company's 2014 Employee Stock Purchase Plan (the "ESPP Amendment"). COMPENSATION
 - ISSUER 806.000000 0 FOR
 806.000000
 FOR
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To elect three directors with terms to expire at the 2028 Annual Meeting of Stockholders; Sean A. McCarthy, D. Phil. DIRECTOR ELECTIONS
 - ISSUER 386.000000 0 AGAINST
 386.000000
 AGAINST
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To elect three directors with terms to expire at the 2028 Annual Meeting of Stockholders; Mani Mohindru, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 386.000000 0 AGAINST
 386.000000
 AGAINST
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To elect three directors with terms to expire at the 2028 Annual Meeting of Stockholders; Zhen Su, M.D., M.B.A. DIRECTOR ELECTIONS
 - ISSUER 386.000000 0 AGAINST
 386.000000
 AGAINST
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 386.000000 0 FOR
 386.000000
 FOR
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To approve the amendment and restatement of our 2015 Equity Incentive Plan; COMPENSATION
 - ISSUER 386.000000 0 FOR
 386.000000
 FOR
 - -
CytomX Therapeutics, Inc. 23284F105 US23284F1057 - 06/11/2025 To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 386.000000 0 FOR
 386.000000
 FOR
 - -
FORIAN INC. 34630N106 US34630N1063 - 06/11/2025 To elect the following to serve as Class I directors until the annual meeting to be held in 2028 or until their successors are duly elected and qualified: Stanley S. Trotman, Jr. DIRECTOR ELECTIONS
 - ISSUER 112.000000 0 WITHHOLD
 112.000000
 AGAINST
 - -
FORIAN INC. 34630N106 US34630N1063 - 06/11/2025 To elect the following to serve as Class I directors until the annual meeting to be held in 2028 or until their successors are duly elected and qualified: Kristiina Vuori, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 112.000000 0 WITHHOLD
 112.000000
 AGAINST
 - -
FORIAN INC. 34630N106 US34630N1063 - 06/11/2025 To amend our 2020 Equity Incentive Plan to increase the number of shares authorized for issuance by 4,000,000 shares. COMPENSATION
 - ISSUER 112.000000 0 AGAINST
 112.000000
 AGAINST
 - -
FORIAN INC. 34630N106 US34630N1063 - 06/11/2025 To ratify the appointment of CBIZ CPAs P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Ram Aiyar DIRECTOR ELECTIONS
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Jean-Francois Formela DIRECTOR ELECTIONS
 - ISSUER 3.000000 0 WITHHOLD
 3.000000
 AGAINST
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Election of three Class III directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katharine Knobil DIRECTOR ELECTIONS
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 3.000000 0 ONE YEAR
 3.000000
 FOR
 - -
Korro Bio, Inc. 500946108 US5009461089 - 06/11/2025 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Election of the five nominees listed below as directors to serve on the OptimizeRx's Board of Directors until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Lynn O'Connor Vos DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 WITHHOLD
 205.000000
 AGAINST
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Election of the five nominees listed below as directors to serve on the OptimizeRx's Board of Directors until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Catherine Klema DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Election of the five nominees listed below as directors to serve on the OptimizeRx's Board of Directors until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: James Lang DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 WITHHOLD
 205.000000
 AGAINST
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Election of the five nominees listed below as directors to serve on the OptimizeRx's Board of Directors until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Patrick Spangler DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 WITHHOLD
 205.000000
 AGAINST
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Election of the five nominees listed below as directors to serve on the OptimizeRx's Board of Directors until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal: Gregory D. Wasson DIRECTOR ELECTIONS
 - ISSUER 205.000000 0 WITHHOLD
 205.000000
 AGAINST
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Advisory (non-binding) approval of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 205.000000 0 AGAINST
 205.000000
 AGAINST
 - -
OptimizeRx Corporation 68401U204 US68401U2042 - 06/11/2025 Ratification of UHY LLP as OptimizeRx's independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 205.000000 0 FOR
 205.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Matthew Ehrlichman DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Sean Kell DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Rachel Lam DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Alan Pickerill DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Amanda Reierson DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Maurice Tulloch DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Camilla Velasquez DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To elect eight directors to serve until the 2026 Annual Meeting of Stockholders: Regi Vengalil DIRECTOR ELECTIONS
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To ratify the appointment of Grant Thornton LLP as the independent registered public accounting firm for Porch Group, Inc. for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 894.000000 0 FOR
 894.000000
 FOR
 - -
Porch Group, Inc. 733245104 US7332451043 - 06/11/2025 To approve of, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 894.000000 0 AGAINST
 894.000000
 AGAINST
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Election of Class III Directors: Rati Sahi Levesque DIRECTOR ELECTIONS
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Election of Class III Directors: Chip Baird DIRECTOR ELECTIONS
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Election of Class III Directors: James Miller DIRECTOR ELECTIONS
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Approval of a management proposal to amend our Amended and Restated Certificate of Incorporation to phase in the declassification of our Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
The RealReal, Inc. 88339P101 US88339P1012 - 06/11/2025 Approval of a management proposal to amend our Amended and Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to the Delaware General Corporation Law. CORPORATE GOVERNANCE
 - ISSUER 940.000000 0 FOR
 940.000000
 FOR
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Hezy Shaked DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 WITHHOLD
 135.000000
 AGAINST
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Teresa Aragones DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 FOR
 135.000000
 FOR
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Doug Collier DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 WITHHOLD
 135.000000
 AGAINST
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Seth Johnson DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 WITHHOLD
 135.000000
 AGAINST
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Janet Kerr DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 WITHHOLD
 135.000000
 AGAINST
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Election of the following directors for a term expiring at the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Michael Relich DIRECTOR ELECTIONS
 - ISSUER 135.000000 0 FOR
 135.000000
 FOR
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Approval of the Third Amended and Restated Tilly's 2012 Equity and Incentive Award Plan COMPENSATION
 - ISSUER 135.000000 0 FOR
 135.000000
 FOR
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Ratification of the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending January 31, 2026. AUDIT-RELATED
 - ISSUER 135.000000 0 FOR
 135.000000
 FOR
 - -
Tilly's, Inc. 886885102 US8868851028 - 06/11/2025 Non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 135.000000 0 FOR
 135.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 To elect four directors to serve on our Board of Directors for a one-year term of office until the next annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal: Gail Sharps Myers DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 To elect four directors to serve on our Board of Directors for a one-year term of office until the next annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal: Christine St.Clare DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 To elect four directors to serve on our Board of Directors for a one-year term of office until the next annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal: Rick Sterling DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 To elect four directors to serve on our Board of Directors for a one-year term of office until the next annual meeting of stockholders, with each director to hold office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal: Sylvia A. Wulf DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
AquaBounty Technologies, Inc. 03842K309 US03842K3095 - 06/12/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Century Therapeutics, Inc. 15673T100 US15673T1007 - 06/12/2025 Election of Class I directors for a three year term expiring in 2028: Daphne Quimi DIRECTOR ELECTIONS
 - ISSUER 96.000000 0 WITHHOLD
 96.000000
 AGAINST
 - -
Century Therapeutics, Inc. 15673T100 US15673T1007 - 06/12/2025 Election of Class I directors for a three year term expiring in 2028: Carlo Rizzuto, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 96.000000 0 WITHHOLD
 96.000000
 AGAINST
 - -
Century Therapeutics, Inc. 15673T100 US15673T1007 - 06/12/2025 Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED
 - ISSUER 96.000000 0 FOR
 96.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To elect the following nominees to serve as directors: Phillip P. Chan, MD, PhD DIRECTOR ELECTIONS
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To elect the following nominees to serve as directors: Michael G. Bator, MBA DIRECTOR ELECTIONS
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To elect the following nominees to serve as directors: Edward R. Jones, MD, MBA DIRECTOR ELECTIONS
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To elect the following nominees to serve as directors: Alan D. Sobel, CPA DIRECTOR ELECTIONS
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To elect the following nominees to serve as directors: Jiny Kim, MBA DIRECTOR ELECTIONS
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers, disclosed pursuant to Item 402 of Regulation S-K. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
CytoSorbents Corporation 23283X206 US23283X2062 - 06/12/2025 To ratify the appointment of WithumSmith+Brown, PC as CytoSorbents Corporation's independent auditors to audit CytoSorbents Corporation's financial statements for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 245.000000 0 FOR
 245.000000
 FOR
 - -
Finch Therapeutics Group, Inc. 31773D200 US31773D2009 - 06/12/2025 Elect Director Christian Lange DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Finch Therapeutics Group, Inc. 31773D200 US31773D2009 - 06/12/2025 Elect Director Jeffery A. Smisek DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 WITHHOLD
 1.000000
 AGAINST
 - -
Finch Therapeutics Group, Inc. 31773D200 US31773D2009 - 06/12/2025 Reduce Authorized Common and Preferred Stock CAPITAL STRUCTURE
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Election of Directors: Ross Fubini DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Election of Directors: Christian Henry DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Election of Directors: Sri Kosuri DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Election of Directors: Shyam Sankar DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Election of Directors: Harry E. Sloan DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Ginkgo Bioworks Holdings, Inc. 37611X209 US37611X2099 - 06/12/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Collard DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Sharmila Dissanaike, M.D., FACS, FCCM DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Craig Johnson DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Michael Kaseta DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Adam Morgan DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To elect six director nominees to serve until the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal: Christian Waage DIRECTOR ELECTIONS
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To ratify the appointment of Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To approve, on a nonbinding advisory basis, compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1100.000000 0 FOR
 1100.000000
 FOR
 - -
Heron Therapeutics, Inc. 427746102 US4277461020 - 06/12/2025 To approve, on a nonbinding advisory basis, the frequency of future advisory votes on the compensation paid to our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1100.000000 0 ONE YEAR
 1100.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 Election of Directors: Avram A. Glazer DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 Election of Directors: Warren H. Gfeller DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 Election of Directors: Brian S. Goldstein DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 Election of Directors: Amy M. Wilkinson DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers (the "Say on Pay Vote"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 To recommend, on a non-binding, advisory basis, whether the Say on Pay Vote should be held every one, two or three years (the "Say on Frequency Vote"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 29.000000 0 ONE YEAR
 29.000000
 FOR
 - -
INNOVATE Corp. 45784J303 US45784J3032 - 06/12/2025 To ratify the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 (the "Accounting Firm Proposal"). AUDIT-RELATED
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 Election of Class II Directors for terms expiring in 2028: Sarah B. Noonberg DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 Election of Class II Directors for terms expiring in 2028: Robert Keith Woods DIRECTOR ELECTIONS
 - ISSUER 10.000000 0 WITHHOLD
 10.000000
 AGAINST
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 To approve an amendment to our 2023 Equity Incentive Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock. COMPENSATION
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 To approve an amendment to our 2023 Employee Stock Purchase Plan to clarify that the number of outstanding shares of common stock used to calculate the automatic share reserve increase includes shares issuable on exercise of prefunded warrants and conversion of preferred stock. COMPENSATION
 - ISSUER 10.000000 0 AGAINST
 10.000000
 AGAINST
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 To approve on an an (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Neurogene, Inc. 64135M105 US64135M1053 - 06/12/2025 To ratify on an advisory (non-binding) basis the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 10.000000 0 FOR
 10.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): Donna D. Fraiche DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): Barbara D. Gilmore DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): William A. Lamkin DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): Elena B. Poptodorova DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 WITHHOLD
 281.000000
 AGAINST
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): Jeffrey P. Somers DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 WITHHOLD
 281.000000
 AGAINST
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Independent Trustee): Mark A. Talley DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Managing Trustee): Jennifer B. Clark DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Election of Trustees. Nominees (for Managing Trustee): Adam Portnoy DIRECTOR ELECTIONS
 - ISSUER 281.000000 0 WITHHOLD
 281.000000
 AGAINST
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 281.000000 0 AGAINST
 281.000000
 AGAINST
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Approval of the Second Amended and Restated Office Properties Income Trust 2009 Incentive Share Award Plan. COMPENSATION
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Office Properties Income Trust 67623C109 US67623C1099 - 06/12/2025 Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 281.000000 0 FOR
 281.000000
 FOR
 - -
Prelude Therapeutics Incorporated 74065P101 US74065P1012 - 06/12/2025 Election of Class II Directors: Martin Babler DIRECTOR ELECTIONS
 - ISSUER 64.000000 0 FOR
 64.000000
 FOR
 - -
Prelude Therapeutics Incorporated 74065P101 US74065P1012 - 06/12/2025 Election of Class II Directors: Victor Sandor, M.D.C.M. DIRECTOR ELECTIONS
 - ISSUER 64.000000 0 WITHHOLD
 64.000000
 AGAINST
 - -
Prelude Therapeutics Incorporated 74065P101 US74065P1012 - 06/12/2025 Ratification of the appointment of Ernst & Young LLP as the Independent registered public accounting firm of the company for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 64.000000 0 FOR
 64.000000
 FOR
 - -
Prelude Therapeutics Incorporated 74065P101 US74065P1012 - 06/12/2025 To approve an amendment to our restated certificate of Incorporation, as amended, to Increase the number of authorized shares of our non-voting common stock from 12,850,259 to 112,850,259, with a corresponding Increase to the total number of authorized shares of our common stock, par value $0.0001 per share. CAPITAL STRUCTURE
 - ISSUER 64.000000 0 FOR
 64.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Courtney Beers, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Robert F. Carey DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Kenneth J. Hillan, M.B., Ch.B. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Margaret A. Horn, J.D. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Alexander D. Macrae, M.B., Ch.B., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: John H. Markels, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: James R. Meyers DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: H. Stewart Parker DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To elect the nine nominees for director, named below, to serve on the Board of Directors until the next annual meeting of stockholders to be held in 2026 and until their successors are duly elected and qualified: Karen L. Smith, M.D., Ph.D., M.B.A, L.L.M. DIRECTOR ELECTIONS
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To approve, on an advisory basis, the compensation of our named executive officers, or NEOs, as described in the accompanying Proxy Statement; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To approve the amendment and restatement of the Sangamo Therapeutics, Inc. 2018 Equity Incentive Plan, or the 2018 Plan, to, among other things, increase the aggregate number of shares of our common stock reserved for issuance under the 2018 Plan by 14,000,000 shares; and COMPENSATION
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Sangamo Therapeutics, Inc. 800677106 US8006771062 - 06/12/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1415.000000 0 FOR
 1415.000000
 FOR
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 Election of Class I Directors: Alexander Cumbo DIRECTOR ELECTIONS
 - ISSUER 23.000000 0 WITHHOLD
 23.000000
 AGAINST
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 Election of Class I Directors: Sukumar Nagendran DIRECTOR ELECTIONS
 - ISSUER 23.000000 0 WITHHOLD
 23.000000
 AGAINST
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 23.000000 0 FOR
 23.000000
 FOR
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 The approval of an amendment to the Company's Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock from 120,000,000 to 240,000,000. CAPITAL STRUCTURE
 - ISSUER 23.000000 0 FOR
 23.000000
 FOR
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 The approval of an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan to increase the number of shares of our common stock available for issuance thereunder by 9,000,000 shares and amend the evergreen provision. COMPENSATION
 - ISSUER 23.000000 0 AGAINST
 23.000000
 AGAINST
 - -
Solid Biosciences Inc. 83422E204 US83422E2046 - 06/12/2025 The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 23.000000 0 AGAINST
 23.000000
 AGAINST
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To elect three Class II directors to serve until the Company's 2028 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Frank E. Thomas DIRECTOR ELECTIONS
 - ISSUER 144.000000 0 FOR
 144.000000
 FOR
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To elect three Class II directors to serve until the Company's 2028 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Patrick Vink, M.D. DIRECTOR ELECTIONS
 - ISSUER 144.000000 0 WITHHOLD
 144.000000
 AGAINST
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To elect three Class II directors to serve until the Company's 2028 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Esther Rajavelu DIRECTOR ELECTIONS
 - ISSUER 144.000000 0 FOR
 144.000000
 FOR
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 144.000000 0 FOR
 144.000000
 FOR
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 144.000000 0 FOR
 144.000000
 FOR
 - -
Spero Therapeutics, Inc. 84833T103 US84833T1034 - 06/12/2025 To approve an amendment to the Company's 2017 Stock Incentive Plan, as amended, to increase the total number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. COMPENSATION
 - ISSUER 144.000000 0 AGAINST
 144.000000
 AGAINST
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Marla Beck DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Brenton L Saunders DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Doug Schillinger DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Stephen J. Fanning DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Brian Miller DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Desiree Gruber DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Election of Directors: Michelle Kerrick DIRECTOR ELECTIONS
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
The Beauty Health Company 88331L108 US88331L1089 - 06/12/2025 Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1022.000000 0 FOR
 1022.000000
 FOR
 - -
VirnetX Holding Corporation 92823T207 US92823T2078 - 06/12/2025 Election of our Class III Director: Michael F. Angelo DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
VirnetX Holding Corporation 92823T207 US92823T2078 - 06/12/2025 To ratify the appointment of Farber Hass Hurley LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
VirnetX Holding Corporation 92823T207 US92823T2078 - 06/12/2025 To approve, on a non-binding advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Werewolf Therapeutics, Inc. 95075A107 US95075A1079 - 06/12/2025 Election of three directors to serve as Class I directors, each for a three-year term expiring at the 2028 Annual Meeting of Shareholders: Briggs Morrison, M.D. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 WITHHOLD
 153.000000
 AGAINST
 - -
Werewolf Therapeutics, Inc. 95075A107 US95075A1079 - 06/12/2025 Election of three directors to serve as Class I directors, each for a three-year term expiring at the 2028 Annual Meeting of Shareholders: Michael Sherman, M.B.A. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 WITHHOLD
 153.000000
 AGAINST
 - -
Werewolf Therapeutics, Inc. 95075A107 US95075A1079 - 06/12/2025 Election of three directors to serve as Class I directors, each for a three-year term expiring at the 2028 Annual Meeting of Shareholders: Anil Singhal, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 153.000000 0 FOR
 153.000000
 FOR
 - -
Werewolf Therapeutics, Inc. 95075A107 US95075A1079 - 06/12/2025 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 153.000000 0 FOR
 153.000000
 FOR
 - -
Zevia PBC 98955K104 US98955K1043 - 06/12/2025 Election of Directors: To be elected for terms expiring in 2028: Andrew Ruben DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 AGAINST
 61.000000
 AGAINST
 - -
Zevia PBC 98955K104 US98955K1043 - 06/12/2025 Election of Directors: To be elected for terms expiring in 2028: Padraic L. Spence DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Zevia PBC 98955K104 US98955K1043 - 06/12/2025 Election of Directors: To be elected for terms expiring in 2028: Amy E. Taylor DIRECTOR ELECTIONS
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
Zevia PBC 98955K104 US98955K1043 - 06/12/2025 Ratification of the selection of Deloitte & Touche LLP as Zevia PBC's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 61.000000 0 FOR
 61.000000
 FOR
 - -
CarParts.com, Inc. 14427M107 US14427M1071 - 06/13/2025 Election of the following Class I Directors: Jim Barnes DIRECTOR ELECTIONS
 - ISSUER 291.000000 0 FOR
 291.000000
 FOR
 - -
CarParts.com, Inc. 14427M107 US14427M1071 - 06/13/2025 Election of the following Class I Directors: Ana Dutra DIRECTOR ELECTIONS
 - ISSUER 291.000000 0 FOR
 291.000000
 FOR
 - -
CarParts.com, Inc. 14427M107 US14427M1071 - 06/13/2025 Election of the following Class I Directors: Jay Greyson DIRECTOR ELECTIONS
 - ISSUER 291.000000 0 FOR
 291.000000
 FOR
 - -
CarParts.com, Inc. 14427M107 US14427M1071 - 06/13/2025 Ratification of the appointment of RSM US, LLP, an independent registered public accounting firm, as independent auditors of the Company for fiscal year 2025. AUDIT-RELATED
 - ISSUER 291.000000 0 FOR
 291.000000
 FOR
 - -
CarParts.com, Inc. 14427M107 US14427M1071 - 06/13/2025 Approval of an advisory (non-binding) resolution regarding the compensation of our named executive officers, or the Say-on-Pay Proposal. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 291.000000 0 FOR
 291.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 06/13/2025 Election of Directors: Timothy C. Barabe, MBA DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 WITHHOLD
 18.000000
 AGAINST
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 06/13/2025 Election of Directors: Carsten Brunn, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 06/13/2025 Election of Directors: Nishan de Silva, MD MBA DIRECTOR ELECTIONS
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 06/13/2025 To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Cartesian Therapeutics, Inc. 816212302 US8162123025 - 06/13/2025 To ratify the appointment of Ernst & Young LLP as Cartesian Therapeutics, Inc. 's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 18.000000 0 FOR
 18.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Transaction Proposal - To consider and vote on a proposal to approve and adopt the Transaction Agreement, dated as of March 13, 2025, by and among Endo, Mallinckrodt plc, a public limited company incorporated in Ireland with registered number 522227 ("Mallinckrodt"), and Salvare Merger Sub LLC, a Delaware limited liability company and wholly owned subsidiary of Mallinckrodt ("Merger Sub"), as it may be amended, supplemented, or otherwise modified from time to time (the "Transaction Agreement"), including the plan of merger contained therein, and the transactions contemplated thereby (the "Transactions"), including the merger of Merger Sub with and into Endo, with Endo continuing as the surviving corporation (the "Business Combination"), which is further described in the sections of the accompanying joint proxy statement/prospectus (the "joint proxy statement/prospectus") entitled "The Transaction" and "The Transaction Agreement" beginning on page 111 and page 305, respectively, of the joint proxy statement/prospectus and a copy of which is attached as Annex B to the joint proxy statement/prospectus. EXTRAORDINARY TRANSACTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Distributable Reserves Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve (i) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account as at the date of the joint proxy statement/prospectus (being the first Mallinckrodt distributable reserves creation); and (ii) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account following the consummation of the Business Combination, (including but not limited to the share premium arising from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement or the amounts credited to Mallinckrodt's share premium account upon the capitalization of any merger reserve or like reserve resulting from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement) (being the second Mallinckrodt distributable reserves creation). CAPITAL STRUCTURE
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Combination-Related Compensation Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve compensation that will or may become payable by Endo to its named executive officers in connection with the Transactions. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 The Mallinckrodt Articles Amendment Proposals - To consider and vote on, on a non-binding, advisory basis, eight separate proposals to approve the following amendments to the Mallinckrodt articles of association, presented separately in accordance with the requirements of the United States Securities and Exchange Commission: Change in Mallinckrodt Capital Structure - To vary the authorized share capital of Mallinckrodt, including through the creation of a new class of preferred shares, the removal of pre-emption rights of certain shareholders over newly issued shares and the deletion of Article 174 of the existing Mallinckrodt constitution, which capped the total number of shares issuable pursuant to Mallinckrodt's management incentive plan at 10%, as shown in Annex K-2 of the joint proxy statement/prospectus; CAPITAL STRUCTURE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Dealings in Transfers and Registration of Mallinckrodt Shares - To delete certain restrictions on Mallinckrodt shareholders' ability to deal in their Mallinckrodt shares, amend the circumstances in which directors can decline to register a transfer of shares and eliminate the drag-along rights and tag-along rights in the existing memorandum and articles of association of Mallinckrodt, as shown in Annex K-3 of the joint proxy statement/prospectus; SHAREHOLDER RIGHTS AND DEFENSES
CAPITAL STRUCTURE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Change in Mallinckrodt Shareholder Meeting Procedure - To change the quorum required for general meetings (to two or more persons holding (or representing by proxy) at least one half in nominal value of the issued shares of an applicable class), the manner in which voting will be conducted (by requiring voting to be carried out by way of a poll) and the procedures required for advance notice of members' business and nominations (by aligning with the customary current approach by U.S. listed companies), as shown in Annex K-4 of the joint proxy statement/prospectus: CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Transactions involving Mallinckrodt - To delete the ability of holders of more than one half of the Mallinckrodt shares to require the Mallinckrodt board to initiate a process for a review of strategic alternatives and a sale of assets or business segments, to delete restrictions on the Mallinckrodt board from selling, leasing or exchanging all or substantially all of Mallinckrodt's property and assets without prior consent of the holders of more than one half of the Mallinckrodt shares, to amend provisions regarding shareholder rights plan to align with the customary approach adopted by Irish incorporated U.S. listed companies and to restrict Mallinckrodt from engaging in business combinations with "interested members" for a period of time, subject to certain exceptions, as shown in Annex K-5 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Proceedings of Mallinckrodt Directors - To permit the Mallinckrodt board to determine its own size (subject to a minimum of two and a maximum of twenty directors) and its own chair, and to allow for the vacation ipso facto of the office of a director where he or she is requested to resign in writing by not less than three quarters of the other directors, as shown in Annex K-6 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Appointment and Removal of Mallinckrodt Directors - To change the provisions regarding appointment of Mallinckrodt directors and add provisions regarding plurality voting of directors, as shown in Annex K-7 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Information Rights and Board Observers - To delete existing provisions in respect of information rights and board observers for certain shareholders, as shown in Annex K-8 of the joint proxy statement/prospectus; and CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/13/2025 Miscellaneous Changes - To make certain other changes to make Mallinckrodt's articles of association in a form that is customary for an Irish public limited company effecting a transaction of the nature of the Transactions and for a potential listing of Mallinckrodt's shares on the New York Stock Exchange, as shown in Annex K-9 of the joint proxy statement/prospectus. CORPORATE GOVERNANCE
 - ISSUER 2262.000000 0 AGAINST
 2262.000000
 AGAINST
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: David Grayzel, M.D. DIRECTOR ELECTIONS
 - ISSUER 13.000000 0 FOR
 13.000000
 FOR
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Isaac Manke, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 13.000000 0 WITHHOLD
 13.000000
 AGAINST
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To elect David Grayzel, M.D., Isaac Manke, Ph.D. and Diyong Xu as Class I directors to our Board of Directors, each to serve until the 2028 Annual Meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation, or removal: Diyong Xu DIRECTOR ELECTIONS
 - ISSUER 13.000000 0 WITHHOLD
 13.000000
 AGAINST
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To approve an amendment to our Restated Certificate of Incorporation, as amended, to limit the liability of certain officers as permitted by amendments to Delaware law; CORPORATE GOVERNANCE
 - ISSUER 13.000000 0 FOR
 13.000000
 FOR
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 13.000000 0 FOR
 13.000000
 FOR
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 13.000000 0 AGAINST
 13.000000
 AGAINST
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 13.000000 0 ONE YEAR
 13.000000
 FOR
 - -
Q32 Bio, Inc. 746964105 US7469641051 - 06/13/2025 To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve Proposal No. 2; and CORPORATE GOVERNANCE
 - ISSUER 13.000000 0 FOR
 13.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: Kevin P. Finney DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 FOR
 715.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: Michael J. Finney, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 FOR
 715.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: Elaine J. Heron, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 WITHHOLD
 715.000000
 AGAINST
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: Steven Lo DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 FOR
 715.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: W. Mark Watson DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 WITHHOLD
 715.000000
 AGAINST
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 Election of Directors: David Wheadon, M.D. DIRECTOR ELECTIONS
 - ISSUER 715.000000 0 WITHHOLD
 715.000000
 AGAINST
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 To adopt and approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of issued shares of the Company's common stock into a lesser number of shares by a ratio of not less than 1-for-5 and not more than 1-for-50, with the exact ratio to be set within this range by the board of directors of the Company in its sole discretion. CAPITAL STRUCTURE
 - ISSUER 715.000000 0 FOR
 715.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 To ratify the selection by our Audit Committee of WithumSmith+Brown, PC as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 715.000000 0 FOR
 715.000000
 FOR
 - -
Vaxart, Inc. 92243A200 US92243A2006 - 06/13/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 715.000000 0 AGAINST
 715.000000
 AGAINST
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Election of Directors: Knute P. Kurtz DIRECTOR ELECTIONS
 - ISSUER 169.000000 0 WITHHOLD
 169.000000
 AGAINST
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Election of Directors: Michael Zilis DIRECTOR ELECTIONS
 - ISSUER 169.000000 0 WITHHOLD
 169.000000
 AGAINST
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 169.000000 0 FOR
 169.000000
 FOR
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Hold an advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 169.000000 0 FOR
 169.000000
 FOR
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock from 75,000,000 to 150,000,000. CAPITAL STRUCTURE
 - ISSUER 169.000000 0 FOR
 169.000000
 FOR
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Approve an amendment to our Certificate of Incorporation to reflect Delaware Law provisions allowing for the exculpation of certain officers. CORPORATE GOVERNANCE
 - ISSUER 169.000000 0 FOR
 169.000000
 FOR
 - -
Veritone, Inc. 92347M100 US92347M1009 - 06/13/2025 Approve an amendment and restatement of the 2023 Equity Incentive Plan. COMPENSATION
 - ISSUER 169.000000 0 AGAINST
 169.000000
 AGAINST
 - -
Asana, Inc. 04342Y104 US04342Y1047 - 06/16/2025 Election of three Class II directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Andrew Lindsay DIRECTOR ELECTIONS
 - ISSUER 853.000000 0 WITHHOLD
 853.000000
 AGAINST
 - -
Asana, Inc. 04342Y104 US04342Y1047 - 06/16/2025 Election of three Class II directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lorrie Norrington DIRECTOR ELECTIONS
 - ISSUER 853.000000 0 WITHHOLD
 853.000000
 AGAINST
 - -
Asana, Inc. 04342Y104 US04342Y1047 - 06/16/2025 Election of three Class II directors to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Justin Rosenstein DIRECTOR ELECTIONS
 - ISSUER 853.000000 0 FOR
 853.000000
 FOR
 - -
Asana, Inc. 04342Y104 US04342Y1047 - 06/16/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2026. AUDIT-RELATED
 - ISSUER 853.000000 0 FOR
 853.000000
 FOR
 - -
Asana, Inc. 04342Y104 US04342Y1047 - 06/16/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 853.000000 0 FOR
 853.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Election of Directors: Juliana F. Hill DIRECTOR ELECTIONS
 - ISSUER 337.000000 0 WITHHOLD
 337.000000
 AGAINST
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Election of Directors: Gyorgy Gattyan DIRECTOR ELECTIONS
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Approve, for purposes of Nasdaq Listing Rule 5635(b), the issuance by PLBY Group, Inc. of 16,956,842 shares of its common stock, par value $0.0001 per share, at a sale price of $1.50 per share, to The Million S.a.r.l., pursuant to the terms of the Securities Purchase Agreement, dated December 14, 2024, by and between PLBY Group, Inc. and The Million S.a.r.l. CAPITAL STRUCTURE
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Approve an amendment to PLBY Group, Inc.'s Second Amended and Restated Certificate of Incorporation (the "Charter") to Increase PLBY Group, Inc.'s number of authorized shares of common stock from 150,000,000 to 400,000,000. CAPITAL STRUCTURE
 - ISSUER 337.000000 0 AGAINST
 337.000000
 AGAINST
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Approve an amendment to the Charter to change PLBY Group, Inc.'s name to "Playboy, Inc." CORPORATE GOVERNANCE
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Ratify the appointment of BDO USA, P.C. as PLBY Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 337.000000 0 FOR
 337.000000
 FOR
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 An advisory, non-binding vote to approve the compensation of PLBY Group, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 337.000000 0 AGAINST
 337.000000
 AGAINST
 - -
PLBY Group, Inc. 72814P109 US72814P1093 - 06/16/2025 Approve the adjournment of the Annual Meeting, if necessary or appropriate, to continue to solicit votes in favor of Proposals 2, 3 and/or 4 above. CORPORATE GOVERNANCE
 - ISSUER 337.000000 0 AGAINST
 337.000000
 AGAINST
 - -
Alpha Teknova, Inc. 02080L102 US02080L1026 - 06/17/2025 To elect two (2) Class I directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Martha J. Demski DIRECTOR ELECTIONS
 - ISSUER 41.000000 0 WITHHOLD
 41.000000
 AGAINST
 - -
Alpha Teknova, Inc. 02080L102 US02080L1026 - 06/17/2025 To elect two (2) Class I directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Alexander Herzick DIRECTOR ELECTIONS
 - ISSUER 41.000000 0 WITHHOLD
 41.000000
 AGAINST
 - -
Alpha Teknova, Inc. 02080L102 US02080L1026 - 06/17/2025 Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 41.000000 0 FOR
 41.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Michael Heffernan DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Garry Neil, MD DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: June Almenoff, MD, PhD DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Mitchell Chan DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Jonathan Goldman, MD DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Aaron Kantoff DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Gilla Kaplan, PhD DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To elect the eight directors nominated by our board of directors and named herein to hold office for a one-year term until the 2026 Annual Meeting of Stockholders: Samantha Truex DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To approve, on a nonbinding advisory basis, a "Say-on-Pay" resolution regarding the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Avalo Therapeutics, Inc. 05338F306 US05338F3064 - 06/17/2025 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; and AUDIT-RELATED
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 Election of Directors: Itzhak Fisher DIRECTOR ELECTIONS
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 Election of Directors: Jeff Murphy DIRECTOR ELECTIONS
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 Election of Directors: Marty Patterson DIRECTOR ELECTIONS
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The approval, on a non-binding advisory basis, of the compensation paid to the company's named executive officers SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The approval of an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares of the company's common stock available for grant by 2,000,000 COMPENSATION
 - ISSUER 20.000000 0 AGAINST
 20.000000
 AGAINST
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The adoption of an amendment to the Amended and Restated Certificate of Incorporation to increase (i) the total number of shares authorized for issuance from 118,750,000 to 121,750,000 and (ii) the number of shares of common stock authorized for issuance from 13,750,000 to 16,750,000 CAPITAL STRUCTURE
 - ISSUER 20.000000 0 FOR
 20.000000
 FOR
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The adoption of an amendment to the Certificate of Designations (the "COD") of the Series B Convertible Preferred Stock ("Series B Preferred Stock") (1) to increase the number of authorized shares designated as Series B Preferred Stock from 100,000,000 to 104,000,000 and (ii) to clarify that shares of Series B Preferred Stock issued as payment for accrued dividends on the Series B Preferred Stock, or in lieu thereof, will count toward the $100,000,000 threshold required for the company to undertake a Mandatory Conversion (as defined in the COD) CAPITAL STRUCTURE
 - ISSUER 20.000000 0 AGAINST
 20.000000
 AGAINST
 - -
comScore, Inc. 20564W204 US20564W2044 - 06/17/2025 The approval, in accordance with Nasdaq Listing Rule 5635(d), of the issuance of common stock or Series B Preferred Stock as payment for accrued dividends on the Series B Preferred Stock or in lieu thereof, if elected by the Disinterested Directors (as defined in the COD) or agreed between the Disinterested Directors and the holders of Series B Preferred Stock, as applicable CAPITAL STRUCTURE
 - ISSUER 20.000000 0 AGAINST
 20.000000
 AGAINST
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Lindsay A. Rosenwald, M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Michael S. Weiss DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 AGAINST
 28.000000
 AGAINST
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Jimmie Harvey, Jr., M.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Malcolm Hoenlein DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Dov Klein, CPA DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: J. Jay Lobell DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Election of Directors: Kevin L. Lorenz, J.D. DIRECTOR ELECTIONS
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 Ratification of the appointment of KPMG LLP as Fortress Biotech, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 The approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 The approval, on an advisory basis, of the frequency of our non-binding advisory votes approving the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 28.000000 0 ONE YEAR
 28.000000
 AGAINST
 - -
Fortress Biotech, Inc. 34960Q307 US34960Q3074 - 06/17/2025 The approval of the Second Amended and Restated Certificate of Incorporation of the Company to provide for, among other things, officer exculpation. CORPORATE GOVERNANCE
 - ISSUER 28.000000 0 FOR
 28.000000
 FOR
 - -
Kezar Life Sciences, Inc. 49372L209 US49372L2097 - 06/17/2025 Election of Directors: Elizabeth Garner, M.D. DIRECTOR ELECTIONS
 - ISSUER 21.000000 0 WITHHOLD
 21.000000
 AGAINST
 - -
Kezar Life Sciences, Inc. 49372L209 US49372L2097 - 06/17/2025 Election of Directors: Michael Kauffman, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 21.000000 0 WITHHOLD
 21.000000
 AGAINST
 - -
Kezar Life Sciences, Inc. 49372L209 US49372L2097 - 06/17/2025 Election of Directors: Courtney Wallace DIRECTOR ELECTIONS
 - ISSUER 21.000000 0 WITHHOLD
 21.000000
 AGAINST
 - -
Kezar Life Sciences, Inc. 49372L209 US49372L2097 - 06/17/2025 Advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 21.000000 0 AGAINST
 21.000000
 AGAINST
 - -
Kezar Life Sciences, Inc. 49372L209 US49372L2097 - 06/17/2025 Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 21.000000 0 FOR
 21.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: Todd J. Carter DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: Alec Cunningham DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: David Mounts Gonzales DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: Leslie V. Norwalk DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: Erin L. Russell DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: L. Heath Sampson DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 Election of Directors: Daniel B. Silvers DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 A non-binding advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
ModivCare Inc. 60783X104 US60783X1046 - 06/17/2025 To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company to serve for the 2025 fiscal year. AUDIT-RELATED
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To elect five directors to serve until the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Paul Travers DIRECTOR ELECTIONS
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To elect five directors to serve until the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Grant Russell DIRECTOR ELECTIONS
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To elect five directors to serve until the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Edward Kay DIRECTOR ELECTIONS
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To elect five directors to serve until the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Timothy Harned DIRECTOR ELECTIONS
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To elect five directors to serve until the 2026 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Paula Whitten-Doolin DIRECTOR ELECTIONS
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To ratify the appointment of Freed Maxick, CPAS, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To conduct a non-binding advisory vote on the compensation disclosed in the Proxy Statement of the Company's executive officers who are named in the Proxy Statement Summary Compensation Table. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To conduct a non-binding advisory vote on the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 349.000000 0 ONE YEAR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To approve, an amendment to our certificate of incorporation to increase our authorized shares of common stock from 100,000,000 to 200,000,000. CAPITAL STRUCTURE
 - ISSUER 349.000000 0 FOR
 349.000000
 FOR
 - -
Vuzix Corporation 92921W300 US92921W3007 - 06/17/2025 To approve, the grant of 594,056 restricted stock units (or RSUs) to executive officers and other employees of the Company under the Company's 2023 Equity Incentive Plan, including 291,878 RSUs to Paul Travers, the Company's chief executive officer, and 118,211 RSUs to Grant Russell, the Company's chief financial officer along with the cancellation of 5,089,500 unvested stock options originally granted to those Senior Officers and others on March 17, 2021. COMPENSATION
 - ISSUER 349.000000 0 AGAINST
 349.000000
 AGAINST
 - -
Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 - 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Scott Myers DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 - 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Karan Takhar DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 - 06/17/2025 Election of Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified, subject to their earlier death, resignation or removal: Luke Walker, M.D. DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 - 06/17/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Zentalis Pharmaceuticals, Inc. 98943L107 US98943L1070 - 06/17/2025 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 428.000000 0 AGAINST
 428.000000
 AGAINST
 - -
Allogene Therapeutics, Inc. 019770106 US0197701065 - 06/18/2025 Election of Directors: Elizabeth Barrett DIRECTOR ELECTIONS
 - ISSUER 811.000000 0 WITHHOLD
 811.000000
 AGAINST
 - -
Allogene Therapeutics, Inc. 019770106 US0197701065 - 06/18/2025 Election of Directors: Arie Belldegrun, M.D. DIRECTOR ELECTIONS
 - ISSUER 811.000000 0 WITHHOLD
 811.000000
 AGAINST
 - -
Allogene Therapeutics, Inc. 019770106 US0197701065 - 06/18/2025 Election of Directors: David Chang, M.D., Ph.D. DIRECTOR ELECTIONS
 - ISSUER 811.000000 0 WITHHOLD
 811.000000
 AGAINST
 - -
Allogene Therapeutics, Inc. 019770106 US0197701065 - 06/18/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 811.000000 0 FOR
 811.000000
 FOR
 - -
Allogene Therapeutics, Inc. 019770106 US0197701065 - 06/18/2025 To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 811.000000 0 FOR
 811.000000
 FOR
 - -
BioAtla, Inc. 09077B104 US09077B1044 - 06/18/2025 Elect the Class II directors listed in the accompanying Proxy Statement, to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Mary Ann Gray, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 92.000000 0 WITHHOLD
 92.000000
 AGAINST
 - -
BioAtla, Inc. 09077B104 US09077B1044 - 06/18/2025 Elect the Class II directors listed in the accompanying Proxy Statement, to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Susan Moran, M.D., M.S.C.E. DIRECTOR ELECTIONS
 - ISSUER 92.000000 0 WITHHOLD
 92.000000
 AGAINST
 - -
BioAtla, Inc. 09077B104 US09077B1044 - 06/18/2025 Elect the Class II directors listed in the accompanying Proxy Statement, to serve a three-year term expiring at the 2028 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Lawrence Steinman, M.D. DIRECTOR ELECTIONS
 - ISSUER 92.000000 0 WITHHOLD
 92.000000
 AGAINST
 - -
BioAtla, Inc. 09077B104 US09077B1044 - 06/18/2025 Ratify the appointment of Emst & Young LLP as the independent registered public accounting firm of BioAtla, Inc. for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 92.000000 0 FOR
 92.000000
 FOR
 - -
BioAtla, Inc. 09077B104 US09077B1044 - 06/18/2025 Approve, by a non-binding advisory vote, the executive compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 92.000000 0 FOR
 92.000000
 FOR
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To elect three Class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Ronald Harold Wilfred Cooper DIRECTOR ELECTIONS
 - ISSUER 460.000000 0 WITHHOLD
 460.000000
 AGAINST
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To elect three Class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Donna Grogan, M.D. DIRECTOR ELECTIONS
 - ISSUER 460.000000 0 FOR
 460.000000
 FOR
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To elect three Class II directors to our Board of Directors, each to serve until the 2028 Annual Meeting of Stockholders and until his/her successor has been duly elected and qualified, or until his/her earlier resignation or removal: Steven Hoerter DIRECTOR ELECTIONS
 - ISSUER 460.000000 0 FOR
 460.000000
 FOR
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 460.000000 0 FOR
 460.000000
 FOR
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To ratify the engagement of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 460.000000 0 FOR
 460.000000
 FOR
 - -
C4 Therapeutics, Inc. 12529R107 US12529R1077 - 06/18/2025 To approve an amendment to our Fifth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000 CAPITAL STRUCTURE
 - ISSUER 460.000000 0 FOR
 460.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Election of Directors: A. John Hass, III DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Election of Directors: Francis S. Soistman DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Election of Directors: Aaron C. Tolson DIRECTOR ELECTIONS
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of eHealth, Inc. for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Approval, on an advisory basis, of the compensation of the Named Executive Officers of eHealth, Inc. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 145.000000 0 FOR
 145.000000
 FOR
 - -
eHealth, Inc. 28238P109 US28238P1093 - 06/18/2025 Approval of an amendment and restatement of the eHealth, Inc. 2024 Equity Incentive Plan to increase the maximum number of shares of common stock that may be issued thereunder by 1,500,000 shares. COMPENSATION
 - ISSUER 145.000000 0 AGAINST
 145.000000
 AGAINST
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: Matthew Conlin DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: James P. Geygan DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: David A. Graff DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: Barbara Shattuck Kohn DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: Donald Mathis DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: Richard C. Pfenniger, Jr. DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 To elect seven directors: Ryan Schulke DIRECTOR ELECTIONS
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve, on an advisory basis, the 2024 compensation of the Company's named executive officers (Say-on-Pay). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve, for the purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of November 29, 2024 to certain of the Company's directors and/or officers and any shares of the Company's common stock issuable upon exercise thereof. CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve, for the purposes of complying with Nasdaq Listing Rules 5635(b) and 5635(c), pre-funded warrants issued pursuant to those certain securities purchase agreements dated as of March 19, 2025 to certain of the Company's directors and/or officers and any shares of the Company's common stock issuable upon exercise thereof. CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve, for the purposes of complying with Nasdaq Listing Rules 5635(b), 5635(c) and 5635(d), convertible subordinated promissory notes issued pursuant to those certain securities purchase agreements dated as of August 19, 2024 to certain of the Company's directors and/or officers, and in certain cases affiliates of such persons, and a principal stockholder of the Company and the conversion of such notes into shares of the Company's common stock in excess of the share cap on conversion and any future adjustments of the Conversion Price of such notes. CAPITAL STRUCTURE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve an amendment to the Fluent, Inc. 2022 Omnibus Equity Incentive Plan to increase the number of shares of common stock reserved thereunder to 3,666,666 shares from 1,666,666 shares. COMPENSATION
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Fluent, Inc. 34380C201 US34380C2017 - 06/18/2025 Approve the adjournment of the annual meeting, if necessary or advisable, to solicit additional proxies in favor of any of the foregoing proposals if there are not sufficient votes to approve any such proposals. CORPORATE GOVERNANCE
 - ISSUER 43.000000 0 FOR
 43.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Jeffrey Siegel DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Robert B. Kay DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Jeffrey H. Evans DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Rachael A. Jarosh DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Cherrie Nanninga DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Craig Phillips DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Veronique Gabai-Pinsky DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Bruce G. Pollack DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Michael J. Regan DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 ELECTION OF DIRECTORS: Michael Schnabel DIRECTOR ELECTIONS
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025. AUDIT-RELATED
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lifetime Brands, Inc. 53222Q103 US53222Q1031 - 06/18/2025 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE 2024 COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 75.000000 0 FOR
 75.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 06/18/2025 Election of Class A Directors: Stanley N. Lapidus DIRECTOR ELECTIONS
 - ISSUER 39.000000 0 WITHHOLD
 39.000000
 AGAINST
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 06/18/2025 Election of Class A Directors: Jacque J. Sokolov, M.D. DIRECTOR ELECTIONS
 - ISSUER 39.000000 0 WITHHOLD
 39.000000
 AGAINST
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 06/18/2025 Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock under the Senior Secured Convertible Notes sold by the Company in a private offering in November 2024. CAPITAL STRUCTURE
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
Lucid Diagnostics Inc. 54948X109 US54948X1090 - 06/18/2025 Ratification of the appointment of the independent registered certified public accounting firm. AUDIT-RELATED
 - ISSUER 39.000000 0 FOR
 39.000000
 FOR
 - -
MiNK Therapeutics, Inc. 603693201 US6036932019 - 06/18/2025 To elect Jennifer Buell and Ulf Wiinberg as Class I directors, each for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Jennifer Buell DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 WITHHOLD
 1.000000
 AGAINST
 - -
MiNK Therapeutics, Inc. 603693201 US6036932019 - 06/18/2025 To elect Jennifer Buell and Ulf Wiinberg as Class I directors, each for a term of three years expiring at the 2028 Annual Meeting of Stockholders: Ulf Wiinberg DIRECTOR ELECTIONS
 - ISSUER 1.000000 0 WITHHOLD
 1.000000
 AGAINST
 - -
MiNK Therapeutics, Inc. 603693201 US6036932019 - 06/18/2025 To approve the option exchange proposal. COMPENSATION
 - ISSUER 1.000000 0 AGAINST
 1.000000
 AGAINST
 - -
MiNK Therapeutics, Inc. 603693201 US6036932019 - 06/18/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1.000000 0 FOR
 1.000000
 FOR
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Election of Class I Directors: Christina C. Correia DIRECTOR ELECTIONS
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Election of Class I Directors: Stephen A. Skaggs DIRECTOR ELECTIONS
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Election of Class I Directors: Ernest E. Maddock DIRECTOR ELECTIONS
 - ISSUER 112.000000 0 WITHHOLD
 112.000000
 AGAINST
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
Ouster, Inc. 68989M202 US68989M2026 - 06/18/2025 Approval of an amendment to the Company's Certificate of Incorporation, as amended, to provide for exculpation of officers from breaches of fiduciary duty to the extent permitted by the General Corporation Law of the State of Delaware. CORPORATE GOVERNANCE
 - ISSUER 112.000000 0 FOR
 112.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Election of Class C Directors: Lishan Aklog, M.D. DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 WITHHOLD
 29.000000
 AGAINST
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Election of Class C Directors: Michael J. Glennon DIRECTOR ELECTIONS
 - ISSUER 29.000000 0 WITHHOLD
 29.000000
 AGAINST
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon exercise of the pre-funded warrants sold by the Company in a private offering in February 2025. CAPITAL STRUCTURE
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Approval of an amendment to the Company's 2014 Long-Term Incentive Equity Plan to increase the total number of shares of the Company's common stock available under the 2014 Plan by an additional 2,500,000 shares, to 4,912,140 shares COMPENSATION
 - ISSUER 29.000000 0 AGAINST
 29.000000
 AGAINST
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Approval, on an advisory basis, of the compensation of the Company's principal executive officer and two highest-paid executive officers other than the principal executive officer, as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
PAVmed Inc. 70387R403 US70387R4039 - 06/18/2025 Ratification of the appointment of the independent registered certified public accounting firm. AUDIT-RELATED
 - ISSUER 29.000000 0 FOR
 29.000000
 FOR
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 06/18/2025 The election of Class I directors named in the proxy statement: Santhosh Palani, Ph.D., CFA DIRECTOR ELECTIONS
 - ISSUER 62.000000 0 WITHHOLD
 62.000000
 AGAINST
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 06/18/2025 The election of Class I directors named in the proxy statement: Darren Cline DIRECTOR ELECTIONS
 - ISSUER 62.000000 0 WITHHOLD
 62.000000
 AGAINST
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 06/18/2025 The election of Class I directors named in the proxy statement: Rachel Humphrey, M.D. DIRECTOR ELECTIONS
 - ISSUER 62.000000 0 WITHHOLD
 62.000000
 AGAINST
 - -
Pyxis Oncology, Inc. 747324101 US7473241013 - 06/18/2025 The ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 62.000000 0 FOR
 62.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 06/18/2025 Election of Directors: Zachary Bogue, J.D. DIRECTOR ELECTIONS
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 06/18/2025 Election of Directors: Zavain Dar DIRECTOR ELECTIONS
 - ISSUER 1343.000000 0 WITHHOLD
 1343.000000
 AGAINST
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 06/18/2025 Election of Directors: Robert Hershberg, M.D. Ph.D. DIRECTOR ELECTIONS
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 06/18/2025 Advisory vote to approve executive compensation as disclosed in the 2025 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Recursion Pharmaceuticals, Inc. 75629V104 US75629V1044 - 06/18/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 1343.000000 0 FOR
 1343.000000
 FOR
 - -
Standard BioTools Inc. 34385P108 US34385P1084 - 06/18/2025 Election of Directors: Kathy Hibbs DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Standard BioTools Inc. 34385P108 US34385P1084 - 06/18/2025 Election of Directors: Frank Witney, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Standard BioTools Inc. 34385P108 US34385P1084 - 06/18/2025 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Standard BioTools Inc. 34385P108 US34385P1084 - 06/18/2025 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 454.000000 0 FOR
 454.000000
 FOR
 - -
Standard BioTools Inc. 34385P108 US34385P1084 - 06/18/2025 To approve an amendment to our Amended and Restated 2011 Equity Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 17,400,000 shares. COMPENSATION
 - ISSUER 454.000000 0 AGAINST
 454.000000
 AGAINST
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 Election of Directors: Darren Lampert DIRECTOR ELECTIONS
 - ISSUER 647.000000 0 FOR
 647.000000
 FOR
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 Election of Directors: Michael Salaman DIRECTOR ELECTIONS
 - ISSUER 647.000000 0 FOR
 647.000000
 FOR
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 Election of Directors: Eula Adams DIRECTOR ELECTIONS
 - ISSUER 647.000000 0 WITHHOLD
 647.000000
 AGAINST
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 Election of Directors: Stephen Aiello DIRECTOR ELECTIONS
 - ISSUER 647.000000 0 WITHHOLD
 647.000000
 AGAINST
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 Election of Directors: Starlett Carter DIRECTOR ELECTIONS
 - ISSUER 647.000000 0 FOR
 647.000000
 FOR
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 To provide an advisory vote to approve the compensation paid to the Company's named executive officers pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 647.000000 0 FOR
 647.000000
 FOR
 - -
GrowGeneration Corp. 39986L109 US39986L1098 - 06/19/2025 To approve and ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm to audit the Company's financial statements as of December 31, 2025 and for the fiscal years then ending. AUDIT-RELATED
 - ISSUER 647.000000 0 FOR
 647.000000
 FOR
 - -
Aeva Technologies, Inc. 00835Q202 US00835Q2021 - 06/20/2025 Election of Class I Directors: Stefan Sommer, Ph. D. DIRECTOR ELECTIONS
 - ISSUER 246.000000 0 WITHHOLD
 246.000000
 AGAINST
 - -
Aeva Technologies, Inc. 00835Q202 US00835Q2021 - 06/20/2025 Election of Class I Directors: Katherine Motlagh DIRECTOR ELECTIONS
 - ISSUER 246.000000 0 FOR
 246.000000
 FOR
 - -
Aeva Technologies, Inc. 00835Q202 US00835Q2021 - 06/20/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 246.000000 0 FOR
 246.000000
 FOR
 - -
Aeva Technologies, Inc. 00835Q202 US00835Q2021 - 06/20/2025 Approval, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 246.000000 0 AGAINST
 246.000000
 AGAINST
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Election of Directors: Betsy Atkins DIRECTOR ELECTIONS
 - ISSUER 324.000000 0 FOR
 324.000000
 FOR
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Election of Directors: Mitchell Garber DIRECTOR ELECTIONS
 - ISSUER 324.000000 0 WITHHOLD
 324.000000
 AGAINST
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Election of Directors: Anthony Roberts DIRECTOR ELECTIONS
 - ISSUER 324.000000 0 FOR
 324.000000
 FOR
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Election of Directors: Anthony Scott DIRECTOR ELECTIONS
 - ISSUER 324.000000 0 FOR
 324.000000
 FOR
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 324.000000 0 FOR
 324.000000
 FOR
 - -
Rackspace Technology, Inc. 750102105 US7501021056 - 06/20/2025 Non-binding advisory vote to approve the compensation of the Company's named executive officers as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 324.000000 0 AGAINST
 324.000000
 AGAINST
 - -
Scilex Holding Company 80880W205 US80880W2052 - 06/20/2025 Election of Directors: Henry Ji, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 14.000000 0 WITHHOLD
 14.000000
 AGAINST
 - -
Scilex Holding Company 80880W205 US80880W2052 - 06/20/2025 Election of Directors: Jaisim Shah DIRECTOR ELECTIONS
 - ISSUER 14.000000 0 WITHHOLD
 14.000000
 AGAINST
 - -
Scilex Holding Company 80880W205 US80880W2052 - 06/20/2025 Proposal to ratify the appointment of BPM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 14.000000 0 FOR
 14.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Robert Ades DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Michael J. Driscoll DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Prathyusha Duraibabu DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Jon Giacomin DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Gary S. Gillheeney, Sr. DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Michele Korfin DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Arthur S. Leibowitz DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Glenn H. Nussdorf DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Election of Directors: Gilberto Quintero DIRECTOR ELECTIONS
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2025 annual meeting of shareholders. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Approval of the issuance of, or in excess of, 20% of the Company's outstanding Class A common stock upon the conversion of the Company's Series A Convertible Preferred Stock at less than the "minimum price under Nasdaq Listing Rule 5635(d), and which may be deemed a "change of control" under Nasdaq Listing Rule 5635(b) or any successor rule, pursuant to the terms of the Certificate of Designations of Series A Convertible Preferred Stock governing the Series A Convertible Preferred Stock. CAPITAL STRUCTURE
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Organogenesis Holdings Inc. 68621F102 US68621F1021 - 06/23/2025 Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED
 - ISSUER 379.000000 0 FOR
 379.000000
 FOR
 - -
Telesis Bio Inc. 192003200 US1920032000 - 06/23/2025 Amend Certificate of Incorporation CORPORATE GOVERNANCE
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
Telesis Bio Inc. 192003200 US1920032000 - 06/23/2025 Amend Bylaws CORPORATE GOVERNANCE
 - ISSUER 3.000000 0 FOR
 3.000000
 FOR
 - -
Telesis Bio Inc. 192003200 US1920032000 - 06/23/2025 Approve Omnibus Stock Plan COMPENSATION
 - ISSUER 3.000000 0 AGAINST
 3.000000
 AGAINST
 - -
Erasca, Inc. 29479A108 US29479A1088 - 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Jonathan E. Lim, M.D. DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 FOR
 335.000000
 FOR
 - -
Erasca, Inc. 29479A108 US29479A1088 - 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: James A. Bristol, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 WITHHOLD
 335.000000
 AGAINST
 - -
Erasca, Inc. 29479A108 US29479A1088 - 06/24/2025 To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Valerie Harding - Start, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 335.000000 0 WITHHOLD
 335.000000
 AGAINST
 - -
Erasca, Inc. 29479A108 US29479A1088 - 06/24/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 AUDIT-RELATED
 - ISSUER 335.000000 0 FOR
 335.000000
 FOR
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 06/24/2025 To elect three (3) nominees as Class B directors, each to serve three-year terms expiring in 2028 and to hold office until his/her successor is duly elected and qualified: Christopher Hayes DIRECTOR ELECTIONS
 - ISSUER 78.000000 0 WITHHOLD
 78.000000
 AGAINST
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 06/24/2025 To elect three (3) nominees as Class B directors, each to serve three-year terms expiring in 2028 and to hold office until his/her successor is duly elected and qualified: Clara Nagy McBane DIRECTOR ELECTIONS
 - ISSUER 78.000000 0 WITHHOLD
 78.000000
 AGAINST
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 06/24/2025 To elect three (3) nominees as Class B directors, each to serve three-year terms expiring in 2028 and to hold office until his/her successor is duly elected and qualified: Shawn Kravetz DIRECTOR ELECTIONS
 - ISSUER 78.000000 0 FOR
 78.000000
 FOR
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 06/24/2025 To approve, in an advisory and non-binding vote, the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 78.000000 0 AGAINST
 78.000000
 AGAINST
 - -
Spruce Power Holding Corporation 9837FR209 US9837FR2091 - 06/24/2025 To ratify the appointment of CohnReznick, LLP, as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 78.000000 0 FOR
 78.000000
 FOR
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 Election of three Class II directors to hold office until our 2028 annual meeting of stockholders: K. Peter Hirth, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 5.000000 0 FOR
 5.000000
 FOR
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 Election of three Class II directors to hold office until our 2028 annual meeting of stockholders: Heather Preston, M.D. DIRECTOR ELECTIONS
 - ISSUER 5.000000 0 FOR
 5.000000
 FOR
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 Election of three Class II directors to hold office until our 2028 annual meeting of stockholders: Margarita Chavez, J.D. DIRECTOR ELECTIONS
 - ISSUER 5.000000 0 FOR
 5.000000
 FOR
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 The ratification of the appointment, by the Audit Committee of our Board, of Ernst & Young LLP, as our independent registered public accounting firm for the year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 5.000000 0 FOR
 5.000000
 FOR
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 The amendment of our 2020 Plan to increase the number of shares reserved and scheduled to be reserved under the 2020 Plan by 1,000,000 shares; COMPENSATION
 - ISSUER 5.000000 0 AGAINST
 5.000000
 AGAINST
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 The amendment of our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of voting common stock from 20,000,000 shares to 100,000,000 shares; and CAPITAL STRUCTURE
 - ISSUER 5.000000 0 AGAINST
 5.000000
 AGAINST
 - -
Aligos Therapeutics, Inc. 01626L204 US01626L2043 - 06/25/2025 The amendment of our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of non-voting common stock from 800,000 shares to 15,800,000 shares. CAPITAL STRUCTURE
 - ISSUER 5.000000 0 AGAINST
 5.000000
 AGAINST
 - -
Arvinas, Inc. 04335A105 US04335A1051 - 06/25/2025 Election of three Class I directors: Linda Bain DIRECTOR ELECTIONS
 - ISSUER 548.000000 0 WITHHOLD
 548.000000
 AGAINST
 - -
Arvinas, Inc. 04335A105 US04335A1051 - 06/25/2025 Election of three Class I directors: John Houston, Ph.D. DIRECTOR ELECTIONS
 - ISSUER 548.000000 0 WITHHOLD
 548.000000
 AGAINST
 - -
Arvinas, Inc. 04335A105 US04335A1051 - 06/25/2025 Election of three Class I directors: Laurie Smaldone Alsup, M.D. DIRECTOR ELECTIONS
 - ISSUER 548.000000 0 WITHHOLD
 548.000000
 AGAINST
 - -
Arvinas, Inc. 04335A105 US04335A1051 - 06/25/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Arvinas, Inc. 04335A105 US04335A1051 - 06/25/2025 Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 548.000000 0 FOR
 548.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 06/25/2025 Election of Directors: Richard J. Lampen DIRECTOR ELECTIONS
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 06/25/2025 Election of Directors: Wilson L. White DIRECTOR ELECTIONS
 - ISSUER 449.000000 0 WITHHOLD
 449.000000
 AGAINST
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 06/25/2025 Approval of ratification of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2025: AUDIT-RELATED
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Douglas Elliman Inc. 25961D105 US25961D1054 - 06/25/2025 Advisory vote on executive compensation (the "say-on-pay" vote): SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 449.000000 0 FOR
 449.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Efron DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Herendeen DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Scott Hirsch DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Sophia Langlois DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Andy Pasternak DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Marc Yoskowitz DIRECTOR ELECTIONS
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve, on an advisory basis, the frequency of soliciting an advisory say-on-pay vote (say-on-frequency). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 2262.000000 0 ONE YEAR
 2262.000000
 FOR
 - -
Endo, Inc. 29290D117 US29290D1173 - 06/25/2025 To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm's remuneration. AUDIT-RELATED
 - ISSUER 2262.000000 0 FOR
 2262.000000
 FOR
 - -
Inozyme Pharma, Inc. 45790W108 US45790W1080 - 06/25/2025 The election of three Class II directors each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Sarah Bhagat DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Inozyme Pharma, Inc. 45790W108 US45790W1080 - 06/25/2025 The election of three Class II directors each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Reinaldo Diaz DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Inozyme Pharma, Inc. 45790W108 US45790W1080 - 06/25/2025 The election of three Class II directors each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Erik Harris DIRECTOR ELECTIONS
 - ISSUER 0.000000 0 - -
Inozyme Pharma, Inc. 45790W108 US45790W1080 - 06/25/2025 The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 0.000000 0 - -
LivePerson, Inc. 538146101 US5381461012 - 06/25/2025 Election of two Class I directors to serve until the 2028 Annual Meeting of Stockholders and until such director's successor shall have been duly elected and qualified: Vanessa Pegueros DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 06/25/2025 Election of two Class I directors to serve until the 2028 Annual Meeting of Stockholders and until such director's successor shall have been duly elected and qualified: William G. Wesemann DIRECTOR ELECTIONS
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 06/25/2025 Ratification of the appointment of BDO USA, P.C. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 06/25/2025 Advisory approval of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
LivePerson, Inc. 538146101 US5381461012 - 06/25/2025 Approval of an amendment to the 2019 Stock Incentive Plan, including to increase the number of shares available for issuance thereunder and to make certain other changes thereto. COMPENSATION
 - ISSUER 775.000000 0 FOR
 775.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Elect five directors to serve on our Board of Directors for a one-year term of office expiring at the 2026 Annual Meeting of Stockholders: Ritsaart J. M. van Montfrans DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Elect five directors to serve on our Board of Directors for a one-year term of office expiring at the 2026 Annual Meeting of Stockholders: Michael C. Battaglia DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Elect five directors to serve on our Board of Directors for a one-year term of office expiring at the 2026 Annual Meeting of Stockholders: Aviv Hillo DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Elect five directors to serve on our Board of Directors for a one-year term of office expiring at the 2026 Annual Meeting of Stockholders: Jack Levine DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 WITHHOLD
 428.000000
 AGAINST
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Elect five directors to serve on our Board of Directors for a one-year term of office expiring at the 2026 Annual Meeting of Stockholders: Martha J. Crawford DIRECTOR ELECTIONS
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Approve, on a non-binding advisory basis, the compensation paid to our executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Blink Charging Co. 09354A100 US09354A1007 - 06/26/2025 Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 428.000000 0 FOR
 428.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Election of Directors: Jill Avery DIRECTOR ELECTIONS
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Election of Directors: Michael Murray DIRECTOR ELECTIONS
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Election of Directors: David Nieuwsma DIRECTOR ELECTIONS
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Election of Directors: Margaret Seif DIRECTOR ELECTIONS
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Election of Directors: Paul Walsh, Jr. DIRECTOR ELECTIONS
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Proposal to amend the Company's 2020 Equity Incentive Plan to increase the number of shares of our Common Stock authorized for issuance thereunder from 14,000,000 to 19,000,000 shares. COMPENSATION
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 A proposal to Amend the Certificate of Incorporation to increase the number of shares of our common stock from 200,000,000 to 275,000,000. CAPITAL STRUCTURE
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 Proposal to ratify the appointment of BDO USA as the independent registered public accounting firm of the Company for the current fiscal year ending December 27, 2025. AUDIT-RELATED
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Kopin Corporation 500600101 US5006001011 - 06/26/2025 An advisory vote to approve the compensation of the Company's named executive officers, during the fiscal year ended December 28, 2024. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 462.000000 0 FOR
 462.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Geoffrey T. Barker DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Maile Naylor DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 WITHHOLD
 37.000000
 AGAINST
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Patrick Gaston DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Gregory Graves DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Laird Hamilton DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Grant LaMontagne DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Election of Directors: Jason Vieth DIRECTOR ELECTIONS
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Laird Superfood, Inc. 50736T102 US50736T1025 - 06/26/2025 Ratification of the appointment of KPMG LLP as the independent registered public accounting firm. AUDIT-RELATED
 - ISSUER 37.000000 0 FOR
 37.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Dipti Amin DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Deborah Andrews DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Neal C. Bradsher DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Brian M. Culley DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Anula Jayasuriya DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael H. Mulroy DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To elect seven directors to hold office until the 2026 annual meeting of shareholders and until their respective successors are duly elected and qualified: Angus C. Russell DIRECTOR ELECTIONS
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 747.000000 0 FOR
 747.000000
 FOR
 - -
Lineage Cell Therapeutics, Inc. 53566P109 US53566P1093 - 06/26/2025 To approve an amendment to the Lineage Cell Therapeutics, Inc. 2021 Equity Incentive Plan to increase the number of common shares available thereunder by 19,500,000. COMPENSATION
 - ISSUER 747.000000 0 AGAINST
 747.000000
 AGAINST
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 06/26/2025 Election of Class II directors to serve until our 2028 meeting of stockholders: Georges Antoun DIRECTOR ELECTIONS
 - ISSUER 1115.000000 0 WITHHOLD
 1115.000000
 AGAINST
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 06/26/2025 Election of Class II directors to serve until our 2028 meeting of stockholders: Jay Leupp DIRECTOR ELECTIONS
 - ISSUER 1115.000000 0 WITHHOLD
 1115.000000
 AGAINST
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 06/26/2025 Ratification of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED
 - ISSUER 1115.000000 0 FOR
 1115.000000
 FOR
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 06/26/2025 Non-binding, advisory vote on the compensation of our Named Executive Officers ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 1115.000000 0 AGAINST
 1115.000000
 AGAINST
 - -
MARA Holdings, Inc. 565788106 US5657881067 - 06/26/2025 Approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (the "2018 Plan") to increase the number of shares of our common stock reserved under the 2018 Plan by 18 million shares. COMPENSATION
 - ISSUER 1115.000000 0 FOR
 1115.000000
 FOR
 - -
Praxis Precision Medicines, Inc. 74006W207 US74006W2070 - 06/26/2025 To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Jeffrey Chodakewitz, M.D. DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 WITHHOLD
 12.000000
 AGAINST
 - -
Praxis Precision Medicines, Inc. 74006W207 US74006W2070 - 06/26/2025 To elect the Class II Directors to serve until the 2028 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Merit Cudkowicz, M.D. DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Praxis Precision Medicines, Inc. 74006W207 US74006W2070 - 06/26/2025 To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Praxis Precision Medicines, Inc. 74006W207 US74006W2070 - 06/26/2025 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Randal Kirk DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Cesar Alvarez DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 AGAINST
 565.000000
 AGAINST
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Steven Frank DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Vinita Gupta DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Fred Hassan DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Jeffrey Kindler DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Nancy Howell Agee DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: Helen Sabzevari DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Election of Directors: James Turley DIRECTOR ELECTIONS
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal Approval of an amendment to the Company's Amended and Restated Articles of Incorporation to increase the Company's authorized shares of common stock. CAPITAL STRUCTURE
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Approval, in compliance with Nasdaq Listing Rule 5635(c), of the additional issuance of shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors. CAPITAL STRUCTURE
 - ISSUER 565.000000 0 AGAINST
 565.000000
 AGAINST
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Approval of an amendment to the 2023 Omnibus Incentive Plan. COMPENSATION
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Precigen, Inc. 74017N105 US74017N1054 - 06/26/2025 Company Proposal - Approval of an amendment to the 2019 Incentive Plan for Non-Employee Service Providers. COMPENSATION
 - ISSUER 565.000000 0 FOR
 565.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To elect the following four (4) director nominees, each to serve until the 2026 annual meeting of shareholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal: Joshua Riggs DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To elect the following four (4) director nominees, each to serve until the 2026 annual meeting of shareholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal: Andrew Arno DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To elect the following four (4) director nominees, each to serve until the 2026 annual meeting of shareholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal: Andrew J. Last DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To elect the following four (4) director nominees, each to serve until the 2026 annual meeting of shareholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal: Louis E. Silverman DIRECTOR ELECTIONS
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To ratify the appointment of CBIZ CPAS P.C. as Oncocyte's independent registered public accounting firm for the year ending December 31, 2025; AUDIT-RELATED
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To approve, on a non-binding advisory basis, Oncocyte's named executive officer compensation for the year ended December 31, 2024; and SECTION 14A SAY-ON-PAY VOTES
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Oncocyte Corporation 68235C206 US68235C2061 - 06/27/2025 To approve an amendment to the Oncocyte Corporation Amended and Restated 2018 Equity Incentive Plan to increase the total number of shares of the Company's common stock authorized for issuance under such plan by 1,500,000, to a total of 3,800,000 shares. COMPENSATION
 - ISSUER 17.000000 0 FOR
 17.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Benjamin (Ben) Gagnon DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Brian Howlett DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Edith M. Hofmeister DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Fanny Philip DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Amy Freedman DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Elect Director Andrew J. Chang DIRECTOR ELECTIONS
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Approve PricewaterhouseCoopers LLP as Auditors and Authorize Board to Fix Their Remuneration AUDIT-RELATED
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Approve Omnibus Long-Term Equity Incentive Plan COMPENSATION
 - ISSUER 12.000000 0 AGAINST
 12.000000
 AGAINST
 - -
Bitfarms Ltd. 09173B107 CA09173B1076 - 06/30/2025 Approve Share Consolidation CAPITAL STRUCTURE
 - ISSUER 12.000000 0 FOR
 12.000000
 FOR
 - -
CuriosityStream Inc. 23130Q107 US23130Q1076 - 06/30/2025 To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their respective successors are duly elected and qualified: John Hendricks DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 WITHHOLD
 155.000000
 AGAINST
 - -
CuriosityStream Inc. 23130Q107 US23130Q1076 - 06/30/2025 To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their respective successors are duly elected and qualified: Clint Stinchcomb DIRECTOR ELECTIONS
 - ISSUER 155.000000 0 WITHHOLD
 155.000000
 AGAINST
 - -
CuriosityStream Inc. 23130Q107 US23130Q1076 - 06/30/2025 To approve an amendment to the CuriosityStream Inc. 2020 Omnibus Incentive Plan (the Plan) to increase the number of shares of Common Stock authorized for issuance under the Plan from 7,725,000 shares of Common Stock to 10,725,000 shares of Common Stock. COMPENSATION
 - ISSUER 155.000000 0 AGAINST
 155.000000
 AGAINST
 - -
CuriosityStream Inc. 23130Q107 US23130Q1076 - 06/30/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED
 - ISSUER 155.000000 0 FOR
 155.000000
 FOR
 - -
CuriosityStream Inc. 23130Q107 US23130Q1076 - 06/30/2025 To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated votes at the time of the Annual Meeting, there are insufficient shares of our capital stock represented, either in person or by proxy, to constitute a quorum necessary to conduct business at the Annual Meeting or to approve Proposal No. 2. CORPORATE GOVERNANCE
 - ISSUER 155.000000 0 AGAINST
 155.000000
 AGAINST
 - -

[Repeat as Necessary]